{"layout": 0, "type": "text", "text": "Regulation of Cosmetics ", "text_level": 1, "page_idx": 0, "bbox": [162, 268, 452, 296], "page_size": [612.0, 792.0]}
{"layout": 1, "type": "text", "text": "Australia •   Brazil  • Canada • China • European Union  France • Germany • Israel   $\\bullet$   Japan   $\\bullet$   Sweden         Turkey   $\\bullet$   United Kingdom  ", "page_idx": 0, "bbox": [149.6300048828125, 342.29962158203125, 471.6480712890625, 389.5640869140625], "page_size": [612.0, 792.0]}
{"layout": 2, "type": "text", "text": "February 2020  ", "page_idx": 0, "bbox": [261.873291015625, 434.7703857421875, 359, 452.8539123535156], "page_size": [612.0, 792.0]}
{"layout": 3, "type": "text", "text": "LL File No. 2020-018501 LRA-D-PUB-001372  ", "page_idx": 0, "bbox": [247.9600067138672, 650.9017333984375, 363.92425537109375, 677.036865234375], "page_size": [612.0, 792.0]}
{"layout": 4, "type": "text", "text": "This report is provided for reference purposes only.  It does not constitute legal advice and does not represent the official  opinion of the United States Government. The information provided  reflects research undertaken as of the date of writing.   It has not been updated. ", "page_idx": 1, "bbox": [142, 350.4826354980469, 472, 421.3716735839844], "page_size": [612.0, 792.0]}
{"layout": 5, "type": "text", "text": "Contents  ", "text_level": 1, "page_idx": 2, "bbox": [71, 74, 136, 89], "page_size": [612.0, 792.0]}
{"layout": 6, "type": "text", "text": "Comparative Summary ............................................................................................................................. 1    Australia ...................................................................................................................................................... 4    Brazil .......................................................................................................................................................... 12    Canada  ....................................................................................................................................................... 17    China  .......................................................................................................................................................... 32    European Union ....................................................................................................................................... 37    France  ......................................................................................................................................................... 46    Germany  .................................................................................................................................................... 47    Israel  ........................................................................................................................................................... 49    Japan .......................................................................................................................................................... 59    Sweden ...................................................................................................................................................... 68    Turkey  ........................................................................................................................................................ 72    United Kingdom ...................................................................................................................................... 79  ", "page_idx": 2, "bbox": [72, 119.46170043945312, 542, 460.77703857421875], "page_size": [612.0, 792.0]}
{"layout": 7, "type": "text", "text": "Comparative Summary  ", "text_level": 1, "page_idx": 3, "bbox": [215, 73, 396, 92], "page_size": [612.0, 792.0]}
{"layout": 8, "type": "text", "text": "Elizabeth Boomer  Legal Research Analyst ", "page_idx": 3, "bbox": [253.92015075683594, 98.58169555664062, 358.00946044921875, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 9, "type": "text", "text": "I.  Introduction  ", "text_level": 1, "page_idx": 3, "bbox": [71, 152, 156, 165], "page_size": [612.0, 792.0]}
{"layout": 10, "type": "text", "text": "This report by the foreign law research staff of the Law Library of Congress’s Global Legal  Research Directorate surveys the regulation of cosmetics in eleven countries and in the European  Union (EU). While there is not a binding international agreement or organization regulating the  registration, safety standards, adverse event reporting, labeling, or manufacturing practices of  cosmetics, several jurisdictions follow internationally recognized standards and guidelines, and  participate in international cooperation arrangements in the area of cosmetics regulation.   ", "page_idx": 3, "bbox": [71, 180.36172485351562, 542, 261.9383850097656], "page_size": [612.0, 792.0]}
{"layout": 11, "type": "text", "text": "A.  Regulation of Cosmetics through Sector-Specific Legislation and Regulations  ", "text_level": 1, "page_idx": 3, "bbox": [72, 276, 477, 288], "page_size": [612.0, 792.0]}
{"layout": 12, "type": "text", "text": "Brazil, Canada , and  Israel  regulate the registration of cosmetics facilities, cosmetic safety review,  cosmetic substantiation standards, adverse event reporting, cosmetics labeling, and good  manufacturing practices through specific domestic legislation pertaining to cosmetics. These  three jurisdictions also adhere to the International Standard Organization (ISO) 22716:2007  standard, discussed below.       ", "page_idx": 3, "bbox": [71, 302.5197448730469, 542, 370.4768371582031], "page_size": [612.0, 792.0]}
{"layout": 13, "type": "text", "text": "B.  Non-Sector-Specific Approaches to the Regulation of Cosmetics  ", "text_level": 1, "page_idx": 3, "bbox": [72, 384, 408, 397], "page_size": [612.0, 792.0]}
{"layout": 14, "type": "text", "text": "Two jurisdictions surveyed regulate cosmetics under broad regulatory statutes not solely  targeting cosmetics.  Japan  regulates “cosmetic products” under its Pharmaceutical and Medical  Devices Act; cosmetic products include cosmetics (beauty products) and quasi-pharmaceutical  products (medicated beauty products that have mild effects on the body). The Ministry of Health,  Labour and Welfare oversees issues regarding licensing, good manufacturing practices,  marketing approvals, safety and quality standards, supervision, adverse event reporting, and  labeling.  Australia  primarily regulates cosmetics through its system for regulating the  importation and manufacture of chemicals, as well as through domestic consumer protection and  competition laws.       ", "page_idx": 3, "bbox": [71, 411.0592956542969, 542, 533.676025390625], "page_size": [612.0, 792.0]}
{"layout": 15, "type": "text", "text": "C.  EU Cosmetics Regulation   ", "text_level": 1, "page_idx": 3, "bbox": [71, 547, 216, 559], "page_size": [612.0, 792.0]}
{"layout": 16, "type": "text", "text": "In the  European Union , and among the current and former EU jurisdictions surveyed ( France ,  Germany ,  Sweden  and the  United Kingdom  [UK]), cosmetics are either directly or principally  regulated by the EU Cosmetics Regulation, which sets forth detailed requirements concerning  safety, labeling, manufacturing procedures, and adverse event reporting. Issues regarding  cosmetics that fall outside of the scope of the EU Cosmetics Regulation are regulated at the  national level.  The legal framework regulating cosmetics in  Turkey  is also largely harmonized  with the EU Cosmetics Regulation.   ", "page_idx": 3, "bbox": [71, 573.8993530273438, 542, 669.1588745117188], "page_size": [612.0, 792.0]}
{"layout": 17, "type": "text", "text": "D.  New and Pending Legislation and Regulations  ", "text_level": 1, "page_idx": 4, "bbox": [71, 85, 325, 100], "page_size": [612.0, 792.0]}
{"layout": 18, "type": "text", "text": "New and pending legislation and regulations regarding cosmetics have recently been introduced  in  China  and  Australia .  With its new legislation coming into effect later this year, Australia will  continue its non-sector-specific approach to the regulation of cosmetics through the scheme  established by the Industrial Chemicals Act, as well as other areas of applicable domestic law. In  China, the new regulations will establish a “responsible person” who will be responsible for the  quality, safety, and efficacy of cosmetic products.   ", "page_idx": 4, "bbox": [71, 113.04074096679688, 542, 194.67782592773438], "page_size": [612.0, 792.0]}
{"layout": 19, "type": "text", "text": "In addition, four of the jurisdictions surveyed have recently introduced new regulations to  progressively reduce or prohibit the use of microbeads or microplastics in cosmetics in an effort  to protect the environment.    ", "page_idx": 4, "bbox": [71, 208.74026489257812, 542, 249.33883666992188], "page_size": [612.0, 792.0]}
{"layout": 20, "type": "text", "text": "II.  International Standards  ", "text_level": 1, "page_idx": 4, "bbox": [71, 263, 222, 278], "page_size": [612.0, 792.0]}
{"layout": 21, "type": "text", "text": "Several nonbinding international cooperation agreements and standards also apply to the  regulation of cosmetics across the jurisdictions surveyed.  ", "page_idx": 4, "bbox": [71, 291.54132080078125, 542, 318.45843505859375], "page_size": [612.0, 792.0]}
{"layout": 22, "type": "text", "text": "A.  International Standards Organization  ", "text_level": 1, "page_idx": 4, "bbox": [71, 332, 279, 345], "page_size": [612.0, 792.0]}
{"layout": 23, "type": "text", "text": "The ISO is a nongovernmental organization with a membership of 164 national standards bodies.   The ISO has 30 published, voluntary international standards to regulate cosmetic products,  including standards on testing, manufacturing, packaging, and labeling, as well as a technical  committee dedicated to developing standards related to cosmetics.  Among the jurisdictions  surveyed, four countries   5    employ the ISO 22716:2007 standard, “Cosmetics – Good  Manufacturing Practices (GMP) – Guidelines on Good Manufacturing Practices,” which gives  guidelines for the production, control, storage, and shipment of cosmetic products. ISO  22716:2007 explicitly does not apply to research, development, or distribution of finished  cosmetic products.     ", "page_idx": 4, "bbox": [71, 359.5207214355469, 542, 482.078857421875], "page_size": [612.0, 792.0]}
{"layout": 24, "type": "text", "text": "B.  International Nomenclature of Cosmetic Ingredients  ", "text_level": 1, "page_idx": 4, "bbox": [71, 495, 352, 509], "page_size": [612.0, 792.0]}
{"layout": 25, "type": "text", "text": "The International Nomenclature of Cosmetic Ingredients (INCI) is a list of labeling ingredient  names for cosmetic products.  The INCI is used as a benchmark for the labeling of cosmetic  products in the United States, the EU, and China. The INCI name does not imply that an  ingredient is safe or that it has been approved for use  it solely serves as an international  identification and standardization tool.   ", "page_idx": 4, "bbox": [71, 523.1411743164062, 542, 563.7388916015625], "page_size": [612.0, 792.0]}
{"layout": 26, "type": "text", "text": "", "page_idx": 5, "bbox": [71, 72.06100463867188, 542, 99.87887573242188], "page_size": [612.0, 792.0]}
{"layout": 27, "type": "text", "text": "C.  International Cooperation on Cosmetics Regulation  ", "text_level": 1, "page_idx": 5, "bbox": [70, 113, 348, 127], "page_size": [612.0, 792.0]}
{"layout": 28, "type": "text", "text": "Established in 2007, the International Cooperation on Cosmetics Regulation (ICCR) is a voluntary,  international group of cosmetics regulatory authorities that discusses issues and produces reports  regarding cosmetics safety and regulation.   9  The current membership of the ICCR is Brazil,  Canada, the European Commission, Japan ,  and the United States.     ", "page_idx": 5, "bbox": [71, 140.88076782226562, 542, 195.15884399414062], "page_size": [612.0, 792.0]}
{"layout": 29, "type": "text", "text": "Australia  ", "text_level": 1, "page_idx": 6, "bbox": [270, 74, 342, 91], "page_size": [612.0, 792.0]}
{"layout": 30, "type": "text", "text": "Kelly Buchanan  Foreign Law Specialist ", "page_idx": 6, "bbox": [255.4794464111328, 98.58169555664062, 356.5152893066406, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 31, "type": "text", "text": "SUMMARY ", "text_level": 1, "page_idx": 6, "bbox": [71, 154, 126, 166], "page_size": [612.0, 792.0]}
{"layout": 32, "type": "text", "text": "New legislation regulating the importation and manufacture of chemicals for industrial  use, including ingredients in cosmetics, will come into force in Australia in July 2020.  Under the law, businesses that introduce such chemicals will be required to register  with the relevant federal agency, apply for assessments of the chemicals (if needed),  submit a declaration or report (if needed), keep certain records, and provide certain  information on request.   ", "page_idx": 6, "bbox": [138, 153.98492431640625, 541, 232.0426025390625], "page_size": [612.0, 792.0]}
{"layout": 33, "type": "text", "text": "In addition to the rules related to industrial chemicals, cosmetic manufacturers must  comply with workplace safety laws and consumer protection legislation. There is no  compulsory code of good manufacturing practice applicable to cosmetics in Australia.  ", "page_idx": 6, "bbox": [138, 245.4840087890625, 542, 284.2422790527344], "page_size": [612.0, 792.0]}
{"layout": 34, "type": "text", "text": "Australia’s consumer protection legislation and related regulations cover cosmetic  labeling requirements and mandatory reporting of adverse events associated with  consumer products.  ", "page_idx": 6, "bbox": [138, 297.6836853027344, 542, 336.4419860839844], "page_size": [612.0, 792.0]}
{"layout": 35, "type": "text", "text": "A separate regulatory system applies to products that make a therapeutic claim.  ", "page_idx": 6, "bbox": [138, 349.8833923339844, 511.4472351074219, 362.5418395996094], "page_size": [612.0, 792.0]}
{"layout": 36, "type": "text", "text": "I.  Introduction  ", "text_level": 1, "page_idx": 6, "bbox": [70, 390, 156, 404], "page_size": [612.0, 792.0]}
{"layout": 37, "type": "text", "text": "In Australia, the current system for regulating the importation and manufacture of chemicals for \n\n “industrial” use, including ingredients used in cosmetics and soaps (even those described as \n\n “natural”),  is the National Industrial Chemicals Notification and Assessment Scheme \n\n (NICNAS).  This system will be replaced on July 1, 2020, by the Australian Industrial Chemicals  Introduction Scheme (AICIS), which was established by the Industrial Chemicals Act 2019 (Cth)  (ICA).  The new legislation also introduced a “ban on the use of new animal test data for  ingredients used solely in cosmetics,” which will also commence on July 1, 2020.    ", "page_idx": 6, "bbox": [71, 419.76171875, 542, 514.9588623046875], "page_size": [612.0, 792.0]}
{"layout": 38, "type": "text", "text": "Where a therapeutic claim is made with respect to a cosmetic product, that product is regulated  under the Therapeutic Goods Act 1989 (Cth). This includes where a product is claimed to prevent,  diagnose, cure, or alleviate a disease, ailment, defect, or injury in a person, or to influence, inhibit,  or modify a physiological process.  The Therapeutic Goods Administration (TGA) explains that  ", "page_idx": 6, "bbox": [71, 529.0817260742188, 542, 583.35888671875], "page_size": [612.0, 792.0]}
{"layout": 39, "type": "text", "text": "[o]ne of the main factors in determining whether a product is a cosmetic or a medicine (or  a medical device) [i.e., a therapeutic good] is the claims made about the product. For  example, moisturisers that contain a sunscreening agent as a secondary component and  have a stated therapeutic purpose (e.g. ‘helps protect skin from the damaging effects of UV  radiation’) are medicines.  ", "page_idx": 7, "bbox": [107, 86.02816772460938, 506, 147.78713989257812], "page_size": [612.0, 792.0]}
{"layout": 40, "type": "text", "text": "Even if a product is intended for marketing as a cosmetic, it may be classified as a medicine.  This depends on:  ", "page_idx": 7, "bbox": [107, 160.54696655273438, 506, 185.10665893554688], "page_size": [612.0, 792.0]}
{"layout": 41, "type": "text", "text": "   its ingredients     the route of administration     if therapeutic claims are made on its label, or in advertising. ", "page_idx": 7, "bbox": [125, 197.46432495117188, 408.4093933105469, 236.16549682617188], "page_size": [612.0, 792.0]}
{"layout": 42, "type": "text", "text": "The Therapeutic Goods (Excluded Goods) Determination 2018 (Cth) 7  sets out the cosmetic  products that are excluded from the operation of the Therapeutic Goods Act, provided those  goods are exported, imported, or supplied in a manner consistent with their terms of exclusion. This includes, for example, anti-acne skincare products, antibacterial skincare products, and  moisturizing skincare products that contain sunscreen where the products do not contain  substances listed in particular schedules of the Poisons Standard 9  and are marketed or presented  in ways set out in the Determination.   ", "page_idx": 7, "bbox": [71, 250.26168823242188, 542, 345.51885986328125], "page_size": [612.0, 792.0]}
{"layout": 43, "type": "text", "text": "The TGA states that “[e]nquiries about the regulation of cosmetic products should be directed to  NICNAS in the first instance.” 11   ", "page_idx": 7, "bbox": [71, 359.6417236328125, 542, 386.558837890625], "page_size": [612.0, 792.0]}
{"layout": 44, "type": "text", "text": "In addition to these two regulatory systems, the manufacture and supply of cosmetic products  may be subject to legislation related to consumer protection, labeling, and workplace safety,  among others.  This includes the Australian Consumer Law (ACL), which is set out in schedule  2 of the Competition and Consumer Act 2010 (Cth); 13  the Trade Practices (Consumer Product  Information Standards) (Cosmetics) Regulations 1991 (Cth); 14  and state and territory workplace  safety laws, many of which implement model work health and safety laws developed at the  national level.   ", "page_idx": 7, "bbox": [71, 400.6213073730469, 542, 468.578857421875], "page_size": [612.0, 792.0]}
{"layout": 45, "type": "text", "text": "", "page_idx": 8, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 46, "type": "text", "text": "This report focuses on the regulation of cosmetics about which no therapeutic claims are made,  and which are therefore not subject to the Therapeutic Goods Act. Information is provided about  the new AICIS, rather than the existing system. Information is also provided about consumer  protection and workplace safety rules relevant to the manufacture and supply of cosmetics.   ", "page_idx": 8, "bbox": [71, 113.46127319335938, 542, 168.0267333984375], "page_size": [612.0, 792.0]}
{"layout": 47, "type": "text", "text": "II.  Approval and Safety Review of Ingredients in Cosmetics  ", "text_level": 1, "page_idx": 8, "bbox": [71, 183, 402, 197], "page_size": [612.0, 792.0]}
{"layout": 48, "type": "text", "text": "The basic obligations under the AICIS for businesses that introduce (i.e., import or manufacture  in Australia) industrial chemicals involve  \n\n ", "page_idx": 8, "bbox": [71, 211.20169067382812, 542, 238.11880493164062], "page_size": [612.0, 792.0]}
{"layout": 49, "type": "text", "text": "   registration (under part 2 of the ICA), \n\n    knowing details about their chemical introductions,  \n\n    understanding the category of the introductions,  \n\n    applying to the regulatory body to assess the introductions (if needed), \n\n    submitting a declaration or report (if needed, under part 6 of the ICA),  \n\n    keeping records of the introductions, and  \n\n    providing information to the regulatory body on request.   ", "page_idx": 8, "bbox": [71, 251.82077026367188, 437, 386.9208068847656], "page_size": [612.0, 792.0]}
{"layout": 50, "type": "text", "text": "Part 3 of the ICA relates to the categorization and assessment of industrial chemicals, with each  introduction of a chemical needing to comply with the category of introduction. The categories  are “based on the level of risk to human health and the environment from the introduction  $^{\\prime\\prime}{}_{17}$    The simplified outline of the ICA explains that  ", "page_idx": 8, "bbox": [71, 401.0417175292969, 542, 455.25885009765625], "page_size": [612.0, 792.0]}
{"layout": 51, "type": "text", "text": "[l]ower risk introductions (exempted and reported introductions) can be made without  being assessed by the Executive Director [of AICIS]. However, record keeping and  reporting obligations apply.  ", "page_idx": 8, "bbox": [107, 469.2481384277344, 506, 506.1675109863281], "page_size": [612.0, 792.0]}
{"layout": 52, "type": "text", "text": "Medium ‑ to ‑ high risk introductions require an assessment certificate issued by the  Executive Director and must comply with the terms of the certificate. A person can also  apply for commercial evaluation authorisations and the Minister can issue exceptional  circumstances authorisations.  ", "page_idx": 8, "bbox": [107, 518.9874267578125, 506, 568.3265380859375], "page_size": [612.0, 792.0]}
{"layout": 53, "type": "text", "text": "Industrial chemicals covered by an assessment certificate are listed on the Australian  Inventory of Industrial Chemicals after 5 years. However, applications can be made for  early listing and industrial chemicals can be listed in certain other circumstances. Any  registered person can introduce an industrial chemical that is listed on the Inventory but  ", "page_idx": 8, "bbox": [107, 581.0863647460938, 506, 630.4254760742188], "page_size": [612.0, 792.0]}
{"layout": 54, "type": "text", "text": "must comply with the terms of the Inventory listing and record keeping and  reporting requirements.  ", "page_idx": 9, "bbox": [108, 72.34811401367188, 506, 96.84768676757812], "page_size": [612.0, 792.0]}
{"layout": 55, "type": "text", "text": "The Executive Director may initiate evaluations of industrial chemicals, or matters relating  to industrial chemicals. Evaluations may result in changes to assessment certificates or  Inventory listings or recommendations being made about the introduction and use of  industrial chemicals.  ", "page_idx": 9, "bbox": [108, 109.60751342773438, 506, 159.00680541992188], "page_size": [612.0, 792.0]}
{"layout": 56, "type": "text", "text": "The Executive Director is required to publish assessment statements, evaluation  statements and other information under this Act. Applications can be made by any person  for confidential business information not to be published.   ", "page_idx": 9, "bbox": [108, 171.76663208007812, 506, 208.68789672851562], "page_size": [612.0, 792.0]}
{"layout": 57, "type": "text", "text": "Part 7 of the ICA relates to enforcement, with inspectors having monitoring, inspection, and  enforcement powers under the Regulatory Powers (Standard Provisions) Act 2014 (Cth) 19  to  ensure compliance with the legislation.   ", "page_idx": 9, "bbox": [71, 222.84170532226562, 542, 263.4388732910156], "page_size": [612.0, 792.0]}
{"layout": 58, "type": "text", "text": "The ICA is accompanied by certain rules and guidance, including the Industrial Chemical  (General) Rules 2019 (Cth) 21  and categorization guidelines.   ", "page_idx": 9, "bbox": [71, 277.5013122558594, 542, 304.4188537597656], "page_size": [612.0, 792.0]}
{"layout": 59, "type": "text", "text": "III.  Manufacturing of Cosmetics  ", "text_level": 1, "page_idx": 9, "bbox": [71, 319, 253, 333], "page_size": [612.0, 792.0]}
{"layout": 60, "type": "text", "text": "Apart from the regulatory system for industrial chemicals, there is no additional registration or  licensing process for companies or facilities that manufacture cosmetics in Australia. However,  various laws and regulations apply to the manufacturing process, along with voluntary standards  and certifications.  ", "page_idx": 9, "bbox": [71, 348.2417297363281, 542, 402.5188293457031], "page_size": [612.0, 792.0]}
{"layout": 61, "type": "text", "text": "A.  Model Laws  ", "text_level": 1, "page_idx": 9, "bbox": [71, 416, 152, 429], "page_size": [612.0, 792.0]}
{"layout": 62, "type": "text", "text": "Work health and safety (WHS) legislation and enforcement come within the responsibilities of  Australia’s states and territories. However, six of the eight jurisdictions, as well as the  Commonwealth, have implemented model laws developed at the national level.  The model  WHS laws include the model WHS Act and model WHS Regulations. Model Codes of Practice  have also been developed “as practical guides to achieving the standards of health and safety  required under the model WHS Act and Regulations.” 24  These instruments are supported by the  National Compliance and Enforcement Policy.  ", "page_idx": 9, "bbox": [71, 443.5207214355469, 542, 538.7788696289062], "page_size": [612.0, 792.0]}
{"layout": 63, "type": "text", "text": "The model WHS Regulations contain detailed obligations applicable to manufacturers, including  with respect to the packing, labeling, and storage, and handling of hazardous chemicals.   ", "page_idx": 10, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 64, "type": "text", "text": "B.  Good Manufacturing Practice  ", "text_level": 1, "page_idx": 10, "bbox": [70, 112, 237, 126], "page_size": [612.0, 792.0]}
{"layout": 65, "type": "text", "text": "While different codes of Good Manufacturing Practice (GMP) apply to therapeutic goods  manufactured in Australia, with compliance required in order to hold a license to manufacture  such goods,  there is no compulsory GMP code with respect to the manufacturing of cosmetics  not considered therapeutic goods. Voluntary training, compliance, and certification for ISO 22716  (GMP for Cosmetics), and other standards applied in different overseas jurisdictions, appear to  be available through private industry mechanisms.   ", "page_idx": 10, "bbox": [71, 139.98129272460938, 542, 221.55886840820312], "page_size": [612.0, 792.0]}
{"layout": 66, "type": "text", "text": "C.  Consumer Protection Legislation  ", "text_level": 1, "page_idx": 10, "bbox": [70, 235, 254, 249], "page_size": [612.0, 792.0]}
{"layout": 67, "type": "text", "text": "Various consumer guarantees apply to manufacturers under the ACL,  including a guarantee as  to the acceptable quality of goods, which includes that they are safe and fit for purpose,  and a  guarantee that the goods have been accurately described.  If a product fails to meet one or more  of the guarantees, a consumer who purchased that product is entitled to a remedy  “either a  repair, replacement or refund and compensation for any consequential loss  depending on the  circumstances.” 31  Consumers may approach manufacturers directly for a remedy, and may take  action against manufacturers to recover costs.  Businesses are “legally obliged to provide the  appropriate remedy under the consumer guarantees provisions of the ACL.” 33  Where a business  ", "page_idx": 10, "bbox": [71, 262.6211853027344, 542, 372.51885986328125], "page_size": [612.0, 792.0]}
{"layout": 68, "type": "text", "text": "(a)  a person who grows, extracts, produces, processes or assembles goods;  (b)  a person who holds himself or herself out to the public as the manufacturer of goods;  (c)  a person who causes or permits the name of the person, a name by which the person carries on   (d)  a person (the first person) who causes or permits another person, in connection with:   (i)  the supply or possible supply of goods by that other person; or   (ii)  the promotion by that other person by any means of the supply or use of goods;  to hold out the first person to the public as the manufacturer of the goods;  (e)  a person who imports goods into Australia if:   (i)  the person is not the manufacturer of the goods; and   (ii)  at the time of the importation, the manufacturer of the goods does not have a place of  business in Australia.  ", "page_idx": 10, "bbox": [108, 490.4699401855469, 503.4726257324219, 613.1612548828125], "page_size": [612.0, 792.0]}
{"layout": 69, "type": "text", "text": "29  ACL s 54.  30   Consumers’ Rights & Obligations , Australian Competition and Consumer Commission (ACCC),  https://perma.cc/C9JQ-T8PC.   31  Id.  32  Id.  33  Id.  ", "page_idx": 10, "bbox": [71, 619.5067749023438, 477.0776062011719, 713.9755249023438], "page_size": [612.0, 792.0]}
{"layout": 70, "type": "text", "text": "fails to do so, the consumer may report the problem to a state or territory consumer protection  agency or the Australian Competition and Consumer Commission (ACCC), which shares  responsibility for product safety regulation with states and territories,  or have the matter heard  in a local small claims tribunal or magistrates court.    ", "page_idx": 11, "bbox": [71, 72.48171997070312, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 71, "type": "text", "text": "The ACCC undertakes various compliance activities with respect to cosmetics, including  regulatory audits of cosmetic-related injury reports and cosmetic product surveys that examine  chemical exposure risks.   ", "page_idx": 11, "bbox": [71, 140.82168579101562, 542, 181.41885375976562], "page_size": [612.0, 792.0]}
{"layout": 72, "type": "text", "text": "Australia’s consumer protection legislation also covers labeling requirements and adverse event  reporting, as outlined below.  ", "page_idx": 11, "bbox": [71, 195.48129272460938, 542, 222.39840698242188], "page_size": [612.0, 792.0]}
{"layout": 73, "type": "text", "text": "IV.  Labeling Requirements  ", "text_level": 1, "page_idx": 11, "bbox": [70, 236, 226, 252], "page_size": [612.0, 792.0]}
{"layout": 74, "type": "text", "text": "The requirements for ingredients labeling on cosmetics are prescribed in the Trade Practices  (Consumer Product Information Standards) (Cosmetics) Regulation 1991 (Cth). This instrument  constitutes a mandatory information standard under part 3-4 of the ACL. The ACCC explains  that, under the mandatory standard,   ", "page_idx": 11, "bbox": [71, 265.4417419433594, 542, 319.658447265625], "page_size": [612.0, 792.0]}
{"layout": 75, "type": "text", "text": "cosmetic products are substances or preparations intended for placement in contact with  any external part of the body, including the mouth and teeth, for the purpose of  ", "page_idx": 11, "bbox": [108, 333.64813232421875, 506.4524841308594, 358.147705078125], "page_size": [612.0, 792.0]}
{"layout": 76, "type": "text", "text": "   altering the odours of the body     changing the appearance of the body     cleansing the body     maintaining the body in good condition     perfuming the body     protecting the body.   ", "page_idx": 11, "bbox": [108, 371.826171875, 304.95208740234375, 479.10791015625], "page_size": [612.0, 792.0]}
{"layout": 77, "type": "text", "text": "Certain goods are exempt from the mandatory information standard, including therapeutic  goods, cosmetics manufactured in Australia for export, free samples of cosmetic products, and  testers of a cosmetic product.  The ACCC lists the following as the key features of the labeling  requirements for cosmetics under the mandatory standard:  ", "page_idx": 11, "bbox": [71, 493.26171875, 542, 547.4788818359375], "page_size": [612.0, 792.0]}
{"layout": 78, "type": "text", "text": "   Product ingredient information should be available to consumers at the point of sale.     The listing of product ingredients is required on the container or on the product itself,  if not packed in a container.     Where the container or the product is of a size, shape or nature that prevents ingredient  labelling by any of the above methods, the mandatory information standard requires  the display of information to allow consumers to be informed.     The labelling of ingredients on cosmetics such as make-up, deodorant or moisturiser  usually appears on the packaging or outer casing of the product for  consumer knowledge.     When listing ingredients, the ingredients need to appear in descending order  calculated by either mass or volume.     Alternatively, the mandatory standard allows for the listing of ingredients in the  following way:  o   ingredients (except colour additives) in concentrations of 1 per cent or more in  descending order by volume or mass  o   followed by ingredients (except for colour additives) in concentrations of less  than 1 per cent in any order  o   followed by colour additives in any order.     The mandatory information standard does not require the listing of the quantity or  percentage of each ingredient.   ", "page_idx": 12, "bbox": [108, 72.00619506835938, 506, 377.7079162597656], "page_size": [612.0, 792.0]}
{"layout": 79, "type": "text", "text": "The requirements for ingredients labeling on cosmetics are explained in more detail in a  December 2018 ACCC guidance document, which provides guidance to both suppliers and  retailers with respect to their responsibilities under the mandatory standard and the ACL.   ", "page_idx": 12, "bbox": [71, 391.8017272949219, 542, 432.3988342285156], "page_size": [612.0, 792.0]}
{"layout": 80, "type": "text", "text": "The ACCC states that it is currently reviewing the information standard for cosmetics ingredient  labeling, with a public consultation period on a consultation paper having run from November  14, 2019, to December 13, 2019.   ", "page_idx": 12, "bbox": [71, 446.5216979980469, 542, 487.058837890625], "page_size": [612.0, 792.0]}
{"layout": 81, "type": "text", "text": "V.  Adverse Event Reporting  ", "text_level": 1, "page_idx": 12, "bbox": [71, 501, 230, 517], "page_size": [612.0, 792.0]}
{"layout": 82, "type": "text", "text": "The ACL requires suppliers to “report any product-related death, serious injury or serious illness  associated with a consumer product.” 42  Mandatory reports must be made to the ACCC within  two days of the supplier becoming aware of a reportable incident. The reporting requirement  applies to all participants in the supply chain, including importers, manufacturers, distributors,  and retailers. Serious illness or injury “refers to an acute physical injury or illness requiring  medical or surgical treatment by, or under the supervision of, a qualified doctor or nurse.” 43  The  law applies whether or not the consumer product was being “used or misused before or at” the  time of the incident.   ", "page_idx": 12, "bbox": [71, 530.8817749023438, 542, 612.5188598632812], "page_size": [612.0, 792.0]}
{"layout": 83, "type": "text", "text": "", "page_idx": 13, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 84, "type": "text", "text": "Rules apply with respect to the government’s disclosure of the information in an incident report  provided by a supplier. In particular, disclosure is allowed if disclosure is in the public interest,  required or authorized by or under law, or “reasonably necessary for the enforcement of the  criminal law or of a law imposing a pecuniary penalty.” 45    ", "page_idx": 13, "bbox": [71, 113.46127319335938, 542, 167.73886108398438], "page_size": [612.0, 792.0]}
{"layout": 85, "type": "text", "text": "Adverse events caused by therapeutic goods are reported to the TGA and are therefore exempt  from the mandatory reporting obligations to the ACCC.  Exemptions also apply where other  existing reporting systems apply under different federal, state, or territory legislation.   ", "page_idx": 13, "bbox": [71, 181.80130004882812, 542, 222.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 86, "type": "text", "text": "Criminal offense provisions apply in situations where a supplier fails to notify the government  of an incident as required by the ACL.   ", "page_idx": 13, "bbox": [71, 236.52169799804688, 542, 263.4388732910156], "page_size": [612.0, 792.0]}
{"layout": 87, "type": "text", "text": "Brazil  ", "text_level": 1, "page_idx": 14, "bbox": [282, 73, 331, 91], "page_size": [612.0, 792.0]}
{"layout": 88, "type": "text", "text": "Eduardo Soares  Senior Foreign Law Specialist ", "page_idx": 14, "bbox": [239.76019287109375, 98.58169555664062, 372.2032470703125, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 89, "type": "text", "text": "SUMMARY   Cosmetics and several other products are subject to sanitary surveillance rules  established by federal law. A federal agency regulates the cosmetic industry in Brazil.   Cosmetic facilities must obtain authorization from the Ministry of Health and the local  health agency where they are located to operate. No product that causes irritation to the  skin or damage to health may be registered as a cosmetic. Evidence that a product is  harmful to health triggers its immediate withdrawal from trade. Labeling of cosmetics  is defined by a law issued by the federal agency responsible for  executing sanitary  control of the production, marketing, and use of products and services subject to  health regulation. The agency also issued a law authorizing the technical regulation  of good manufacturing practices for cosmetics.   ", "page_idx": 14, "bbox": [71, 156.63809204101562, 545, 291.7588195800781], "page_size": [612.0, 792.0]}
{"layout": 90, "type": "text", "text": "I.  Legal Framework  ", "text_level": 1, "page_idx": 14, "bbox": [71, 319, 182, 334], "page_size": [612.0, 792.0]}
{"layout": 91, "type": "text", "text": "According to article 1 of Law No. 6,360 of September 23, 1976, medicines, drugs, pharmaceutical  elements, and related items (insumos farmacêuticos e correlatos), as defined in Law No. 5,991, of  December 17, 1973, as well as hygiene products, cosmetics, perfumes, household sanitizers,  aesthetic correction products, and other products are subject to the sanitary surveillance rules  established by Law No. 6,360.   ", "page_idx": 14, "bbox": [71, 347.8817138671875, 545, 415.7788391113281], "page_size": [612.0, 792.0]}
{"layout": 92, "type": "text", "text": "The cosmetic industry is regulated by the Brazilian Health Regulatory Agency (Agência Nacional  de Vigilância Sanitária, ANVISA), which is  a federal agency (autarquia) linked to the Ministry of  Health. ANVISA’s role is to promote the protection of the population’s health by executing  sanitary control of the production, marketing, and use of products and services subject to health  regulation, including related environments, processes, ingredients, and technologies, as well as  compliance in ports and airports and at borders.   ", "page_idx": 14, "bbox": [71, 429.9017028808594, 545, 511.4788513183594], "page_size": [612.0, 792.0]}
{"layout": 93, "type": "text", "text": "II.  Registration of Cosmetic Facilities  ", "text_level": 1, "page_idx": 14, "bbox": [71, 524, 279, 540], "page_size": [612.0, 792.0]}
{"layout": 94, "type": "text", "text": "Law No. 6,360 determines that companies may only extract, produce, manufacture, transform,  synthesize, purify, fractionate, pack, repackage, import, export, store or ship the products referred to  in article 1 when they are authorized for this purpose by the Ministry of Health and whose  establishments have been licensed by the health agency of the federative unit in which they are located. ", "page_idx": 14, "bbox": [71, 553.7417602539062, 545, 594.2784423828125], "page_size": [612.0, 792.0]}
{"layout": 95, "type": "text", "text": "", "page_idx": 15, "bbox": [71, 72.48171997070312, 536.82080078125, 85.71884155273438], "page_size": [612.0, 792.0]}
{"layout": 96, "type": "text", "text": "Article 3(V) of Law No. 6,360 defines cosmetics as products for external use, intended to protect  or beautify different parts of the body, and lists several different types of products.   ", "page_idx": 15, "bbox": [71, 99.78128051757812, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 97, "type": "text", "text": "Without prior and express consent from the Ministry of Health, the importation for industrial  and commercial purposes of medicines, drugs, pharmaceutical supplies, and other products  referred to in Law No. 6.360 is forbidden.   ", "page_idx": 15, "bbox": [71, 140.82168579101562, 542, 181.41885375976562], "page_size": [612.0, 792.0]}
{"layout": 98, "type": "text", "text": "None of the products listed in Law No. 6,360, including imported ones, may be manufactured,  offered for sale, or delivered for consumption before being registered with the Ministry of Health.   ", "page_idx": 15, "bbox": [71, 195.48129272460938, 542, 222.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 99, "type": "text", "text": "Decree No. 8,077 of August 14, 2013, which   regulates the conditions for the operation of  companies subject to sanitary licensing, and the registration, control, and monitoring, within the  scope of sanitary surveillance, of the products listed in Law No. 6,360, further determines that the  exercise of activities related to the products referred to in article 1 of the Law will depend on the  authorization of the ANVISA and the licensing of the establishments by the competent health  agency of the states, Federal District, or municipalities, observing the technical requirements  defined in the regulation of these bodies.   ", "page_idx": 15, "bbox": [71, 236.52169799804688, 542, 331.7788391113281], "page_size": [612.0, 792.0]}
{"layout": 100, "type": "text", "text": "III.  Cosmetic Safety Review and Substantiation Standards  ", "text_level": 1, "page_idx": 15, "bbox": [71, 345, 395, 360], "page_size": [612.0, 792.0]}
{"layout": 101, "type": "text", "text": "Under article 16 of Law No. 6,360, the registration of drugs, pharmaceutical elements, and related  items, given their sanitary, medicinal or prophylactic, curative, or palliative characteristics, or  even for diagnostic purposes, is subject, in addition to meeting their own requirements, to the  following specific requirements:  ", "page_idx": 15, "bbox": [71, 371.221435546875, 542, 421.35797119140625], "page_size": [612.0, 792.0]}
{"layout": 102, "type": "text", "text": "I - the product complies with the provisions of article 5 of Law No. 6,360 and its paragraphs.  ", "page_idx": 15, "bbox": [107, 431.56842041015625, 506, 443.648193359375], "page_size": [612.0, 792.0]}
{"layout": 103, "type": "text", "text": "II - that the product, through scientific proof and analysis, is recognized as safe and effective  for its intended use, and has the necessary identity, activity, quality, purity and safety;  ", "page_idx": 15, "bbox": [107, 453.9490966796875, 506, 477.18914794921875], "page_size": [612.0, 792.0]}
{"layout": 104, "type": "text", "text": "III - in the case of a new product, ample information on its composition and use is offered  to assess its nature and to determine the degree of safety and efficacy required;  ", "page_idx": 15, "bbox": [107, 487.49005126953125, 506, 510.7301025390625], "page_size": [612.0, 792.0]}
{"layout": 105, "type": "text", "text": "IV - presentation, when requested, of a sample for analyses and tests that are deemed  necessary by the competent bodies of the Ministry of Health;  ", "page_idx": 15, "bbox": [107, 521.0309448242188, 506, 544.3311767578125], "page_size": [612.0, 792.0]}
{"layout": 106, "type": "text", "text": "V - when there is a new substance in the composition of the drug, the delivery of a sample  accompanied by the chemical and physicochemical data that identify it;  ", "page_idx": 15, "bbox": [107, 554.5719604492188, 506, 577.8720703125], "page_size": [612.0, 792.0]}
{"layout": 107, "type": "text", "text": "VI - in the case of a drug or medicine whose preparation requires technical and specific  equipment, proof that the establishment is properly equipped and keeps qualified  personnel to handle or contract with third parties for this purpose.   ", "page_idx": 16, "bbox": [107, 71.38815307617188, 506, 105.84860229492188], "page_size": [612.0, 792.0]}
{"layout": 108, "type": "text", "text": "Only products for personal hygiene, perfumes and others of similar nature and purpose that are  intended for external use or in the environment, depending on their aesthetic, protective, hygienic  or aromatic purpose, that do not cause irritation to the skin or damage to health, will be registered  as cosmetics.   ", "page_idx": 16, "bbox": [71, 117.18173217773438, 542, 171.45883178710938], "page_size": [612.0, 792.0]}
{"layout": 109, "type": "text", "text": "In addition to being subject to their own specific regulatory requirements, the registration of  cosmetics, personal care products, perfumes and products of that kind, of similar purpose, will  depend on the satisfaction of the following requirements:  ", "page_idx": 16, "bbox": [71, 185.58169555664062, 542, 226.11837768554688], "page_size": [612.0, 792.0]}
{"layout": 110, "type": "text", "text": "I - fit the list of substances declared harmless, prepared by the competent organ of the  Ministry of Health and published in the Official Gazette of the Union, which will contain  the specifications relevant to each category as well as drugs, elements (insumos), raw  materials, dyes, solvents and others permitted in their manufacture;  ", "page_idx": 16, "bbox": [107, 236.68850708007812, 506, 282.3092346191406], "page_size": [612.0, 792.0]}
{"layout": 111, "type": "text", "text": "II - not fitting in the list above, the harmlessness of the respective formulas has been  recognized in conclusive opinions issued by the competent analytical and technical bodies  of the Ministry of Health.   ", "page_idx": 16, "bbox": [107, 292.6101379394531, 506, 327.0104675292969], "page_size": [612.0, 792.0]}
{"layout": 112, "type": "text", "text": "The list of substances referred to in item I above may be changed to exclude substances that may  be considered harmful to health, or to include others that may be approved.   ", "page_idx": 16, "bbox": [71, 337.32171630859375, 542, 362.8588562011719], "page_size": [612.0, 792.0]}
{"layout": 113, "type": "text", "text": "The registration of cosmetics, products intended for personal hygiene, and others of the same  purpose, which contain medicinal substances, although in a non-therapeutic dose, must obey the  norms contained in articles 16 through 21 of Law No. 6,360 and the Decree No. 8.077, of August  14, 2013.   ", "page_idx": 16, "bbox": [71, 376.68194580078125, 542, 430.8988342285156], "page_size": [612.0, 792.0]}
{"layout": 114, "type": "text", "text": "IV.  Adverse Event Reporting  ", "text_level": 1, "page_idx": 16, "bbox": [71, 444, 235, 459], "page_size": [612.0, 792.0]}
{"layout": 115, "type": "text", "text": "The proof that a product previously considered useful is harmful to health or does not fulfill  the requirements established by law calls for its immediate withdrawal from trade and the  modification of the formula’s composition and the product’s labels, leaflets and packaging,  under penalty of cancellation of registration and seizure of the product, throughout the national  territory.  It is the exclusive responsibility of the Ministry of Health to register and permit the  use of medicines, as well as the approval or requirement of modification of their components.   ", "page_idx": 16, "bbox": [71, 473.1617126464844, 542, 554.7388916015625], "page_size": [612.0, 792.0]}
{"layout": 116, "type": "text", "text": "As a health and safety measure, and in view of the considered arguments of the competent  body, the Ministry of Health may, at any time, suspend the manufacture and sale of any of the  products listed in Law No. 6,360, which, although registered, become suspected of having  harmful effects on human health.   ", "page_idx": 17, "bbox": [71, 72.48171997070312, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 117, "type": "text", "text": "V.  Cosmetics Labeling  ", "text_level": 1, "page_idx": 17, "bbox": [71, 141, 200, 155], "page_size": [612.0, 792.0]}
{"layout": 118, "type": "text", "text": "Law No. 6,360 defines label as a printed or lithographed identification, as well as the words  painted or engraved by fire, pressure or decal, applied directly on canisters, containers, wrappers,  cartridges or any other packaging protector.  The products listed in Law No. 6,360 may not have  names, designations, labels or packages that induce error.   ", "page_idx": 17, "bbox": [71, 168.96170043945312, 542, 223.17886352539062], "page_size": [612.0, 792.0]}
{"layout": 119, "type": "text", "text": "Drugs, medicines, and any pharmaceutical elements and related items, hygiene products,  cosmetics and household sanitizers, imported or not, can only be delivered for consumption in  the original packaging or in others previously authorized by the Ministry of Health.  Imported  products, whose commercialization in the domestic market does not require medical  prescription, must have clarifying statements in Portuguese about their composition, medical  indications, and use   added to their labeling.     ", "page_idx": 17, "bbox": [71, 237.30172729492188, 542, 319.45458984375], "page_size": [612.0, 792.0]}
{"layout": 120, "type": "text", "text": "The executive branch must provide, by regulation, for the labeling, package leaflets, printed  materials, labels and prospectuses referring to the products dealt with in Law No. 6,360.  For this  purpose, on February 10, 2015, ANVISA enacted Resolution RDC No. 7, which approved the  technical regulation establishing the definition, classification, technical requirements, labeling,  and electronic procedure for regularization of toiletries, cosmetics, and perfumes.   ", "page_idx": 17, "bbox": [71, 333.001708984375, 542, 400.8988342285156], "page_size": [612.0, 792.0]}
{"layout": 121, "type": "text", "text": "VI.  Good Manufacturing Practices  ", "text_level": 1, "page_idx": 17, "bbox": [71, 414, 263, 429], "page_size": [612.0, 792.0]}
{"layout": 122, "type": "text", "text": "On October 25, 2013, ANVISA enacted Resolution RDC No. 48, which approved the technical  regulation of good manufacturing practice for toiletries, cosmetics, and perfumes, determining, among  other things, that these products must be safe under normal or foreseeable conditions of use and that  good manufacturing practices should reflect the minimum requirements required by the industries  in the manufacture, packaging and storage, and quality control of such products.   ", "page_idx": 17, "bbox": [71, 443.1617126464844, 542, 511.058837890625], "page_size": [612.0, 792.0]}
{"layout": 123, "type": "text", "text": "VII.  Different Treatments of Cosmetic Firms  ", "text_level": 1, "page_idx": 18, "bbox": [71, 72, 319, 87], "page_size": [612.0, 792.0]}
{"layout": 124, "type": "text", "text": "No distinction has been identified between small and large cosmetic firms.  ", "page_idx": 18, "bbox": [72, 100.62173461914062, 436.98394775390625, 113.85885620117188], "page_size": [612.0, 792.0]}
{"layout": 125, "type": "text", "text": "VIII.  Cosmetics Imports into the US  ", "text_level": 1, "page_idx": 18, "bbox": [71, 128, 272, 141], "page_size": [612.0, 792.0]}
{"layout": 126, "type": "text", "text": "The Brazilian Embassy in Washington, DC, prepared a report in August 2018 to inform current  and future Brazilian exporters about the challenges of the US market but also the opportunities  it offers for Brazilian products. The report states that Brazil, the United States, Canada, the  European Union, and Japan are members of the International Cooperation on Cosmetics  Regulation (ICCR), an organization that seeks to harmonize regulation to maximize consumer  protection while minimizing barriers to trade,  and that the similarity in cosmetics regulations  in these markets facilitates trade and provides a business opportunity.   ", "page_idx": 18, "bbox": [72, 156.06130981445312, 542, 251.31881713867188], "page_size": [612.0, 792.0]}
{"layout": 127, "type": "text", "text": "Canada  ", "text_level": 1, "page_idx": 19, "bbox": [276, 74, 335, 91], "page_size": [612.0, 792.0]}
{"layout": 128, "type": "text", "text": "Tariq Ahmad \\*   Foreign Law Specialist ", "page_idx": 19, "bbox": [255.48001098632812, 98.58169555664062, 356.515869140625, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 129, "type": "text", "text": "SUMMARY ", "text_level": 1, "page_idx": 19, "bbox": [71, 153, 114, 164], "page_size": [612.0, 792.0]}
{"layout": 130, "type": "text", "text": "All cosmetics in Canada must meet the requirements set out in the Food and Drugs Act  (FDA) and the Cosmetic Regulations. This legal framework requires that cosmetics sold  in Canada be manufactured, prepared, preserved, packed, and stored under sanitary  conditions. The manufacturer and importer must provide notice to Health Canada that  it is selling the product and information on the manufacturing facilities and a list of  ingredients. Cosmetics are subject to certain packaging and labeling requirements  under the Consumer Packaging and Labelling Act and its implementing regulations.  Lastly, any chemicals used in a cosmetic product may be subject to the Canadian  Environmental Protection Act.   ", "page_idx": 19, "bbox": [138, 152.72491455078125, 541, 269.78277587890625], "page_size": [612.0, 792.0]}
{"layout": 131, "type": "text", "text": "Not all products sold by the cosmetics industry fall under the FDA category of a  cosmetic, and thus are not governed by the Cosmetic Regulations. Some fall under other  categories of natural health products, personal care products, or product at the  cosmetic-drug interface.  ", "page_idx": 19, "bbox": [138, 283.2242126464844, 542, 335.00250244140625], "page_size": [612.0, 792.0]}
{"layout": 132, "type": "text", "text": "I.  Overview  ", "text_level": 1, "page_idx": 19, "bbox": [71, 363, 140, 376], "page_size": [612.0, 792.0]}
{"layout": 133, "type": "text", "text": "The Food and Drugs Act (FDA),  enacted in 1985, and its implementing regulations, the  Cosmetic Regulations,  are the main laws governing cosmetic products. According to Health  Canada, the agency that regulates cosmetics, “[a]ll cosmetics sold in Canada must be safe to use  and must not pose any health risk” and must meet the requirements of this legal framework. Section 2 of the FDA defines “cosmetic” as “including any substance or mixture of substances  manufactured, sold or represented for use in cleansing, improving or altering the complexion,  skin, hair or teeth, and includes deodorants and perfumes.” 4  According to Health Canada, this  definition includes “cosmetics used by professional esthetic services, bulk institutional  products (such as hand soap in school rest rooms), as well as ”handmade“ cosmetics sold at  craft sales or home-based businesses.” 5   ", "page_idx": 19, "bbox": [71, 392.2217102050781, 542, 528.4588623046875], "page_size": [612.0, 792.0]}
{"layout": 134, "type": "text", "text": "The legal framework established by the FDA and the Cosmetic Regulations prohibit the sale of  cosmetic products that were “manufactured, prepared, preserved, packaged or stored under  unsanitary conditions.” 6  The manufacturer or importer must provide   information on the  manufacturing facilities and a list of ingredients to Health Canada when a cosmetic product is  first put on the market.  The ingredients in any cosmetic product should comply with Health  Canada’s Cosmetic Ingredient Hotlist (Hotlist), which details prohibited or restricted ingredients,  and if there is a new ingredient that is not included in the agency’s Domestic Substance List, a  New Substance Notification form should be submitted to the Minister of Environment. These lists  are discussed infra in Part II(B)(2) and (3), respectively.  ", "page_idx": 20, "bbox": [71, 72.48171997070312, 542, 195.03842163085938], "page_size": [612.0, 792.0]}
{"layout": 135, "type": "text", "text": "Cosmetics are subject to certain packaging and labeling requirements under the Consumer  Packaging and Labelling Act,  as well as its implementing regulations.  Any chemicals used in a  cosmetic product also may be subject to the Canadian Environmental Protection Act.    ", "page_idx": 20, "bbox": [71, 209.16128540039062, 542, 249.75881958007812], "page_size": [612.0, 792.0]}
{"layout": 136, "type": "text", "text": "It is important to note that not all products sold by the cosmetics industry fall under the FDA  category of a cosmetic, and thus are not governed by the Cosmetic Regulations. Some fall under  other categories of a drug, natural health products, or personal care products (PCP), or product  at the cosmetic-drug interface (PCDI). When a product is not easily categorized as a cosmetic or  a drug, the government calls it a Product at the Cosmetic-Drug Interface (PCDI) and has a special  criteria to assess its correct category.    ", "page_idx": 20, "bbox": [71, 263.8212585449219, 542, 345.3988342285156], "page_size": [612.0, 792.0]}
{"layout": 137, "type": "text", "text": "II.  Legal Framework Applicable to Cosmetics  ", "text_level": 1, "page_idx": 20, "bbox": [71, 359, 323, 374], "page_size": [612.0, 792.0]}
{"layout": 138, "type": "text", "text": "The following regulations are applicable to what is considered a “cosmetic” product under  section 2 of the FDA.   ", "page_idx": 20, "bbox": [71, 388.9217224121094, 515.6897583007812, 415.8388366699219], "page_size": [612.0, 792.0]}
{"layout": 139, "type": "text", "text": "A.  Registration of Cosmetic Facilities  ", "text_level": 1, "page_idx": 20, "bbox": [71, 430, 262, 444], "page_size": [612.0, 792.0]}
{"layout": 140, "type": "text", "text": "A manufacturer or importer must submit to Health Canada a Cosmetic Notification Form (CNF)  within 10 days after it first begins selling any cosmetic in the market.  This is mandatory for  every new product on the market. There is no exception for test-marketing.  The CNF  must contain  ", "page_idx": 20, "bbox": [71, 457.68218994140625, 542, 511.8984375], "page_size": [612.0, 792.0]}
{"layout": 141, "type": "text", "text": "   the name and address of the manufacturer that appears on the label of the cosmetic; \n\n    the name under which the cosmetic is sold; \n\n  the function of the cosmetic; \n\n   a list of the cosmetic’s ingredients and, for each ingredient, either its exact concentration or  the concentration range that includes the concentration of that ingredient; \n\n  the form of the cosmetic; \n\n   the name and address in Canada of the manufacturer, importer or distributor; \n\n    if the cosmetic was not manufactured or formulated by the person whose name appears on  the label, the name and address of the person who manufactured or formulated it; and \n\n    the name and title of the person who signed the notification.   ", "page_idx": 21, "bbox": [71, 72.06100463867188, 542, 254.68161010742188], "page_size": [612.0, 792.0]}
{"layout": 142, "type": "text", "text": "Submitting a CNF does not guarantee that the cosmetic is safe, and failure to notify Health  Canada may result in the product’s removal from sale or denial of entry into Canada (for  importers).  Under section 31 of the Cosmetic Regulations, a new CNF should be submitted  “within 10 days after the document or information becomes inaccurate” for any changes to the  previously submitted information, including modification of the cosmetic formula, change of  company name, change of address or contact information for the manufacturer, change of  product name, or discontinuation of sale.     ", "page_idx": 21, "bbox": [71, 268.8017272949219, 542, 364.058837890625], "page_size": [612.0, 792.0]}
{"layout": 143, "type": "text", "text": "The Cosmetic Notification Form is an online form found on the Health Canada website.  There  are nine sections to complete, and a government guide on how to complete the form can be found  online as well.   ", "page_idx": 21, "bbox": [71, 378.1213073730469, 542, 418.7188415527344], "page_size": [612.0, 792.0]}
{"layout": 144, "type": "text", "text": "B.  Cosmetic Safety Review and Substantiation Standards    ", "text_level": 1, "page_idx": 21, "bbox": [70, 431, 362, 446], "page_size": [612.0, 792.0]}
{"layout": 145, "type": "text", "text": "All cosmetics sold in Canada, including those manufactured elsewhere and imported into  Canada, have to follow four safety rules under the FDA and the Cosmetic Regulations. According  to Health Canada,  a cosmetic must: (1) be free of any substance that may cause injury to the  health of the user when the cosmetic is used according to the directions on the label; 20  (2) be free  from any filthy or decomposed substance or of any foreign matter; 21  (3) be manufactured,  prepared, preserved, packaged and stored under sanitary conditions; 22  and (4) have its  composition and ingredients declared to the government by submitting a CNF.   ", "page_idx": 21, "bbox": [71, 459.66143798828125, 542, 527.618896484375], "page_size": [612.0, 792.0]}
{"layout": 146, "type": "text", "text": "", "page_idx": 22, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 147, "type": "text", "text": "The first safety rule can be satisfied by complying with the prohibitions and restrictions regarding  certain ingredients found in the Hotlist. Canada encourages manufacturers and importers to  follow the Hotlist and apply the Good Manufacturing Practices (GMPs) discussed infra Part I(E)  to conform to the second safety rule. Following the GMPs will also satisfy safety rule three.  Compliance with the fourth rule enables the government to monitor ingredients and check them  against the Hotlist, so that if a safety concern arises, the product can be prohibited and removed  from the market.  ", "page_idx": 22, "bbox": [71, 113.82144165039062, 542, 209.07809448242188], "page_size": [612.0, 792.0]}
{"layout": 148, "type": "text", "text": "According to section 29 of the Cosmetic Regulations,  the Minister of Health may request that a  manufacturer submit in writing, on or before a specified date, evidence to establish the safety of  the cosmetic. If the manufacturer does not submit the evidence, the Minister will bar the sale of  the cosmetic until further evidence is submitted and the Minister has issued a notification  declaring the evidence for the product’s safety is sufficient.   ", "page_idx": 22, "bbox": [71, 218.16110229492188, 542, 286.0583801269531], "page_size": [612.0, 792.0]}
{"layout": 149, "type": "text", "text": "It is important to note that cosmetics are excluded from regulation under the Canada Consumer  Product Safety Act (CCPSA),  as are Natural Health Products (NHPs).    ", "page_idx": 22, "bbox": [71, 300.1812438964844, 542, 327.0988464355469], "page_size": [612.0, 792.0]}
{"layout": 150, "type": "text", "text": "Canada is a member of the International Cooperation on Cosmetics Regulation (ICCR), a  voluntary organization with the goal of maintaining the highest level of global consumer  protection while minimizing barriers to international trade. In 2011, the ICCR published a  document on basic principles of cosmetic product safety assessment.  The ICCR is discussed in  more detail in Part II.E.1. of this report.  ", "page_idx": 22, "bbox": [71, 341.16131591796875, 542, 409.0584411621094], "page_size": [612.0, 792.0]}
{"layout": 151, "type": "text", "text": "1.  What Constitutes “Sufficient Evidence of Safety”?  ", "page_idx": 22, "bbox": [71, 422.7607727050781, 312.907958984375, 435.9978942871094], "page_size": [612.0, 792.0]}
{"layout": 152, "type": "text", "text": "Although we were unable to locate detailed guidance or a description of what evidence is deemed  sufficient, Health Canada determines whether an ingredient is safe by applying evidence-based  analysis and the principles of toxicology.  Health Canada consistently monitors global legal  developments in cosmetic regulation in other countries, and the Health Canada scientists keep  up with the scientific literature and recent developments on the safety of ingredients.  They  monitor information from the “Chemicals Management Plan, the European Union and United  States Food and Drug Administration (U.S. FDA).” 30   ", "page_idx": 22, "bbox": [71, 450.1207580566406, 542, 518.0189208984375], "page_size": [612.0, 792.0]}
{"layout": 153, "type": "text", "text": "", "page_idx": 23, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 154, "type": "text", "text": "2.  Cosmetic Ingredient Hotlist  ", "text_level": 1, "page_idx": 23, "bbox": [71, 112, 211, 126], "page_size": [612.0, 792.0]}
{"layout": 155, "type": "text", "text": "The Hotlist currently includes 573   ingredients listed, the use of which are either prohibited or  restricted.  Health Canada describes the Hotlist as “an administrative tool that is used to  communicate to manufacturers and others that certain substances, when present in a cosmetic,  may contravene the general prohibition found in section 16 of the FDA,” which states that “no  person shall sell any cosmetic that may cause injury to the health of the user when the cosmetic  is used.” 32  Additionally, according to Health Canada,  the presence of a substance from the  Hotlist in a product may cause that product to be excluded from the definition of a cosmetic under  the FDA.  ", "page_idx": 23, "bbox": [71, 137.08799743652344, 542, 247.23843383789062], "page_size": [612.0, 792.0]}
{"layout": 156, "type": "text", "text": "The Hotlist is not exhaustive and is continuously being updated. Proposed updates to the Hotlist  are put forward as needed, and decisions on the updates depend on the strength of the scientific  evidence ranging from recognized scientific journals to expert panel opinions.  As the Hotlist is  continually growing, a manufacturer or importer should not rely entirely on the list, and the sale  of a cosmetic should stop as soon as it is known that an ingredient may cause injury. Once a  proposal to update the Hotlist is put forward, a Notice to Stakeholders is issued approximately  three months before a 60-day consultation   period on proposed updates.  In this amount of time,  Health Canada expects manufacturers and importers to determine which of their products might  be affected by a possible update. If they have products that might be affected, during this time  they can start planning changes to their “product formulations, distribution and sale.” 36  After the  60-day consultation period, but before it publishes the final revised version of the Hotlist, Health  Canada will evaluate the comments it received and respond to them.  Health Canada publishes  the revised hotlist on the official website. Additionally, Health Canada will send the updated list  to subscribers to the Cosmetics Mailing List,  as well as those who have previously submitted a  CNF.  The last update   to the Hotlist was made in December 2019.     ", "page_idx": 23, "bbox": [71, 259.6813049316406, 542, 464.4599914550781], "page_size": [612.0, 792.0]}
{"layout": 157, "type": "text", "text": "Although Canada has regulations that ban plastic microbeads in toiletries, there does not appear  to be a ban in cosmetics.   ", "page_idx": 24, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 158, "type": "text", "text": "3.  New Substances Notification   ", "text_level": 1, "page_idx": 24, "bbox": [71, 113, 216, 125], "page_size": [612.0, 792.0]}
{"layout": 159, "type": "text", "text": "In 1994, Environment and Climate Change Canada published the Domestic Substances List  (DSL).   It is the only database   where a manufacturer or importer can determine whether a  substance is considered to be “new” in Canada.  Under the New Substances Notification   Regulation,  if the cosmetic has a substance that is not registered under the DSL, it should be  reported as a new substance to the Minister of Environment before importation or manufacturing,  so the government can assess whether the substance is toxic and whether it poses any safety  issues.  These “new” substances might be found in a variety of products, including cosmetics,  natural health products, and personal care products.   ", "page_idx": 24, "bbox": [71, 139.62338256835938, 542, 248.49880981445312], "page_size": [612.0, 792.0]}
{"layout": 160, "type": "text", "text": "C. Adverse Reaction Reporting  ", "text_level": 1, "page_idx": 24, "bbox": [70, 262, 229, 276], "page_size": [612.0, 792.0]}
{"layout": 161, "type": "text", "text": "Manufacturers, professionals, and consumers can report adverse reactions to Health Canada and  its partners.  In the official Guidance Document for Industry on Reporting Adverse Reactions to  Marketed Health Products, a distinction is made between an adverse event (AE) and an adverse  reaction (AR).  In its glossary, AE is defined as “any untoward medical occurrence in a patient  administered a medicinal product and which does not necessarily have to have a causal  relationship with this treatment,” while AR is defined as “a noxious and unintended response to  a product” under the Food and Drug Regulations and the NHP Regulation. For cosmetic  products, reporting safety-related incidents is categorized as adverse reaction reporting.   ", "page_idx": 24, "bbox": [71, 288.72003173828125, 542, 397.6588439941406], "page_size": [612.0, 792.0]}
{"layout": 162, "type": "text", "text": "Because cosmetics are exempt from the CCPSA, as noted above, the industry is not required to  report health- or safety-related incidents.  However, Health Canada encourages the cosmetics  industry to report any issues   voluntarily to the Consumer Product Safety Program.   ", "page_idx": 24, "bbox": [71, 411.3622741699219, 542, 452.03997802734375], "page_size": [612.0, 792.0]}
{"layout": 163, "type": "text", "text": "Consumers can also submit an adverse reaction report online by filling out the Consumer Product  Incident Report Form.  If Health Canada is not the right organization, it notifies the consumer  and asks whether it can direct the report to the right agency. Personal information included in  the report is protected by the Privacy Act.    ", "page_idx": 25, "bbox": [71, 72.48171997070312, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 164, "type": "text", "text": "Health Canada asks that reports from both consumers and the industry provide detailed  information on the product (product brand, name, description, the store where it was bought,  etc.), the incident (describing the injury, date, the type of medical care needed, etc.), and the  manufacturing details on the label (serial number, date of manufacture, address of the  manufacturer, etc.).   ", "page_idx": 25, "bbox": [71, 140.40115356445312, 542, 208.29885864257812], "page_size": [612.0, 792.0]}
{"layout": 165, "type": "text", "text": "D.  Cosmetic Labeling  ", "text_level": 1, "page_idx": 25, "bbox": [71, 222, 185, 235], "page_size": [612.0, 792.0]}
{"layout": 166, "type": "text", "text": "Cosmetic labeling is governed by the FDA, the Cosmetic Regulation, the Consumer Packaging  and Labelling Act, and the Consumer Packaging and Labelling Regulations.  According to  section 17 of the FDA, “[w]here a standard has been prescribed for a cosmetic, no person shall  label, package, sell or advertise any article in such a manner that it is likely to be mistaken for  that cosmetic, unless the article complies with the prescribed standard.” 55  Section 16 of the  Cosmetic Regulations prohibits the sale of a cosmetic product unless it complies with all of the  labeling requirements.   ", "page_idx": 25, "bbox": [71, 248.52011108398438, 542, 343.7788391113281], "page_size": [612.0, 792.0]}
{"layout": 167, "type": "text", "text": "Health Canada’s  Industry Guide for the Labelling of Cosmetics  states that  ", "page_idx": 25, "bbox": [71, 357.9017028808594, 412.4197082519531, 371.1388244628906], "page_size": [612.0, 792.0]}
{"layout": 168, "type": "text", "text": "[t]he Food and Drugs Act and the Cosmetic Regulations govern the classification and  labelling of cosmetic products with regard to the:  • expression of the product’s identity on its label,  • name and address of the principal place of business of the manufacturer (see definition)  indicated on the label,  • listing of ingredients on the label, and  • avoidable hazards presented by the cosmetic.  In addition, the Act and Regulations also address the issues of composition, safety,  and advertising.  The Cosmetic Regulations under the Food and Drugs Act allow a designated Health  Canada inspector to inspect:  • cosmetic products,  ", "page_idx": 25, "bbox": [107, 385.1281433105469, 506, 575.8855590820312], "page_size": [612.0, 792.0]}
{"layout": 169, "type": "text", "text": "• locations where cosmetics are manufactured or stored, and  • any labelling or advertising material related to a cosmetic product.   ", "page_idx": 26, "bbox": [107, 72.34811401367188, 419.68499755859375, 102.84793090820312], "page_size": [612.0, 792.0]}
{"layout": 170, "type": "text", "text": "Section 18 of the Cosmetic Regulations   states that any information on the label must be clear and  legible for the duration of the life of the product.    ", "page_idx": 26, "bbox": [71, 117.00173950195312, 542, 143.91885375976562], "page_size": [612.0, 792.0]}
{"layout": 171, "type": "text", "text": "The Consumer Packaging and Labelling Act and Regulations “prescribe the mandatory  information that must appear on the label of a pre-packaged cosmetic product.” 59  A list of  ingredients must appear on the outer label of a cosmetic, with each ingredient listed only by its  International Nomenclature of Cosmetic Ingredients (INCI) name,  in descending order.   ", "page_idx": 26, "bbox": [71, 157.98129272460938, 542, 212.25881958007812], "page_size": [612.0, 792.0]}
{"layout": 172, "type": "text", "text": "Until a November 16, 2006, amendment to the Cosmetics Regulations, there was no requirement  to put the ingredients list on the label of a cosmetic product.  According to some industry  experts,  this requirement carried with it the problem of fitting an ingredients list onto the labels  in both French and English.    ", "page_idx": 26, "bbox": [71, 226.32125854492188, 542, 280.5988464355469], "page_size": [612.0, 792.0]}
{"layout": 173, "type": "text", "text": "Section 18 of the Cosmetic Regulations stipulates that   ", "page_idx": 26, "bbox": [71, 294.7217102050781, 336.89453125, 307.9588317871094], "page_size": [612.0, 792.0]}
{"layout": 174, "type": "text", "text": "The information required by these Regulations to be provided on the label of a cosmetic  must  (a) be shown both in English and in French, except for the INCI name; and  (b) be clearly legible and remain so throughout the useful life of the cosmetic, or in the case  of a refillable container, throughout its useful life, under normal conditions of sale and use.  ", "page_idx": 26, "bbox": [107, 321.52813720703125, 506, 383.287109375], "page_size": [612.0, 792.0]}
{"layout": 175, "type": "text", "text": "The Canadian government recognizes the INCI system required in the European Union as the  standard for ingredient terms because of its application in several countries.  A list of ingredients  must appear on the outer label of a cosmetic, with each ingredient listed by its INCI name,  if not  by the appropriate English and French equivalents.  All ingredients must be listed in descending  order of predominance.   ", "page_idx": 26, "bbox": [71, 397.44171142578125, 542, 437.9788513183594], "page_size": [612.0, 792.0]}
{"layout": 176, "type": "text", "text": "", "page_idx": 27, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 177, "type": "text", "text": "Other labeling requirements include \n\n ", "page_idx": 27, "bbox": [71, 113.46127319335938, 251.3713836669922, 126.69839477539062], "page_size": [612.0, 792.0]}
{"layout": 178, "type": "text", "text": "   the name of the manufacturer and the address of their principal place of business,   \n\n    the identity of the cosmetic in terms of its common or generic name or in terms of its function,  unless the identity is obvious 70  \n\n    the net quantity of the product,  (units of measure in the metric system),  and \n\n    the avoidable hazards and cautions.   ", "page_idx": 27, "bbox": [71, 140.40036010742188, 542, 228.69924926757812], "page_size": [612.0, 792.0]}
{"layout": 179, "type": "text", "text": "Ad Standards,  the self-regulating body   of Canada’s   advertising industry, has published a  guidance document on acceptable claims that can be made on cosmetic labels.   ", "page_idx": 27, "bbox": [71, 242.82168579101562, 542, 269.7388610839844], "page_size": [612.0, 792.0]}
{"layout": 180, "type": "text", "text": "E.  Good Manufacturing Practices  ", "text_level": 1, "page_idx": 27, "bbox": [71, 283, 242, 296], "page_size": [612.0, 792.0]}
{"layout": 181, "type": "text", "text": "Section 16 paragraph c of the FDA   states that  ", "page_idx": 27, "bbox": [71, 310.3202209472656, 292.8357238769531, 323.558837890625], "page_size": [612.0, 792.0]}
{"layout": 182, "type": "text", "text": "No person shall sell any cosmetic that  (a) has in or on it any substance that may cause injury to the health of the user when  the cosmetic is used,  (i) according to the directions on the label or accompanying the cosmetic, or  (ii) for such purposes and by such methods of use as are customary or usual  therefor;  (b) consists in whole or in part of any filthy or decomposed substance or of any foreign  matter; or  (c) was manufactured, prepared, preserved, packaged or stored under unsanitary  conditions.     ", "page_idx": 27, "bbox": [108.0, 337.5481262207031, 506, 462.75885009765625], "page_size": [612.0, 792.0]}
{"layout": 183, "type": "text", "text": "Similarly, section 18 of the FDA   states: “No person shall manufacture, prepare, preserve,  package or store for sale any cosmetic under unsanitary conditions.” 77    ", "page_idx": 28, "bbox": [71, 72.48171997070312, 506.7432861328125, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 184, "type": "text", "text": "“Unsanitary conditions” are defined by section 2 of the FDA   as such conditions or circumstances  as might contaminate with dirt or filth, or render injurious to health, a food, drug or cosmetic.    ", "page_idx": 28, "bbox": [71, 113.04074096679688, 542, 139.95895385742188], "page_size": [612.0, 792.0]}
{"layout": 185, "type": "text", "text": "To adhere these safety and quality conditions, Health Canada strongly encourages manufacturers  to comply with GMPs.   ", "page_idx": 28, "bbox": [71, 154.08169555664062, 542, 180.99887084960938], "page_size": [612.0, 792.0]}
{"layout": 186, "type": "text", "text": "1.  ICCR  ", "text_level": 1, "page_idx": 28, "bbox": [71, 194, 113, 208], "page_size": [612.0, 792.0]}
{"layout": 187, "type": "text", "text": "As mentioned above, Canada is a member of the ICCR, which was established in 2007.  The  ICCR’s purpose is to harmonize regulatory standards among its members to ensure a maximum  level of consumer protection while also stimulating international trade in cosmetic products by  minimizing trade barriers.  Currently, the ICCR has five members.    ", "page_idx": 28, "bbox": [71, 222.00173950195312, 542, 276.2788391113281], "page_size": [612.0, 792.0]}
{"layout": 188, "type": "text", "text": "In ICCR’s first annual meeting in September 2007, the members committed to International  Standard Organization (ISO) standard 22716 on good manufacturing standards in the  cosmetics industry, as they recognized the importance of GMPs and a need to work towards  a common GMPs goal.  To this end, Canada created GMP guidelines taking into  consideration the ISO standard.   ", "page_idx": 28, "bbox": [71, 276.7217102050781, 542, 344.61883544921875], "page_size": [612.0, 792.0]}
{"layout": 189, "type": "text", "text": "The International Standards Organization (ISO) published guidelines (ISO 22716:2007) on good  manufacturing standards in the cosmetics industry in 2007, which recommend industry  standards on production, control, storage, and shipment of cosmetic products.  The guidelines  are concerned with the quality aspects of the product, and they do not cover safety aspects for  employees in manufacturing facilities or environmental concerns.    ", "page_idx": 28, "bbox": [71, 358.322265625, 542, 426.2188415527344], "page_size": [612.0, 792.0]}
{"layout": 190, "type": "text", "text": "Health Canada has made available GMP guidelines to provide manufacturers with a basic,  unenforceable, and nonbinding list of considerations to encourage them to comply with the  standards set under FDA sections 16 and 18.  They are manufacturing guidelines which are used  to “ensure product quality control and an effective approach to risk management. These  guidelines set out standards for product manufacturing, testing, storage, handling and  distribution, to ensure that each step of manufacturing is acceptable for quality and safety of the  product.” 88  These guidelines are not specific rules on the manufacturing of cosmetics, but they  provide a framework for desired outcomes during manufacture. Health Canada states that each  manufacturer, large or small, may have their own ways of reaching these expected outcomes.  Canada GMP guidelines recommend that manufacturers in Canada benefit from the more  detailed accounts of the GMPs on the ISO website,  the US Good Manufacturing Practice (GMP)  Guidelines/Inspection Checklist for Cosmetics,  the US Draft Guidance for Industry: Cosmetic  Good Manufacturing Practices,  and the Personal Care Products Council,  specifically the 2018  Quality Assurance Guidelines.  Health Canada provides the following list as guidelines:   ", "page_idx": 29, "bbox": [71, 113.04183959960938, 543, 303.99884033203125], "page_size": [612.0, 792.0]}
{"layout": 191, "type": "text", "text": "Building and Facilities  ", "text_level": 1, "page_idx": 29, "bbox": [107, 318, 212, 330], "page_size": [612.0, 792.0]}
{"layout": 192, "type": "text", "text": "  • building is adequate for the manufacture and storage of cosmetics    • walls, floors, fixtures, ducts, pipes, lighting, ventilation, water supply, drainage, toilet       facilities are adequate for the work and in good repair    • building has adequate air supply quality    • building has adequate pest control program to prevent attracting or harbouring pests  ", "page_idx": 29, "bbox": [108, 342.1086120605469, 502, 403.8675842285156], "page_size": [612.0, 792.0]}
{"layout": 193, "type": "text", "text": "Equipment  ", "text_level": 1, "page_idx": 29, "bbox": [107, 415, 160, 429], "page_size": [612.0, 792.0]}
{"layout": 194, "type": "text", "text": "  • equipment used in processing is adequate, well maintained, and free from        contamination  ", "page_idx": 29, "bbox": [108, 440.7485046386719, 451.732177734375, 465.3081970214844], "page_size": [612.0, 792.0]}
{"layout": 195, "type": "text", "text": "Personnel  ", "text_level": 1, "page_idx": 29, "bbox": [107, 477, 154, 489], "page_size": [612.0, 792.0]}
{"layout": 196, "type": "text", "text": "  • personnel have adequate education, training, experience and personal cleanliness  ", "page_idx": 29, "bbox": [108, 502.1891174316406, 483.9454650878906, 514.2688598632812], "page_size": [612.0, 792.0]}
{"layout": 197, "type": "text", "text": "Raw Materials  ", "text_level": 1, "page_idx": 30, "bbox": [107, 70, 176, 84], "page_size": [612.0, 792.0]}
{"layout": 198, "type": "text", "text": "  • raw materials are stored and handled to prevent contamination or alteration    • materials are tested or examined to assure quality  ", "page_idx": 30, "bbox": [108, 96.46859741210938, 462, 120.96817016601562], "page_size": [612.0, 792.0]}
{"layout": 199, "type": "text", "text": "Production  ", "text_level": 1, "page_idx": 30, "bbox": [107, 132, 160, 145], "page_size": [612.0, 792.0]}
{"layout": 200, "type": "text", "text": "  • manufacturing and control procedures are established and written instructions for       procedures are maintained  ", "page_idx": 30, "bbox": [108, 157.48934936523438, 488.26605224609375, 181.98892211914062], "page_size": [612.0, 792.0]}
{"layout": 201, "type": "text", "text": "Laboratory Controls  ", "text_level": 1, "page_idx": 30, "bbox": [107, 195, 201, 206], "page_size": [612.0, 792.0]}
{"layout": 202, "type": "text", "text": "  • raw materials, samples and finished products are tested or examined to ensure they       meet the defined standard    • water supply is free from contamination  ", "page_idx": 30, "bbox": [108, 206.80978393554688, 493.8771667480469, 243.72915649414062], "page_size": [612.0, 792.0]}
{"layout": 203, "type": "text", "text": "Records  ", "text_level": 1, "page_idx": 30, "bbox": [107, 256, 146, 268], "page_size": [612.0, 792.0]}
{"layout": 204, "type": "text", "text": "  • records are maintained for raw materials, manufacturing, finished products and        distribution  ", "page_idx": 30, "bbox": [108, 280.6091003417969, 477.8945007324219, 305.1687927246094], "page_size": [612.0, 792.0]}
{"layout": 205, "type": "text", "text": "Labelling  ", "text_level": 1, "page_idx": 30, "bbox": [107, 317, 153, 330], "page_size": [612.0, 792.0]}
{"layout": 206, "type": "text", "text": "  • labels on finished product contain the required information  ", "page_idx": 30, "bbox": [108, 342.0497131347656, 386.9186096191406, 354.1294860839844], "page_size": [612.0, 792.0]}
{"layout": 207, "type": "text", "text": "Complaints  ", "text_level": 1, "page_idx": 30, "bbox": [107, 366, 162, 379], "page_size": [612.0, 792.0]}
{"layout": 208, "type": "text", "text": "  • establishment maintains a consumer complaint file  ", "page_idx": 30, "bbox": [108, 391.0104064941406, 350, 403.0901794433594], "page_size": [612.0, 792.0]}
{"layout": 209, "type": "text", "text": "Other  ", "text_level": 1, "page_idx": 30, "bbox": [107, 415, 136, 428], "page_size": [612.0, 792.0]}
{"layout": 210, "type": "text", "text": "  • products adhere to all regulatory requirements    • products do not contain prohibited ingredients or substances 94 ", "page_idx": 30, "bbox": [108, 439.9710998535156, 398.3702087402344, 465.4906921386719], "page_size": [612.0, 792.0]}
{"layout": 211, "type": "text", "text": "F. Imports into the United States  ", "text_level": 1, "page_idx": 30, "bbox": [71, 479, 236, 492], "page_size": [612.0, 792.0]}
{"layout": 212, "type": "text", "text": "The FDA and Consumer Packaging and Labelling Regulations have sections stipulating that  cosmetic products manufactured or imported for the purposes of export are exempt from all of  their provisions.  ", "page_idx": 30, "bbox": [71, 505.9800720214844, 542, 546.5167846679688], "page_size": [612.0, 792.0]}
{"layout": 213, "type": "text", "text": "Exports   Conditions under which exports exempt  ", "text_level": 1, "page_idx": 30, "bbox": [106, 560, 292, 584], "page_size": [612.0, 792.0]}
{"layout": 214, "type": "text", "text": "37  (1) This Act does not apply to any packaged food, drug, cosmetic or device if  (a) it is manufactured or prepared in Canada;  (b) it is intended for export and is not manufactured or prepared for consumption or use  in Canada nor sold for consumption or use in Canada;  (c) a certificate that the package and its contents do not contravene any known requirement  of the law of the country to which it is or is about to be consigned has been issued in respect  of the package and its contents in prescribed form and manner; and  ", "page_idx": 30, "bbox": [108, 596.2686767578125, 506, 682.9273071289062], "page_size": [612.0, 792.0]}
{"layout": 215, "type": "text", "text": "(d) the packaged food, drug, cosmetic or device meets any other prescribed requirement.  ", "page_idx": 31, "bbox": [107, 72.34811401367188, 502.62664794921875, 84.42788696289062], "page_size": [612.0, 792.0]}
{"layout": 216, "type": "text", "text": "Conditions under which transhipment exempt  38  This Act does not apply to any packaged food, drug, cosmetic or device if  (a) it is manufactured or prepared outside Canada;  (b) it is imported solely for the purpose of export and is not sold for consumption or use in  Canada; and  (c) it meets any other prescribed requirement.   ", "page_idx": 31, "bbox": [107, 97.00833129882812, 506, 171.06790161132812], "page_size": [612.0, 792.0]}
{"layout": 217, "type": "text", "text": "Exemptions from All Provisions of the Act  ", "page_idx": 31, "bbox": [107, 183.64834594726562, 303.8592529296875, 195.72811889648438], "page_size": [612.0, 792.0]}
{"layout": 218, "type": "text", "text": "3   (2)  Prepackaged products that are produced or manufactured only for export or for sale  to a duty-free store, are exempt from all the provisions of the Act.   ", "page_idx": 31, "bbox": [107, 204.28854370117188, 506, 228.78811645507812], "page_size": [612.0, 792.0]}
{"layout": 219, "type": "text", "text": "III.  Classification of Products at Cosmetic-Drug Interface  ", "text_level": 1, "page_idx": 31, "bbox": [71, 258, 387, 272], "page_size": [612.0, 792.0]}
{"layout": 220, "type": "text", "text": "There are instances when a product does not clearly fall within the definition of “a cosmetic”  under Section 2 of the FDA. Certain products might be mistaken for cosmetic products even  though they are classified under different categories of products, e.g., drugs, natural health  products, food, or pesticides, and are thus subject to different regulations. For example, Health  Canada lists soap as an example of a cosmetic, whereas sunscreens (including makeup products  with sun protection factor) are not considered cosmetics.    ", "page_idx": 31, "bbox": [71, 286.32171630859375, 542, 367.8988342285156], "page_size": [612.0, 792.0]}
{"layout": 221, "type": "text", "text": "Natural Health Products are considered to be a subset of the category of drug.  Although the  term “drug” includes the Natural Health Products, the Natural Health Products are not regulated  by the Food and Drug Regulation but regulation by the Natural Health Products Regulations.  ", "page_idx": 31, "bbox": [71, 382.0216979980469, 542, 422.5584411621094], "page_size": [612.0, 792.0]}
{"layout": 222, "type": "text", "text": "A personal care product (PCP) is defined as a “substance or mixture of substances which is  generally recognized by the public for use in daily cleansing or grooming” and “may fall into one  of three regulatory categories in Canada: cosmetics, drugs or natural health products.  Health  Canada recognizes certain personal care products as Products at the Cosmetic-Drug Interface  (PCDI). These PCDI share characteristics of both a “cosmetic” and a “drug” defined under section  2 of the FDA.  Examples of PCDI include   acne therapy products, antiperspirants, anti-dandruff  products, skin whiteners, tooth whiteners, etc.  A PCDI may be regulated by one of the three  implementing regulations of the FDA, which are the Cosmetic Regulations, the Food and Drug  Regulations, and the Natural Health Products Regulations. Health Canada has published an  official document   providing guidance for industry professionals and clarifying how it interprets  PCDI and decides on the relevant regulatory framework for PCDI.    ", "page_idx": 31, "bbox": [71, 436.6813049316406, 542, 559.298828125], "page_size": [612.0, 792.0]}
{"layout": 223, "type": "text", "text": "", "page_idx": 32, "bbox": [71, 72.48171997070312, 542.747314453125, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 224, "type": "text", "text": "Health Canada will classify a PCDI taking into consideration three criteria on a case-by-case  basis.  According to Health Canada, these criteria are: 104    ", "page_idx": 32, "bbox": [71, 113.46127319335938, 521.5673217773438, 140.37887573242188], "page_size": [612.0, 792.0]}
{"layout": 225, "type": "text", "text": "1.   Representation: On the market, a cosmetic product should be represented as serving a  cosmetic function (such as cleansing or moisturizing etc.) If there is claim on the label,  package or advertisement of the product suggesting or implying that the product does  have a therapeutic effect, that product will not be a cosmetic.  It will be considered to be  a drug and will be regulated under different legislations. Health Canada provides the  following example: 106  Claiming ”cleanser for oily skin” versus claiming ”prevents and kills  acne bacteria.” An official guideline   for differentiating between non-therapeutic and  therapeutic claims is available.    ", "page_idx": 32, "bbox": [108, 153.10794067382812, 506, 252.18789672851562], "page_size": [612.0, 792.0]}
{"layout": 226, "type": "text", "text": "2.   Composition of the product: Although the composition of a product alone does not  determine its classification, the presence of an ingredient (for example if a restricted  ingredient from the Cosmetic Ingredient Hotlist), or its concentration, may make the  product unsuitable for classification as a cosmetic. Certain uses of some active ingredients  from Category IV Monographs may define the product as a non-prescription drug.  ", "page_idx": 32, "bbox": [108, 277.3675231933594, 506, 339.1866149902344], "page_size": [612.0, 792.0]}
{"layout": 227, "type": "text", "text": "3.   Level of action: Cosmetics are normally applied to an external part of the body. For  example, a cosmetic can be applied to area around the eyes, but if the product is directly  applied into the eyes, it is not classified as a cosmetic. The only exception to this factor is  tattoo ink.   ", "page_idx": 32, "bbox": [108, 364.3662414550781, 506, 413.7079162597656], "page_size": [612.0, 792.0]}
{"layout": 228, "type": "text", "text": "Lastly, when a product is reclassified, a Product Assessment Against Criteria (PAAC) providing  for a detailed justification for the reclassification decision is published. Currently completed  PAACs include antiperspirants,  diaper rash products,  and upon-request medicated skin  care products.    ", "page_idx": 33, "bbox": [71, 72.48171997070312, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 229, "type": "text", "text": "China  ", "text_level": 1, "page_idx": 34, "bbox": [281, 73, 329, 91], "page_size": [612.0, 792.0]}
{"layout": 230, "type": "text", "text": "Laney Zhang  Foreign Law Specialist ", "page_idx": 34, "bbox": [255.4796600341797, 98.58169555664062, 356, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 231, "type": "text", "text": "", "text_level": 1, "page_idx": 34, "bbox": [71, 160, 125, 164.75], "page_size": [612.0, 792.0]}
{"layout": 232, "type": "text", "text": "2020. Once it takes effect, the new Regulation will repeal the current overarching  cosmetics regulation. The final version of the Regulation has not been released.  ", "page_idx": 34, "bbox": [137, 172.1644287109375, 545, 197.9027099609375], "page_size": [612.0, 792.0]}
{"layout": 233, "type": "text", "text": "According to a draft of the Regulation, manufacturers must apply for a cosmetics  production license by submitting proof of proper facilities. Cosmetic products are also  subject to pre-market registration or filing. The applicant for the registration or filing is  responsible for the quality, safety, and efficacy of the products (“Responsible Person”).   ", "page_idx": 34, "bbox": [137, 212.72491455078125, 545, 264.56304931640625], "page_size": [612.0, 792.0]}
{"layout": 234, "type": "text", "text": "Prior to the registration or filing, a product safety assessment must be performed by a  person who has the relevant professional knowledge in medicine, pharmacy, chemistry,  or toxicology and five years’ work experience.  ", "page_idx": 34, "bbox": [137, 278.0044860839844, 545, 316.7627868652344], "page_size": [612.0, 792.0]}
{"layout": 235, "type": "text", "text": "If a cosmetic product has quality defects or may otherwise present a risk to human  health, the Responsible Person must immediately stop the manufacturing activities,  recall the products, and notify retailers and consumers, among other measures  prescribed by the Regulation. The Responsible Person must also report the recall and  measures taken to the local medical product authorities at the county level.  ", "page_idx": 34, "bbox": [137, 330.1443176269531, 545, 395.0024719238281], "page_size": [612.0, 792.0]}
{"layout": 236, "type": "text", "text": "I.  Legal Framework  ", "text_level": 1, "page_idx": 34, "bbox": [71, 423, 181, 438], "page_size": [612.0, 792.0]}
{"layout": 237, "type": "text", "text": "In China, the primary regulation of cosmetics is the Regulation Concerning the Hygiene  Supervision over Cosmetics issued by the State Council (i.e., cabinet) in 1989 (Hygiene  Regulation).  There are also a series of subsidiary rules, standards, and guidance documents  issued by the former competent authority, the China Food and Drug Administration (CFDA)  under the Ministry of Health, and the current competent authority, the National Medical  Products Administration (NMPA) under the   State Administration for Market Regulation.    ", "page_idx": 34, "bbox": [72, 451.9217224121094, 545, 533.4989013671875], "page_size": [612.0, 792.0]}
{"layout": 238, "type": "text", "text": "Since the issuance of the 1989 Hygiene Regulation, the country’s cosmetic market has grown  significantly and the cosmetics industry has undergone “tremendous change.” 3  As a result, in  2013, China started the process of revising the outdated Hygiene Regulation.  On January 3, 2020,  the State Council passed the Cosmetic Supervision and Administration Regulation (Regulation).   Once it takes effect, the new Regulation will repeal the Hygiene Regulation and overhaul the  current cosmetic regulatory system.        ", "page_idx": 34, "bbox": [72, 547.5613403320312, 545, 574.4788818359375], "page_size": [612.0, 792.0]}
{"layout": 239, "type": "text", "text": "", "page_idx": 35, "bbox": [71, 72.48171997070312, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 240, "type": "text", "text": "Although the final version of the new Regulation has not been released, the State Council  published an official draft in 2015 to solicit comments from the public.  Later, in December 2018,  China submitted an updated draft of the Regulation to the World Trade Organization  (Draft Regulation).    ", "page_idx": 35, "bbox": [71, 140.82168579101562, 542, 195.03884887695312], "page_size": [612.0, 792.0]}
{"layout": 241, "type": "text", "text": "II.  Registration of Cosmetics Facilities  ", "text_level": 1, "page_idx": 35, "bbox": [71, 208, 285, 223], "page_size": [612.0, 792.0]}
{"layout": 242, "type": "text", "text": "A.  Pre-market Registration and Filing of Cosmetic Products  ", "text_level": 1, "page_idx": 35, "bbox": [71, 236, 374, 251], "page_size": [612.0, 792.0]}
{"layout": 243, "type": "text", "text": "According to the Draft Regulation, special use cosmetics, i.e., hair dyes, hair-perming products,  freckle-removing and whitening products, sunscreens, and any other products claiming to have  new efficacies, require pre-market registration with the NMPA.  Non-special use cosmetics are  subject to pre-market filing with the medical products administration (MPA) at the  provincial level.    ", "page_idx": 35, "bbox": [71, 264.2411804199219, 542, 332.13885498046875], "page_size": [612.0, 792.0]}
{"layout": 244, "type": "text", "text": "The applicant for the cosmetic product registration or filing is responsible for the quality, safety,  and efficacy of the product (“Responsible Person”). The Responsible Persons may produce the  product on its own or entrust other manufacturers to produce the product.    ", "page_idx": 35, "bbox": [71, 346.26171875, 542, 386.7988586425781], "page_size": [612.0, 792.0]}
{"layout": 245, "type": "text", "text": "B. Cosmetics Production License  ", "text_level": 1, "page_idx": 35, "bbox": [71, 399, 237, 414], "page_size": [612.0, 792.0]}
{"layout": 246, "type": "text", "text": "Manufacturers must apply for a cosmetics production license from the provincial MPA. The  license is valid for five years and may be renewed in accordance with the laws.    ", "page_idx": 35, "bbox": [71, 427.86114501953125, 542, 454.7788391113281], "page_size": [612.0, 792.0]}
{"layout": 247, "type": "text", "text": "When applying for the license, a manufacturer must submit materials to prove that it has the  proper facilities, including: \n\n ", "page_idx": 36, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 248, "type": "text", "text": "(1)   proper production sites, environments, and production facilities and equipment for the types  of cosmetics to be produced \n\n (2)   technical personnel suitable for cosmetics production \n\n (3)   inspectors and facilities for quality inspection of the cosmetics to be produced  \n\n (4)   a safety management system 13   ", "page_idx": 36, "bbox": [71, 113.46127319335938, 542, 199.41891479492188], "page_size": [612.0, 792.0]}
{"layout": 249, "type": "text", "text": "III.  Cosmetic Safety Review and Substantiation Standards  ", "text_level": 1, "page_idx": 36, "bbox": [70, 212, 394, 228], "page_size": [612.0, 792.0]}
{"layout": 250, "type": "text", "text": "Under the Draft Regulation, prior to the registration or filing of a cosmetic product, a product  safety assessment must be performed by a person who has the relevant professional knowledge  in medicine, pharmacy, chemistry, or toxicology and five years’ work experience.   ", "page_idx": 36, "bbox": [71, 241.62173461914062, 542, 282.2188415527344], "page_size": [612.0, 792.0]}
{"layout": 251, "type": "text", "text": "In addition, manufacturers must appoint a person responsible for the safety and quality of their  products. The person must have the relevant professional knowledge in medicine, pharmacy,  chemistry, toxicology, chemical engineering, or biology and five years’ cosmetics production or  quality control experience.   ", "page_idx": 36, "bbox": [71, 296.28131103515625, 542, 350.558837890625], "page_size": [612.0, 792.0]}
{"layout": 252, "type": "text", "text": "The Draft Regulation does not specify the requirements for the safety assessment, which are  expected to be formulated by the NMPA in the   Guidance for Safety Risk Assessment of  Cosmetics.  The former regulator, CFDA, published draft guidance in 2015, which contains the  requirements for safety assessor, procedures for the assessment, and requirements for the safety  assessment reports.   ", "page_idx": 36, "bbox": [71, 364.68170166015625, 542, 432.578857421875], "page_size": [612.0, 792.0]}
{"layout": 253, "type": "text", "text": "IV.  Adverse Event Reporting  ", "text_level": 1, "page_idx": 36, "bbox": [70, 446, 236, 461], "page_size": [612.0, 792.0]}
{"layout": 254, "type": "text", "text": "If a cosmetic product has quality defects or may otherwise present a risk to human health, the  Responsible Person must immediately stop the manufacturing activities, recall the products, and  notify retailers and consumers, among other measures prescribed by the Regulation. The  Responsible Person must also report the recall and measures taken to the local medical product  authorities at the county level.   ", "page_idx": 36, "bbox": [71, 474.78131103515625, 542, 542.7388916015625], "page_size": [612.0, 792.0]}
{"layout": 255, "type": "text", "text": "If the local authority at or above the county level finds a cosmetic product has quality defects or  may otherwise present a risk to human health, it may order the product to be recalled or the  suspension of manufacturing activities and sales.    ", "page_idx": 37, "bbox": [71, 72.48171997070312, 542, 113.01882934570312], "page_size": [612.0, 792.0]}
{"layout": 256, "type": "text", "text": "V.  Cosmetics Labeling  ", "text_level": 1, "page_idx": 37, "bbox": [71, 126, 200, 141], "page_size": [612.0, 792.0]}
{"layout": 257, "type": "text", "text": "Labels on cosmetic products must be in Chinese and contain the following items: \n\n ", "page_idx": 37, "bbox": [71, 155.28170776367188, 467.8673095703125, 168.51882934570312], "page_size": [612.0, 792.0]}
{"layout": 258, "type": "text", "text": "   name of the product \n\n    name and address of the Responsible Person \n\n    license number, name, and address of the manufacturer \n\n    license number of special use cosmetics \n\n    number of the product standard \n\n    all ingredients \n\n    period of use \n\n    net volume  \n\n    direction of use and necessary safety warnings \n\n    other content prescribed by laws or regulations 20   ", "page_idx": 37, "bbox": [71, 182.22079467773438, 363.6837463378906, 377.80206298828125], "page_size": [612.0, 792.0]}
{"layout": 259, "type": "text", "text": "VI.  Good Manufacturing Practices  ", "text_level": 1, "page_idx": 37, "bbox": [71, 391, 264, 406], "page_size": [612.0, 792.0]}
{"layout": 260, "type": "text", "text": "According to the Draft Regulation, cosmetics manufacturers must comply with the  manufacturing guidelines issued by the central government medical product authority and  implement management systems concerning supplier selection, raw material evaluation, product  recall, etc.    ", "page_idx": 37, "bbox": [71, 420.06170654296875, 542, 474.3388366699219], "page_size": [612.0, 792.0]}
{"layout": 261, "type": "text", "text": "The CFDA previously issued the Practice for Cosmetics Manufacturing Licensing, which contain  the requirements and conditions for companies that want to manufacture cosmetics.  Manufacturers must comply with the document in order to obtain the cosmetics  production license.   ", "page_idx": 37, "bbox": [71, 488.40130615234375, 542, 542.6788940429688], "page_size": [612.0, 792.0]}
{"layout": 262, "type": "text", "text": "VII.  Treatment of Small and Medium-Sized Enterprises (SMEs)  ", "text_level": 1, "page_idx": 37, "bbox": [71, 556, 424, 571], "page_size": [612.0, 792.0]}
{"layout": 263, "type": "text", "text": "No special treatment has been identified specifically applying to small and medium-sized  cosmetics enterprises. China passed the Law on the Promotion of Small and Medium-sized  ", "page_idx": 37, "bbox": [71, 586.1417846679688, 542, 613.058837890625], "page_size": [612.0, 792.0]}
{"layout": 264, "type": "text", "text": "19  Id.   20  Id. art. 39.  21  Id. art. 25.  ", "page_idx": 37, "bbox": [71, 637.3267822265625, 124, 684.3955078125], "page_size": [612.0, 792.0]}
{"layout": 265, "type": "text", "text": "Enterprises in 2002 and revised the Law in 2017, calling for government protection and promotion  of SMEs.   ", "page_idx": 38, "bbox": [72, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 266, "type": "text", "text": "VIII.  Cosmetics Imports into the United States  ", "text_level": 1, "page_idx": 38, "bbox": [71, 113, 329, 128], "page_size": [612.0, 792.0]}
{"layout": 267, "type": "text", "text": "China is not a member of the International Cooperation on Cosmetics Regulation (ICCR), a  network of regulatory authorities of the European Union, United States, Canada, Japan, and  Brazil, but its representative participated in the ICCR annual meetings as an observer from 2013  to 2015.    ", "page_idx": 38, "bbox": [72, 141.60183715820312, 542, 195.87893676757812], "page_size": [612.0, 792.0]}
{"layout": 268, "type": "text", "text": "European Union  ", "text_level": 1, "page_idx": 39, "bbox": [242, 73, 369, 92], "page_size": [612.0, 792.0]}
{"layout": 269, "type": "text", "text": "Jenny Gesley  Foreign Law Specialist ", "page_idx": 39, "bbox": [255.48013305664062, 98.58169555664062, 356.5159912109375, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 270, "type": "text", "text": "SUMMARY   The European Union (EU) started regulating cosmetics as early as 1976. The main  legislation in the EU in the area of cosmetics is the Cosmetics Regulation, which aims  “to ensure the functioning of the internal market and a high level of protection of  human health.”   In addition, the Regulation on Registration, Evaluation, Authorisation  and Restriction of Chemicals (REACH) applies to the ingredients in cosmetics.   ", "page_idx": 39, "bbox": [70, 156.63809204101562, 542, 224.00323486328125], "page_size": [612.0, 792.0]}
{"layout": 271, "type": "text", "text": "Every manufacturer and importer of cosmetics must appoint a responsible person. The  responsible person must submit detailed information on the cosmetic product before it  is placed on the market. Furthermore, a safety assessment and a safety report, which  must be kept up-to-date, are mandatory. Responsible persons who become aware that  their product is unsafe or have reason to believe that it might be unsafe must take  corrective actions and inform the respective national authorities. Any undesirable and  serious undesirable effects of the cosmetic product and any corrective measures taken  must be communicated to the public and the national authorities.   ", "page_idx": 39, "bbox": [137, 237.44464111328125, 542, 341.4226379394531], "page_size": [612.0, 792.0]}
{"layout": 272, "type": "text", "text": "The EU Cosmetics Regulation contains detailed rules on the labeling of cosmetic  products. The list of ingredients must use the names established in the common  glossary by the European Commission to ensure consistency, or use internationally  recognized nomenclature.   ", "page_idx": 39, "bbox": [137, 354.8640441894531, 542, 406.642333984375], "page_size": [612.0, 792.0]}
{"layout": 273, "type": "text", "text": "The manufacture of cosmetics must comply with good manufacturing practice. There  is a presumption that the manufacture is in accordance with such practices when it  complies with the relevant harmonized standards as established by the European  standardization bodies.    ", "page_idx": 39, "bbox": [137, 420.083740234375, 542, 471.9219055175781], "page_size": [612.0, 792.0]}
{"layout": 274, "type": "text", "text": "The Cosmetics Regulation generally establishes the same rules for small and medium- sized enterprises (SMEs) and large enterprises, but takes the specific needs of SMEs into  account, in accordance with general EU policy on SMEs.   ", "page_idx": 39, "bbox": [137, 486.0849304199219, 542, 525.2667236328125], "page_size": [612.0, 792.0]}
{"layout": 275, "type": "text", "text": "I.  Introduction  ", "text_level": 1, "page_idx": 39, "bbox": [71, 555, 155, 569], "page_size": [612.0, 792.0]}
{"layout": 276, "type": "text", "text": "The European Union (EU) cosmetics market is the largest in the world. In 2018, it was valued at  €78.6 billion (about US\\$87.6 billion), according to Cosmetics Europe, the European trade  association for the cosmetics and personal care industry.  The largest national markets can be  found in Germany (€13.8 billion (about   $\\mathrm{US}\\Phi15.4$   billion)), France (€11.4 billion (about   $\\mathrm{USS12.7}$  billion)), the United Kingdom (€10.9 billion (about   $\\mathrm{USS12.2}$   billion)), Italy (€10.1 billion (about   $\\mathrm{USS11.3}$   billion)), and Spain (€7 billion (about  $\\mathrm{US}\\S7.8$   billion).  Germany and France were also the  largest exporters of cosmetic products from Europe, with a combined volume of   $50\\%$   of the total  €21.5 billion (about  $\\mathrm{US}\\S24$   billion) exports in 2018.   ", "page_idx": 39, "bbox": [70, 583.26171875, 542, 664.8388671875], "page_size": [612.0, 792.0]}
{"layout": 277, "type": "text", "text": "", "page_idx": 40, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 278, "type": "text", "text": "The EU started regulating cosmetics as early as 1976 with the adoption of the Cosmetics  Directive.  The Directive established rules on the composition, labeling, and packaging of  cosmetic products. It was amended several times over the years. In 2004 and 2009 respectively,  an animal testing ban on finished cosmetics products and on ingredients or combinations of  ingredients took effect. In addition, since 2009, a marketing ban for finished cosmetics products  and ingredients that were tested on animals has been in force. For some specific health effects,  the marketing ban has been applied since 2013. The Directive was replaced by the Cosmetics  Regulation, which entered into force on July 11, 2013.   ", "page_idx": 40, "bbox": [71, 113.46127319335938, 542, 222.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 279, "type": "text", "text": "II.  Legal Framework  ", "text_level": 1, "page_idx": 40, "bbox": [70, 236, 188, 252], "page_size": [612.0, 792.0]}
{"layout": 280, "type": "text", "text": "The main legislation in the EU in the area of cosmetics is the Cosmetics Regulation. An EU  regulation is directly applicable in the EU Member States once it enters into force and does not  need to be transposed into national law.  Member States are only allowed to regulate topics that  fall outside the scope of such a regulation.   ", "page_idx": 40, "bbox": [71, 264.6617126464844, 542, 318.87884521484375], "page_size": [612.0, 792.0]}
{"layout": 281, "type": "text", "text": "The aim of the Cosmetics Regulation is “to ensure the functioning of the internal market and a  high level of protection of human health.” 7  The Regulation maintains the legal regime put in place  by the Cosmetics Directive, but tightens the safety requirements and updates the rules to keep  abreast with technological development, in particular the use of nanomaterials. It defines  cosmetic products as “any substance or mixture intended to be placed in contact with the external  parts of the human body (epidermis, hair system, nails, lips and external genital organs) or with  the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to  cleaning them, perfuming them, changing their appearance, protecting them, keeping them in  good condition or correcting body odours.” 8   ", "page_idx": 40, "bbox": [71, 333.001708984375, 542, 455.558837890625], "page_size": [612.0, 792.0]}
{"layout": 282, "type": "text", "text": "In addition, the Regulation on Registration, Evaluation, Authorisation and Restriction of  Chemicals (REACH) applies to the ingredients in cosmetics.  The REACH entered into force in  2007 and is also directly applicable in the EU Member States. In January 2019, the European  Chemicals Agency (ECHA) proposed to restrict microplastics that are intentionally added to  mixtures.  Several EU Member States have introduced or are in the process of introducing bans  on the use of microplastics in certain types of products, mostly with regard to wash-off  cosmetic products.   ", "page_idx": 40, "bbox": [71, 469.68170166015625, 542, 523.8984375], "page_size": [612.0, 792.0]}
{"layout": 283, "type": "text", "text": "", "page_idx": 41, "bbox": [71, 72.48171997070312, 542, 113.01882934570312], "page_size": [612.0, 792.0]}
{"layout": 284, "type": "text", "text": "A.   Registration of Cosmetics Facilities  ", "text_level": 1, "page_idx": 41, "bbox": [70, 127, 268, 140], "page_size": [612.0, 792.0]}
{"layout": 285, "type": "text", "text": "Manufacturers in the EU are not required to register their cosmetics facilities; however, they must  appoint a “responsible person” who ensures compliance with the provisions of the Cosmetics  Regulation.  Only companies that have appointed such a person may place their cosmetic  products on the EU market. For products manufactured within the EU, the manufacturer  established within the EU is deemed the responsible person, whereas manufacturers that are  established outside the EU must designate a responsible person within the EU.  For imported  products, the importer is the responsible person, unless he or she appoints in writing a person  within the EU.  A distributor is deemed the responsible person where he or she places a cosmetic  product on the market under his name or trademark or modifies a product already placed on the  market in such a way that compliance with the applicable requirements might be affected.   ", "page_idx": 41, "bbox": [71, 154.08114624023438, 542, 290.31884765625], "page_size": [612.0, 792.0]}
{"layout": 286, "type": "text", "text": "Before a product may be placed on the market, the responsible person must submit detailed  product information through the online Cosmetic Products Notification Portal (CPNP) regarding,  among others, the category of the cosmetic product, contact information of the responsible person  where the product information file is available, presence of substances in the form of  nanomaterials, and the formula used.   ", "page_idx": 41, "bbox": [71, 304.44171142578125, 542, 372.3388366699219], "page_size": [612.0, 792.0]}
{"layout": 287, "type": "text", "text": "B.   Cosmetic Safety Review/Substantiation Standards  ", "text_level": 1, "page_idx": 41, "bbox": [71, 386, 343, 399], "page_size": [612.0, 792.0]}
{"layout": 288, "type": "text", "text": "Every cosmetic product placed on the market must have undergone a safety assessment.  The  safety assessment must be completed by a person with a diploma or other evidence of formal  qualifications awarded on completion of a university course of theoretical and practical study in  pharmacy, toxicology, medicine, or a similar discipline.  The requirements for the safety  assessment are outlined in part B of annex I of the Cosmetics Regulation. The responsible person  must make certain that the safety assessment takes into account the intended use of the cosmetic  product and the anticipated systematic exposure to individual ingredients, and that an  appropriate weight-of-evidence approach is used for reviewing data.  The safety assessment  must contain an assessment conclusion, an explanation of the scientific reasoning leading to the  assessment conclusion, a statement on the need to label any particular warnings and instructions  of use, and the assessor’s credentials and approval of the safety assessment.   ", "page_idx": 41, "bbox": [71, 413.401123046875, 542, 508.6588134765625], "page_size": [612.0, 792.0]}
{"layout": 289, "type": "text", "text": "", "page_idx": 42, "bbox": [71, 72.48171997070312, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 290, "type": "text", "text": "In addition, a safety report must be prepared.  The requirements for the safety report are outlined  in part A of annex I of the Cosmetics Regulation. The responsible person must ensure that the  product safety report is kept up to date.    ", "page_idx": 42, "bbox": [71, 140.82168579101562, 542, 181.41885375976562], "page_size": [612.0, 792.0]}
{"layout": 291, "type": "text", "text": "Safety reports must, as a minimum, cover the following information: \n\n ", "page_idx": 42, "bbox": [71, 195.48129272460938, 408, 208.71841430664062], "page_size": [612.0, 792.0]}
{"layout": 292, "type": "text", "text": "   quantitative and qualitative composition of the cosmetic product \n\n    physical/chemical characteristics and stability of the cosmetic product \n\n    microbiological quality \n\n    impurities, traces, information about the packaging material \n\n    normal and reasonably foreseeable use \n\n    exposure to the cosmetic product in relation to the site(s) of application, the surface area(s) of  application, the amount of product applied, the duration and frequency of use, the normal  and reasonably foreseeable exposure route(s), and the targeted (or exposed) population(s) \n\n    exposure to the substances   for the relevant toxicological endpoints \n\n    toxicological profile of the substances \n\n    undesirable effects and serious undesirable effects \n\n    other relevant information on the cosmetic product, such as existing studies from  human volunteers 23   ", "page_idx": 42, "bbox": [71, 222.42037963867188, 542, 459.0399475097656], "page_size": [612.0, 792.0]}
{"layout": 293, "type": "text", "text": "C.   Adverse Event Reporting  ", "text_level": 1, "page_idx": 42, "bbox": [70, 472, 220, 487], "page_size": [612.0, 792.0]}
{"layout": 294, "type": "text", "text": "Responsible persons who become aware that their product is unsafe or have reason to believe  that it might be unsafe must take corrective actions, including withdrawing or recalling the  product if necessary.  In addition, if the product presents a risk to human health, the competent  national authorities in the EU Member States must be notified immediately.  The notification  must include detailed information of the non-compliance with the Cosmetics Regulation and the  corrective measures taken.  Upon request of the national authorities, the responsible persons  must cooperate with them on any action to eliminate the risks, and provide them with all  necessary information and documentation in a language easily understood by the national  authorities.  If responsible persons do not comply with requests from national authorities, there  is a serious risk to human health, and the non-compliance is not limited to the EU Member State  in question, the national authorities must inform the European Commission and the authorities  of the other EU Member States of the measures required of the responsible person.  The national  authorities may also take provisional measures to withdraw, recall, or restrict the availably of the  cosmetic product in question.   ", "page_idx": 42, "bbox": [71, 500.10113525390625, 542, 567.9988403320312], "page_size": [612.0, 792.0]}
{"layout": 295, "type": "text", "text": "", "page_idx": 43, "bbox": [71, 72.48171997070312, 542, 195.03884887695312], "page_size": [612.0, 792.0]}
{"layout": 296, "type": "text", "text": "Furthermore, responsible persons must communicate without delay to the public and to the  competent national authorities where the effect in question occurred any undesirable and serious  undesirable effects (SUEs) of the cosmetic product and any corrective measures taken.   Undesirable effects are defined as “adverse reaction[s] for human health attributable to the  normal or reasonably foreseeable use of a cosmetic product.” 31  Serious undesirable effects (SUEs)  are “undesirable effect[s] which result in temporary or permanent functional incapacity,  disability, hospitalisation, congenital anomalies or an immediate vital risk or death  $^{\\prime\\prime}32$   The data  on undesirable effects and SUEs must be included in the product safety reports.  The competent  national authorities are cooperating and exchanging information on SUEs on the platform of  European market surveillance authorities for cosmetics (PEMSAC) to ensure a coherent  approach.  The European Commission has issued guidelines to streamline the reporting of SUEs  and to ensure the follow-up by national authorities.    ", "page_idx": 43, "bbox": [71, 209.16171264648438, 542, 372.75885009765625], "page_size": [612.0, 792.0]}
{"layout": 297, "type": "text", "text": "If a national market surveillance authority seriously doubts the safety of substance contained in  a cosmetics product that is made available on its market, it may make a reasoned request to  require the responsible person to submit a list of all cosmetics products containing that substance,  including the concentration of the substance in question.    ", "page_idx": 43, "bbox": [71, 386.8817138671875, 542, 441.0988464355469], "page_size": [612.0, 792.0]}
{"layout": 298, "type": "text", "text": "D.   Cosmetics Labeling  ", "text_level": 1, "page_idx": 44, "bbox": [69, 71, 192, 87], "page_size": [612.0, 792.0]}
{"layout": 299, "type": "text", "text": "Containers and packaging of cosmetics products must mention in indelible, easily legible, and  visible lettering: \n\n ", "page_idx": 44, "bbox": [71, 99.42166137695312, 542, 126.27835083007812], "page_size": [612.0, 792.0]}
{"layout": 300, "type": "text", "text": "   the name and address of the responsible person \n\n    the nominal contents at the time of packaging, by weight or by volume \n\n     the date of minimum durability (“best used before the end of”) for products with a minimum  durability of 30 months \n\n    the period of time after opening for which the product can be used for products with a  minimum durability of more than 30 months (indicated with the symbol representing an open  pot of cream) \n\n    particular precautions for use \n\n    the batch number of manufacture \n\n    the function of the cosmetic product, unless clear \n\n    a list of ingredients, meaning substances or mixtures intentionally used in the manufacturing  of the cosmetic product 37   ", "page_idx": 44, "bbox": [71, 139.98031616210938, 542, 349.9608154296875], "page_size": [612.0, 792.0]}
{"layout": 301, "type": "text", "text": "The information must be in the official language of the respective Member State.  With regard to  the list of ingredients, they must be indicated by using the common ingredient name set out in  the glossary established by the European Commission.  The European Commission must take  account of internationally recognized nomenclature, including the International Nomenclature  of Cosmetic Ingredients (INCI).  If there is no common ingredient name, the INCI term or other  generally accepted nomenclature must be used.   CosIng  is the European Commission database  for information on cosmetic substances and ingredients.   ", "page_idx": 44, "bbox": [71, 364.0816955566406, 542, 459.3388366699219], "page_size": [612.0, 792.0]}
{"layout": 302, "type": "text", "text": "E.   Good Manufacturing Practices  ", "text_level": 1, "page_idx": 44, "bbox": [70, 472, 245, 487], "page_size": [612.0, 792.0]}
{"layout": 303, "type": "text", "text": "Article 8 of the Cosmetics Regulation provides that the manufacture of cosmetics must comply  with good manufacturing practice to ensure the functioning of the internal market and a high  level of protection of human health.  There is a presumption that the manufacturer is in  accordance with such practices when it complies with the relevant harmonized standards.   Manufacturers remain free to use other methods to demonstrate compliance with the  requirements of the Cosmetics Regulation. Harmonized standards are “standard[s] adopted by  one of the European standardisation bodies . . . on the basis of a request made by the  Commission.” 45  The recognized European standardization bodies are CEN, CENELEC, and  ETSI.  Standards are defined as “technical specifications, adopted by a recognized  standardization body, for repeated or continuous application, with which compliance is not  compulsory.” 47  Technical specification means “a document that prescribes technical requirements  to be fulfilled by a product . . . and which lays down . . . the characteristics required of a product.” 48   The references to these harmonized standards have been published in the  Official Journal .   ", "page_idx": 44, "bbox": [71, 500.3407287597656, 542, 540.9388427734375], "page_size": [612.0, 792.0]}
{"layout": 304, "type": "text", "text": "", "page_idx": 45, "bbox": [71, 72.48171997070312, 542, 208.71884155273438], "page_size": [612.0, 792.0]}
{"layout": 305, "type": "text", "text": "F.   Treatment of Small and Medium-Sized Enterprises   ", "text_level": 1, "page_idx": 45, "bbox": [70, 222, 347, 236], "page_size": [612.0, 792.0]}
{"layout": 306, "type": "text", "text": "The EU is generally committed to creating an improved business environment for small and  medium-sized enterprises (SMEs) and avoiding disproportionate burdens on them. The Small  Business Act (SBA) is the EU’s overarching framework to achieve that purpose.  It is not legally  binding, but contains 10 principles that are supposed to guide EU and EU Member State policy.   ", "page_idx": 45, "bbox": [71, 249.78115844726562, 542, 303.99884033203125], "page_size": [612.0, 792.0]}
{"layout": 307, "type": "text", "text": "The principles are as follows: \n\n ", "page_idx": 45, "bbox": [71, 318.1217041015625, 216.49661254882812, 331.35882568359375], "page_size": [612.0, 792.0]}
{"layout": 308, "type": "text", "text": "   Create an environment in which entrepreneurs and family businesses can thrive and  entrepreneurship is rewarded \n\n    Ensure that honest entrepreneurs who have faced bankruptcy quickly get a second chance \n\n    Design rules according to the “Think Small First” principle, meaning taking SMEs’ interests  into account at a very early stage of policy making \n\n    Make public administrations responsive to the needs of SMEs \n\n    Adapt public policy tools to SMEs’ needs: facilitate SMEs’ participation in public procurement  and better use state aid possibilities for SMEs \n\n    Facilitate SMEs’ access to finance and develop a legal and business environment supportive  to timely payments in commercial transactions \n\n    Help SMEs to benefit more from the opportunities offered by the EU’s single market  ", "page_idx": 45, "bbox": [71, 345.0608215332031, 542, 534.8204345703125], "page_size": [612.0, 792.0]}
{"layout": 309, "type": "text", "text": "   Promote the upgrading of skills in SMEs and all forms of innovation \n\n    Enable SMEs to turn environmental challenges into opportunities \n\n    Encourage and support SMEs to benefit from the growth of markets 51 ", "page_idx": 46, "bbox": [71, 72.06100463867188, 427, 126.51962280273438], "page_size": [612.0, 792.0]}
{"layout": 310, "type": "text", "text": "The Cosmetics Regulation generally establishes the same rules for SMEs and large enterprises.  However, the Cosmetics Regulation, in accordance with general EU policy on SMEs, takes the  specific needs of SMEs into account. With regard to the safety requirements for cosmetics, the  European Commission, in close cooperation with stakeholders, is required to adopt appropriate  guidelines to enable all enterprises, and in particular SMEs, to comply with the requirements for  safety reports as outlined in annex I of the Cosmetics Regulation.  In November 2013, the  Commission adopted such guidelines, which were developed in cooperation with representatives  from SMEs.  Furthermore, the Commission, in its annual report on animal testing to the  European Parliament and the Council, must include a section “on the manner in which the  specific needs of small and medium-sized enterprises have been taken into account.” 54   ", "page_idx": 46, "bbox": [71, 140.64169311523438, 542, 276.8788757324219], "page_size": [612.0, 792.0]}
{"layout": 311, "type": "text", "text": "III.  Cosmetics Imports into the U.S.  ", "text_level": 1, "page_idx": 46, "bbox": [71, 291, 268, 306], "page_size": [612.0, 792.0]}
{"layout": 312, "type": "text", "text": "The EU cooperates with international stakeholders to enhance trade with non-EU countries and  has therefore concluded various bilateral and multilateral cooperation agreements. The European  Commission signed a confidentially agreement with the U.S. Food and Drug Administration  (FDA) in 2007, which allows the EU and the FDA to exchange confidential information about the  safety of cosmetics as part of their regulatory mandates in the field of cosmetics.  It covers  information on advance drafts of legislation and/or regulatory guidance documents, post- marketing data and information that could have an impact on the public health, and information  on ongoing and emerging regulatory issues of health and safety in the U.S. or the EU.  According  to the Commission’s press release announcing the agreement, in 2007, around  $7\\%$   of all cosmetic  products in the U.S. were imported from the EU.   ", "page_idx": 46, "bbox": [71, 319.1417236328125, 542, 455.37884521484375], "page_size": [612.0, 792.0]}
{"layout": 313, "type": "text", "text": "Furthermore, the EU and the U.S. discuss regulatory convergence in order to minimize trade  barriers through the International Cooperation on Cosmetics Regulation (ICCR), which was  established together with Japan and Canada.  Brazil joined the ICCR in 2014 and China has an  observer status.   ", "page_idx": 46, "bbox": [71, 469.501708984375, 542, 496.4188232421875], "page_size": [612.0, 792.0]}
{"layout": 314, "type": "text", "text": "", "page_idx": 47, "bbox": [72, 72.48171997070312, 542.7567138671875, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 315, "type": "text", "text": "France  ", "text_level": 1, "page_idx": 48, "bbox": [279, 74, 332, 90], "page_size": [612.0, 792.0]}
{"layout": 316, "type": "text", "text": "Nicolas Boring  Foreign Law Specialist ", "page_idx": 48, "bbox": [255.48007202148438, 98.58169555664062, 356.51593017578125, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 317, "type": "text", "text": "Cosmetics in France are principally regulated by the 2009 European Regulation on Cosmetic  Products.  The designated competent authority under article 6 of the Regulation on Cosmetic  Products is, for France, the Agence nationale de sécurité du médicament et des produits de santé  (National Agency for the Safety of Medication and Health Products).   ", "page_idx": 48, "bbox": [71, 152.82070922851562, 542, 207.09884643554688], "page_size": [612.0, 792.0]}
{"layout": 318, "type": "text", "text": "In addition to the provisions of the European Regulation on Cosmetic Products, the French  government has recently adopted a law that prohibits the use of microplastics in certain  cosmetics.   Specifically, this law prohibits the intentional inclusion of a concentration of  $0.01\\%$   or  more of microplastics to rinsable exfoliation or washing cosmetics, and, from January 1, 2027,  onwards, to all other rinsable cosmetics.  This prohibition does not apply to natural or  biodegradable microplastics.   ", "page_idx": 48, "bbox": [71, 221.16128540039062, 542, 302.7388610839844], "page_size": [612.0, 792.0]}
{"layout": 319, "type": "text", "text": "Germany  ", "text_level": 1, "page_idx": 49, "bbox": [268, 74, 343, 93], "page_size": [612.0, 792.0]}
{"layout": 320, "type": "text", "text": "Jenny Gesley  Foreign Law Specialist ", "page_idx": 49, "bbox": [255.48013305664062, 98.58169555664062, 356.5159912109375, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 321, "type": "text", "text": "I.   Introduction  ", "text_level": 1, "page_idx": 49, "bbox": [71, 155, 160, 169], "page_size": [612.0, 792.0]}
{"layout": 322, "type": "text", "text": "The German cosmetics market is the largest in the European Union (EU), according to Cosmetics  Europe, the European trade association for the cosmetics and personal care industry.  In 2018, it  had a sales volume of €13.8 billion (about  $\\mathrm{US}\\S15.4$   billion), followed by France with €11.4 billion  (about US\\$12.7 billion).  Germany and France were also the largest exporters of cosmetic products  from Europe, with a combined volume of  $50\\%$   of the total €21.5 billion (about  $\\mathrm{US}\\S24$   billion) EU  exports in 2018.   ", "page_idx": 49, "bbox": [71, 183.42129516601562, 542, 265.0588684082031], "page_size": [612.0, 792.0]}
{"layout": 323, "type": "text", "text": "The main legislation in Germany is the EU Cosmetics Regulation, which entered into force on  July 11, 2013, and is directly applicable in Germany.  Germany therefore was only allowed to  regulate topics that fall outside the scope of the Regulation. Those rules are mainly codified in the  German Cosmetics Regulation.   ", "page_idx": 49, "bbox": [71, 279.1213073730469, 542, 333.3988342285156], "page_size": [612.0, 792.0]}
{"layout": 324, "type": "text", "text": "II.   German Cosmetics Regulation  ", "text_level": 1, "page_idx": 49, "bbox": [71, 347, 258, 361], "page_size": [612.0, 792.0]}
{"layout": 325, "type": "text", "text": "Manufacturers who manufacture their cosmetic product in Germany must notify the competent  German market surveillance authority of the production location of the cosmetic product prior to  placing the product on the market.  Importers must notify the authority of the location where the  cosmetic product enters Germany for the first time.  All notifications and labeling of cosmetics  products must be in the German language.   Cosmetics products that are not prepackaged, are  packaged at the point of sale at the purchaser's request, or are prepackaged for immediate sale,  may only be placed on the market if the labeling information appears in an enclosed leaflet or on  an attached label, paper tape, tag, or card.  If labeling is impossible, in particular because of the  small size of the package or the shape of the cosmetic product, the labeling information must  ", "page_idx": 49, "bbox": [71, 375.6017150878906, 542, 498.2188415527344], "page_size": [612.0, 792.0]}
{"layout": 326, "type": "text", "text": "6  Id. § 3.  7  Id.  8  Id. § 4.  9  Id. § 5, para. 1.  ", "page_idx": 49, "bbox": [71, 649.1467895507812, 141.016845703125, 713.9755249023438], "page_size": [612.0, 792.0]}
{"layout": 327, "type": "text", "text": "appear on a sign in immediate proximity to the product or container in which the cosmetic  product is exposed for sale.  In addition, the cosmetics products must comply with the rules on  nominal quantities for prepackaged products codified in the German Regulation on Prepackaged  Products.  There are special rules for aerosol dispensers that contain more than  $50\\,\\mathrm{mol}.$  .   ", "page_idx": 50, "bbox": [72, 72.48171997070312, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 328, "type": "text", "text": "Lastly, the German Cosmetics Regulation makes certain noncompliance with the EU Cosmetics  Regulation a crime or administrative offense, in particular when a cosmetic product placed on  the market is unsafe for human health.   ", "page_idx": 50, "bbox": [72, 140.82168579101562, 542, 181.41885375976562], "page_size": [612.0, 792.0]}
{"layout": 329, "type": "text", "text": "Israel  ", "text_level": 1, "page_idx": 51, "bbox": [284, 74, 328, 90], "page_size": [612.0, 792.0]}
{"layout": 330, "type": "text", "text": "Ruth Levush  Senior Foreign Law Specialist ", "page_idx": 51, "bbox": [239.7603302001953, 98.58169555664062, 374, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 331, "type": "text", "text": "SUMMARY   The production, import, and marketing of cosmetic products require both a general  cosmetic license as well as a license for the specific cosmetic product involved under  Israeli law. The production and export of a cosmetic product that is intended  exclusively for export, however, requires only a general cosmetic license. A license for  a specific cosmetic product requires submission of a certificate from the director of the  Institute of Standards and Control of Medical Materials, Ministry of Health, indicating  that the specific cosmetic product has been tested.    ", "page_idx": 51, "bbox": [71, 151.65811157226562, 542, 245.1224365234375], "page_size": [612.0, 792.0]}
{"layout": 332, "type": "text", "text": "The distribution of a cosmetic product in Israel generally requires that it first be subject  to a professional safety assessment and that an updated safety report be prepared in  relation to the product’s contents and the manner in which the safety assessment was  conducted, ways in which it can be updated, and the competency required to perform  it. Specific sensitivity tests are required for “dedicated cosmetic products.” Cosmetic  products may only be stored at a location licensed for manufacturing and marketing  cosmetics or at a drug store.   ", "page_idx": 51, "bbox": [137, 258.56475830078125, 542, 349.462890625], "page_size": [612.0, 792.0]}
{"layout": 333, "type": "text", "text": "Self-regulation and supervision requirements have been proposed by the Ministry of  Health. Adverse event reporting is similarly proposed in draft regulations. The  Ministry’s website enables online reporting of side effects, though such reporting does  not appear to be mandatory as of now. Detailed labeling requirements apply to cosmetic  products, including a mandatory duty to identify nanoparticles in the product’s  ingredients list on the label.  ", "page_idx": 51, "bbox": [137, 362.904296875, 542, 440.8423156738281], "page_size": [612.0, 792.0]}
{"layout": 334, "type": "text", "text": "A sharp increase in requests for the export of cosmetic products to the US was reported  in 2016-2017, with an increasing number of small cosmetic firms entering the cosmetics  and toiletries sector. Small and large companies do not appear to be treated differently  in terms of cosmetic regulations.   ", "page_idx": 51, "bbox": [137, 453.0249328613281, 542, 504.80322265625], "page_size": [612.0, 792.0]}
{"layout": 335, "type": "text", "text": "I.   Introduction  ", "text_level": 1, "page_idx": 51, "bbox": [71, 532, 160, 547], "page_size": [612.0, 792.0]}
{"layout": 336, "type": "text", "text": "A.   General Licensing Requirements  ", "text_level": 1, "page_idx": 51, "bbox": [72, 560, 256, 574], "page_size": [612.0, 792.0]}
{"layout": 337, "type": "text", "text": "Under Israeli law the manufacture, import, export, wholesale storage operation, and distribution  of cosmetic products requires a cosmetic license from the Director General of the Ministry of  Health or the Director’s designee.  In accordance with the Pharmacists Ordinance [New Version],  5741-1981, a “cosmetic [product]” means   ", "page_idx": 51, "bbox": [71, 587.2807006835938, 542, 641.558837890625], "page_size": [612.0, 792.0]}
{"layout": 338, "type": "text", "text": "any substance or mixture of substances intended to come into contact with external parts  of the human body, with the sole or primary purpose of cleaning, perfuming, altering its  appearance, protecting or preserving it, or enhancing the odors of the body, other than a  preparation or medical device; For this purpose, “external part of the human body”  [means]– the outer layer of skin, hair, nails, lips, teeth, mucous membranes and  externa genitalia.   ", "page_idx": 52, "bbox": [108, 72.34811401367188, 506, 146.58792114257812], "page_size": [612.0, 792.0]}
{"layout": 339, "type": "text", "text": "A valid cosmetic license may be issued by the Director in accordance with the provisions of the  Ordinance and the terms of the license, including instructions and conditions regarding the types  of activity and cosmetics to which it applies.  Accordingly, an applicant must comply with the  following requirements:  \n\n ", "page_idx": 52, "bbox": [71, 160.68173217773438, 542, 214.95883178710938], "page_size": [612.0, 792.0]}
{"layout": 340, "type": "text", "text": "   Have a business license or permit, including a temporary permit, or approval granted under  the Business Licensing Law, 5728-1968,  which concerns cosmetics; \n\n    Employ professionals of the type prescribed by the Minister of Health for the protection of  public health and for ensuring the effectiveness of the cosmetic, and its safety and quality; \n\n    Appoint a representative responsible for each type of cosmetic license, unless the cosmetic  product is intended to be manufactured or distributed solely for export outside of Israel; \n\n    Be in compliance with the conditions set out in ISO standard 22716 as updated,  or with  conditions specified in other international standards or professional guidelines that the  Director has found to be at least equivalent to the said standard and which were specified on  the Ministry of Health’s (MOH’s) website as such; \n\n    Have the appropriate conditions required for the proper transport and distribution of  cosmetics, as prescribed by the Minister of Health, in order to ensure the efficiency, safety,  and quality of the cosmetics; \n\n    Not have been convicted or indicted for an offense that, in its essence, severity, or  circumstances, makes the applicant unworthy of obtaining a cosmetic license, in the Director  General’s opinion.   ", "page_idx": 52, "bbox": [71, 227.64077758789062, 542, 479.2591552734375], "page_size": [612.0, 792.0]}
{"layout": 341, "type": "text", "text": "The issue of a license is also subject to any other conditions set by the MOH, with the approval of  the Knesset Welfare and Health Committee, including conditions for protecting public health and  ensuring the effectiveness, safety, and quality of cosmetics.   ", "page_idx": 52, "bbox": [71, 493.3817138671875, 542, 533.9788818359375], "page_size": [612.0, 792.0]}
{"layout": 342, "type": "text", "text": "A cosmetic license is valid for a period of five years. The Ordinance prescribes procedures for the  issuance and renewal of cosmetic licenses, including relevant dates, particulars, and documents  to be included or attached to the application.   ", "page_idx": 53, "bbox": [71, 72.48171997070312, 542, 113.01882934570312], "page_size": [612.0, 792.0]}
{"layout": 343, "type": "text", "text": "B.   Licensing of Specific Cosmetic Products  ", "text_level": 1, "page_idx": 53, "bbox": [70, 126, 292, 141], "page_size": [612.0, 792.0]}
{"layout": 344, "type": "text", "text": "Additional rules on the licensing of cosmetic products are contained in the Commodity and  Services Supervision (Cosmetics) Order, 5733-1973, as amended. For purpose of its application,  “a cosmetic product” is defined as “any product used or intended to be used for the treatment,  beautification, cleaning, coloring, alteration or improvement of the facial skin, body skin, hair,  oral cavity, nails or teeth, including other such products.” 9    ", "page_idx": 53, "bbox": [71, 154.08114624023438, 542, 221.97885131835938], "page_size": [612.0, 792.0]}
{"layout": 345, "type": "text", "text": "Unlike the production, import, and marketing of cosmetic products, which require both a general  cosmetic license as well as a license for the specific cosmetic product involved, the production  and export of a cosmetic product that is intended exclusively for export requires only a general  cosmetic license.  The order provides that a cosmetic license may only be issued to a person who  holds a license under the Business Licensing Law, 5728-1968 11  for a craft or business dealing in  cosmetics, or who holds a pharmacy license.  Additionally, a license for a specific cosmetic  product requires submission of a certificate from the director of the Institute of Standards and  Control of Medical Materials within the MOH that the specific cosmetic product has been tested. ", "page_idx": 53, "bbox": [71, 236.10171508789062, 542, 345.038818359375], "page_size": [612.0, 792.0]}
{"layout": 346, "type": "text", "text": "C.   Regulation of Safety, Labeling, Adverse Event Reporting, and Other Related Topics   ", "text_level": 1, "page_idx": 53, "bbox": [70, 358, 511, 372], "page_size": [612.0, 792.0]}
{"layout": 347, "type": "text", "text": "The MOH has issued several directives and circulars that address registration of cosmetic  facilities, safety reviews, cosmetic labeling, etc. In addition, the MOH has issued a document titled  Guidelines for Proper Manufacturing Procedures for Cosmetics Products  (CGMP) containing  recommendations for good practice.   ", "page_idx": 53, "bbox": [71, 386.0407409667969, 542, 440.31884765625], "page_size": [612.0, 792.0]}
{"layout": 348, "type": "text", "text": "The Knesset Labor, Welfare and Health Committee has considered draft regulations, the Pharmacists (Cosmetics) Regulations, 5778-2018, that regulate topics including the distribution of  cosmetic products, nano-ingredients in such products, safety reviews, importation, prohibited  ingredients, labeling, and adverse event reporting.  The Committee has held several meetings to  discuss the draft regulations, with the last meeting held on March 22, 2018. The regulations,  however, were never approved and thus are not in effect.    ", "page_idx": 53, "bbox": [71, 454.3813171386719, 542, 508.6588439941406], "page_size": [612.0, 792.0]}
{"layout": 349, "type": "text", "text": "", "page_idx": 54, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 350, "type": "text", "text": "On December 3, 2019, the MOH’s cosmetics department published a document (the 2019  document) in response to a request from the Prime Minister’s Office and the Director General of  the Ministry of Health. The document describes the “principles for the adoption of Swiss  cosmetics regulation in Israel with necessary adjustments and includes initial information.” 17    ", "page_idx": 54, "bbox": [71, 113.46127319335938, 542, 167.73886108398438], "page_size": [612.0, 792.0]}
{"layout": 351, "type": "text", "text": "The 2019 document proposes to adopt an up-to-date cosmetic regulation in Israel similar to the  one applied in Switzerland, with necessary adjustments, to ensure public health, while at the  same time attempting to reduce the regulatory burden imposed on cosmetics dealers in Israel.  The document provides as follows:  ", "page_idx": 54, "bbox": [71, 181.80130004882812, 542, 236.07839965820312], "page_size": [612.0, 792.0]}
{"layout": 352, "type": "text", "text": "Swiss cosmetics regulation is based on the principle of self-regulation, whereby there exists  trust between the regulator and dealers in the industry to carry out the controls and tests  required to ensure public health before disseminating the cosmetics in the market and for  the duration of the cosmetic’s shelf life.  ", "page_idx": 54, "bbox": [108, 250.06814575195312, 506, 299.4073181152344], "page_size": [612.0, 792.0]}
{"layout": 353, "type": "text", "text": "Switzerland is a country where an “island economy” exists. The number of residents in  Switzerland is similar to Israel. Despite its geographical location, it is not part of the  European Union, with all its regulatory implications. Compared to Israel . . . . Switzerland  enjoys geographical proximity to continental Europe and the fact that most cosmetics are  imported from or exported to Europe. This situation is different from the situation in Israel.  ", "page_idx": 54, "bbox": [108, 312.828125, 506, 374.58709716796875], "page_size": [612.0, 792.0]}
{"layout": 354, "type": "text", "text": "", "page_idx": 54, "bbox": [107, 380.25, 122, 386], "page_size": [612.0, 792.0]}
{"layout": 355, "type": "text", "text": "Swiss cosmetics regulation is based on European Regulation (EC) 1223/2009 with some  adjustments tailored to the cosmetics market in Switzerland.   ", "page_idx": 54, "bbox": [108, 399.7667236328125, 506, 424.3279113769531], "page_size": [612.0, 792.0]}
{"layout": 356, "type": "text", "text": "This report addresses specific aspects of the regulation of cosmetics in Israel based on current  law. References to the text of the draft regulations, the CGMP, and the 2019 document are also  included, as relevant.  ", "page_idx": 54, "bbox": [71, 438.4217224121094, 542, 479.0188293457031], "page_size": [612.0, 792.0]}
{"layout": 357, "type": "text", "text": "II.   Registration of Cosmetics Facilities  ", "text_level": 1, "page_idx": 54, "bbox": [71, 491, 284, 508], "page_size": [612.0, 792.0]}
{"layout": 358, "type": "text", "text": "Cosmetic products may only be stored at a location licensed for manufacturing and marketing  cosmetics or at a drug store. An application form for a general license to store cosmetics is  available as an addendum to the Requirements for Granting a General License for Storage and  Marketing of Cosmetics, Directive No. 68 (Aug. 2006), issued by the MOH in August 2006.   ", "page_idx": 54, "bbox": [71, 520.8616333007812, 542, 575.078857421875], "page_size": [612.0, 792.0]}
{"layout": 359, "type": "text", "text": "Directive No. 68 provides the following conditions for operating a cosmetic storage facility:  ", "page_idx": 55, "bbox": [71, 72.48171997070312, 517.749755859375, 85.71884155273438], "page_size": [612.0, 792.0]}
{"layout": 360, "type": "text", "text": "3.3.1 The size of the warehouse will fit the scope of the activity in it but will not be less than  15 square meters [161.459 feet].    3.3.2 The warehouse should be built and sealed to ensure protection against animals, flies,  rodents, or insects.    3.3.3 The walls, ceiling, and floor should be completely cleanable, as well as waterproof.    3.3.4 The shelves should be made of nonabsorbent material and of sufficient height to  enable cleaning of the floor and draining fluid.    3.3.5 The mode of storage should ensure the quality of the cosmetics.    3.3.6 The warehouse should be ventilated and illuminated.  ", "page_idx": 55, "bbox": [108, 99.70816040039062, 506, 273.3054504394531], "page_size": [612.0, 792.0]}
{"layout": 361, "type": "text", "text": "3.3.7 The place should be clean and have a controlled temperature not exceeding   $30^{\\circ}\\subset.$  .   $[86^{\\circ}$   Fahrenheit]. If there is a toilet in the room, the entrance to it will be through a foyer  with another door. This room [will have] a sink and water faucet and means for cleaning  hands and disposable wipes.   ", "page_idx": 55, "bbox": [108, 285, 506, 335.4645690917969], "page_size": [612.0, 792.0]}
{"layout": 362, "type": "text", "text": "Directive No. 68 further requires that storage conditions in licensed facilities should meet  requirements established by manufacturers. Cosmetics should also be stored separately from any  other products, and be prepackaged.   Easy access to cosmetics stored in the facility should further  be maintained, according to a first-in, first-out (FIFO) method of inventory, or in production-date  order. Additionally, packages intended for return or destruction should be separately collected  in the designated area and marked accordingly.    ", "page_idx": 55, "bbox": [71, 349.2016296386719, 542, 430.7788391113281], "page_size": [612.0, 792.0]}
{"layout": 363, "type": "text", "text": "The draft regulations would require the Director to determine that an applicant’s business meets  storage and distribution conditions that are appropriate for cosmetics as a condition of issuance  or renewal of a cosmetic license.  The Director would also be required to ascertain that the  production site meets the proper conditions for manufacturing of cosmetics according to ISO  standard 22716 as updated, or conditions specified in other international standards or  professional guidelines that the Director finds are at least equivalent to the said standard and are  specified on the MOH’s website as such.  The draft regulations suggest, however, that for  purposes of renewal of a cosmetic license the Director would be allowed to rely on an approval  by an authorized body that the applicant has complied with ISO 22716 without checking the  production site itself.   ", "page_idx": 55, "bbox": [71, 444.84130859375, 542, 581.1388549804688], "page_size": [612.0, 792.0]}
{"layout": 364, "type": "text", "text": "III.   Safety Review and Substantiation Standards  ", "text_level": 1, "page_idx": 56, "bbox": [71, 72, 345, 87], "page_size": [612.0, 792.0]}
{"layout": 365, "type": "text", "text": "A.   Safety Review and Testing  ", "text_level": 1, "page_idx": 56, "bbox": [72, 100, 226, 113], "page_size": [612.0, 792.0]}
{"layout": 366, "type": "text", "text": "In accordance with the Pharmacists Ordinance, a cosmetic dealer may not distribute a cosmetic  product in Israel unless it has been subjected to a professional safety assessment and an updated  safety report has been prepared in relation to the content and manner of conducting the safety  assessment, ways in which it can be updated, and the competency required to perform it.   ", "page_idx": 56, "bbox": [71, 127.14114379882812, 542, 181.35885620117188], "page_size": [612.0, 792.0]}
{"layout": 367, "type": "text", "text": "The Grant of a Cosmetic License according to the Commodity and Services Supervision  (Cosmetics) Order 5733-1973, Directive No. 2 (May 1999), distinguishes between a dedicated  cosmetic and a regular cosmetic product. A dedicated cosmetic product is one that is “designed  for a defined purpose after demonstrating its safety and suitability for its purpose.” 26  A regular  cosmetic product is one that is not a dedicated cosmetic, the components of which are examined  only from a safety aspect.    ", "page_idx": 56, "bbox": [71, 195.48171997070312, 542, 277.0588684082031], "page_size": [612.0, 792.0]}
{"layout": 368, "type": "text", "text": "According to the MOH website, ", "page_idx": 56, "bbox": [71, 291.1817321777344, 227.16229248046875, 304.4188537597656], "page_size": [612.0, 792.0]}
{"layout": 369, "type": "text", "text": "[a] [r]egular cosmetic product [is a] substance intended to come in contact with the external  parts of the human body in order to clean, scent or beautify it, change its appearance,  protect or guard it, or improve body odors. All products intended for use on hair, nails,  teeth and oral orifice are included under this definition.   ", "page_idx": 56, "bbox": [107, 318.40814208984375, 506, 367.7479248046875], "page_size": [612.0, 792.0]}
{"layout": 370, "type": "text", "text": "A dedicated cosmetic is described as one of the following products:  ", "page_idx": 56, "bbox": [71, 381.9017028808594, 401.7130126953125, 395.1388244628906], "page_size": [612.0, 792.0]}
{"layout": 371, "type": "text", "text": "   Intended for lightening the skin, protecting from UV rays, preventing sweat  (antiperspirant), wrinkle treatment, slowing down skin aging, or treating dandruff;     Gets into contact with the external genitalia, body mucus or oral cavity;     Hypoallergenic or designed for sensitive skin;     Noncomedogenic – does not lead to blocking of the pores      Tear-free     Containing ingredients from living organisms, microorganisms or through  biotechnology process.   ", "page_idx": 56, "bbox": [107, 409.0681457519531, 506, 508.1479187011719], "page_size": [612.0, 792.0]}
{"layout": 372, "type": "text", "text": "An application for a dedicated cosmetic license must be submitted to the MOH’s pharmacy  division and include testing results performed by one of the recognized laboratories listed in  Directive No. 2.    ", "page_idx": 56, "bbox": [71, 522.3017578125, 542, 562.8988647460938], "page_size": [612.0, 792.0]}
{"layout": 373, "type": "text", "text": "Details about the tests that are required for registration and licensing are contained in a circular  issued by the MOH on May 1, 2009, entitled “Procedure for Registration and Licensing –  Appendices 1,3,4, Circular Tm_2_124.” 31  Accordingly,   ", "page_idx": 57, "bbox": [71, 72.48171997070312, 542, 113.01882934570312], "page_size": [612.0, 792.0]}
{"layout": 374, "type": "text", "text": "[m]icrobial load  is required from all cosmetics (except nail varnish), except when  reasons justifying exemption from this test were received. The upper limit shall not exceed  1000 per gram of product. In cosmetics for use in the eye area and in infants, no more than  500 microorganisms are allowed per gram product. In any case, a count of less than 1000  grams per product requires testing to exclude the presence of pathogens.   ", "page_idx": 57, "bbox": [107, 127.00814819335938, 506, 188.82791137695312], "page_size": [612.0, 792.0]}
{"layout": 375, "type": "text", "text": "Additionally,  $\\mathrm{pH}$   testing is required for ointments and creams, solutions, emulsions, detergents,  gels, and pencils. Stability at  $40^{\\circ}\\mathrm{C}$     $(104^{\\circ}\\mathrm{F})$   for a period of 14 days is further required for all these  categories of products as well as nail polish. In alcoholic solutions the methanol concentration  should not exceed   $0.2\\%$  . The circular includes additional detailed requirements for testing  irritation levels.    ", "page_idx": 57, "bbox": [71, 202.98171997070312, 542, 270.8788757324219], "page_size": [612.0, 792.0]}
{"layout": 376, "type": "text", "text": "The circular provides the following list of tests required for cosmetic products according to their  objectives. Proof of the objective of dedicated cosmetics are determined in accordance with  appropriate protocols, such as the following:  ", "page_idx": 57, "bbox": [71, 284.94134521484375, 542, 325.5384521484375], "page_size": [612.0, 792.0]}
{"layout": 377, "type": "text", "text": "1.   Sun protection factor SPF according to the protocol of FDA or COLIPA.  2.   Hypoallergenic: according to protocol of repeat-insult patch test.   3.   Tears free cosmetic: according to protocol approved by the Ministry of Health.  4.   Lead residue: In toothpastes containing calcium carbonate  CaCO3 .  ", "page_idx": 57, "bbox": [107, 339.52813720703125, 474.6429443359375, 388.8673095703125], "page_size": [612.0, 792.0]}
{"layout": 378, "type": "text", "text": "The performance of sensitivity tests for cosmetic products is further regulated under circular  Tm_18071999 issued by the MOH in July 1999. Testing for sensitivity must take place in hospitals,  clinics, or dermatology units under the supervision of a specialized dermatologist. The test results  must be attached to the application for registration of the cosmetic product. Circular  Tm_18071999 further establishes the criteria for including candidates in the test, rules of  participants’ behavior, and rules of testing, among others.    ", "page_idx": 57, "bbox": [71, 403.021728515625, 542, 484.5988464355469], "page_size": [612.0, 792.0]}
{"layout": 379, "type": "text", "text": "B.   Self- Regulation and Supervision   ", "text_level": 1, "page_idx": 57, "bbox": [71, 497, 258, 512], "page_size": [612.0, 792.0]}
{"layout": 380, "type": "text", "text": "As noted above, the December 2019 document issued by the MOH proposes a regulatory model  similar to the Swiss model, which the document views as based on the principle of self- regulation.  Among the responsibilities of cosmetics manufacturers, distributers, importers, and  exporters (cosmetics dealers) is the duty to implement self-regulation in connection with the  safety risks of cosmetic products and the volume of production.  Cosmetic dealers must ensure  the participation of appropriate professionals in conducting self-control and carry out self-control  activities by taking samples and conducting laboratory tests (themselves or through third  parties), among other measures.    ", "page_idx": 57, "bbox": [71, 525.6611938476562, 542, 552.5178833007812], "page_size": [612.0, 792.0]}
{"layout": 381, "type": "text", "text": "", "page_idx": 58, "bbox": [71, 72.48171997070312, 542, 154.05886840820312], "page_size": [612.0, 792.0]}
{"layout": 382, "type": "text", "text": "In addition to regular supervision that must be undertaken by manufacturers and importers to  ensure that a cosmetic product is safe for use and that its quality and effectiveness have not been  impacted, the document requires special attention to “cosmetics under strict standards,” listed as  one of the following: sun protection products, cosmetics intended for infants and children up to  the age of 12, cosmetics intended for the eyes or oral cavity, cosmetics for pregnant or lactating  women, and cosmetics containing nanoparticles.   ", "page_idx": 58, "bbox": [71, 168.18173217773438, 542, 249.75881958007812], "page_size": [612.0, 792.0]}
{"layout": 383, "type": "text", "text": "IV.   Adverse Event Reporting  ", "text_level": 1, "page_idx": 58, "bbox": [71, 263, 234, 278], "page_size": [612.0, 792.0]}
{"layout": 384, "type": "text", "text": "The proposed Pharmacists (Cosmetics) Regulations, 5778-2018, would require the manufacturer,  importer, or their representative who has learned of any serious side effect resulting from the use  of a cosmetic product manufactured or imported, or for which they are responsible, to  immediately notify the Director. The notice would contain the following details:  ", "page_idx": 58, "bbox": [71, 291.5412292480469, 542, 345.8183288574219], "page_size": [612.0, 792.0]}
{"layout": 385, "type": "text", "text": "1) The name of the cosmetic product and information that allows its specific  identification;   2) Information about all serious side effects known to him/her about the product, as well  as about any side effects that are not serious but appear in high prevalence;  3) Details of the measures taken regarding these side effects.  ", "page_idx": 58, "bbox": [108, 359.8081359863281, 506, 421.5671081542969], "page_size": [612.0, 792.0]}
{"layout": 386, "type": "text", "text": "The Director may use the information . . . for the purpose of protection of public health. ", "page_idx": 58, "bbox": [108, 434.3269348144531, 493.9644775390625, 446.4067077636719], "page_size": [612.0, 792.0]}
{"layout": 387, "type": "text", "text": "Similar provisions are proposed in the 2019 document. Accordingly, any manufacturer, importer,  exporter, or wholesaler of cosmetic products (cosmetic dealer) who has a reasonable concern that  a product may cause injury or damage to a person or serious side effects would immediately need  to take measures to prevent its distribution by withdrawing it from the market or by recall. The  product would be held in a location exclusively under the control of the cosmetic dealer, who  would immediately report to the Director the concern about the adverse event or side effect, the  scope of the problem, and the measures taken to prevent the product’s distribution  and marketing.   ", "page_idx": 58, "bbox": [71, 459.0017395019531, 542, 567.87890625], "page_size": [612.0, 792.0]}
{"layout": 388, "type": "text", "text": "The 2019 document further suggests that a cosmetic dealer would also need to document all  complaints about existing or potential damage to a person’s health in relation to any product the  dealer has produced, imported, or sold. Documentation would need to be held for a minimum  period of ten years from the date of receipt of any complaint.   ", "page_idx": 59, "bbox": [71, 72.48171997070312, 542, 126.69882202148438], "page_size": [612.0, 792.0]}
{"layout": 389, "type": "text", "text": "The MOH website currently enables reporting of side effects and drug-related adverse events by  filling out a report form.    ", "page_idx": 59, "bbox": [71, 140.82168579101562, 542, 167.73886108398438], "page_size": [612.0, 792.0]}
{"layout": 390, "type": "text", "text": "V.   Cosmetics Labeling  ", "text_level": 1, "page_idx": 59, "bbox": [70, 181, 191, 195], "page_size": [612.0, 792.0]}
{"layout": 391, "type": "text", "text": "The Commodity and Services Supervision (Cosmetics) Order, 5733-1973 requires each cosmetic  or container containing a cosmetic product to be labeled. The label must include the following  cosmetic product details: name of the product; the manufacturer’s name and address; if imported,  the importer’s name and address; the quantity in decimal measurements; a list of ingredients; the  date of manufacture in a secret mark; instructions for use and cautions; and a notation of the sun  protection level where relevant, as prescribed by the MHDG.  A detailed list of requirements  associated with these and additional labeling information is provided by the 1999 circular and  include the following:  \n\n ", "page_idx": 59, "bbox": [71, 208.44125366210938, 542, 317.37884521484375], "page_size": [612.0, 792.0]}
{"layout": 392, "type": "text", "text": "   A list of ingredients in decreasing quantitative order according to the International  Nomenclature of Cosmetic Ingredients – INCI 45  \n\n    The date of manufacture of the cosmetic or its identification code \n\n    Instructions for use and warnings as prescribed in the license \n\n    Cosmetic license number 46   \n\n    In designated cosmetics, the notation “approved use objectives” must be placed under the  license number, followed by a list of the objectives approved in the license \n\n    When the cosmetic product is in a capsule or ampoule it must be labeled “For external use  only” and “keep away from children.” 47   ", "page_idx": 59, "bbox": [71, 331.0808410644531, 542, 487.0595703125], "page_size": [612.0, 792.0]}
{"layout": 393, "type": "text", "text": "Special warnings labels must be attached to cosmetic products containing acetone. ", "page_idx": 59, "bbox": [71, 501.1213073730469, 471.7822265625, 514.3584594726562], "page_size": [612.0, 792.0]}
{"layout": 394, "type": "text", "text": "In Israel it is mandatory to mark nanoparticles in the product’s ingredients on the label. An  nanoparticle would be labeled “NANO” next to the name of the ingredient.   ", "page_idx": 60, "bbox": [71, 72.48171997070312, 542, 99.97457885742188], "page_size": [612.0, 792.0]}
{"layout": 395, "type": "text", "text": "VI.   Good Manufacturing Practices  ", "text_level": 1, "page_idx": 60, "bbox": [70, 112, 268, 128], "page_size": [612.0, 792.0]}
{"layout": 396, "type": "text", "text": "As noted above, the MOH published the Guidelines for Proper Manufacturing Procedures for  Cosmetics Products (CGMP) on June 1, 2003. The Guidelines merely constitute recommendations  for good practice; they are not mandatory.   ", "page_idx": 60, "bbox": [71, 141.60183715820312, 542, 182.19894409179688], "page_size": [612.0, 792.0]}
{"layout": 397, "type": "text", "text": "The   CGMP provides for recording and maintaining batches of raw materials, and for packaging  of materials, bulk products, and finished products that have passed inspection. Among other  things, the CGMP proposes ways by which control laboratories may help production  departments and sets detailed procedures for other aspects of quality control.   ", "page_idx": 60, "bbox": [71, 195.30160522460938, 542, 249.51882934570312], "page_size": [612.0, 792.0]}
{"layout": 398, "type": "text", "text": "VII.   How Small Cosmetic Firms are Treated Differently than Larger Firms   ", "text_level": 1, "page_idx": 60, "bbox": [71, 262, 485, 278], "page_size": [612.0, 792.0]}
{"layout": 399, "type": "text", "text": "The Israeli cosmetics industry is reportedly characterized by the growth of new, small factories  alongside the large and established factories.  No difference in treatment of small cosmetic firms  versus large ones was identified.  ", "page_idx": 60, "bbox": [71, 290.342041015625, 542, 330.8784484863281], "page_size": [612.0, 792.0]}
{"layout": 400, "type": "text", "text": "VIII.   Cosmetics Imported into the US  ", "text_level": 1, "page_idx": 60, "bbox": [70, 344, 284, 360], "page_size": [612.0, 792.0]}
{"layout": 401, "type": "text", "text": "A sharp increase in requests for the export of cosmetic products was reported by the Export  Institute in 2017, with   $33\\,\\%$   of all cosmetics exported to the US, an increase of   $16\\%$   from 2016  to 2017.     ", "page_idx": 60, "bbox": [71, 372.1221923828125, 542, 412.71929931640625], "page_size": [612.0, 792.0]}
{"layout": 402, "type": "text", "text": "Japan  ", "text_level": 1, "page_idx": 61, "bbox": [282, 74, 329, 94], "page_size": [612.0, 792.0]}
{"layout": 403, "type": "text", "text": "Sayuri Umeda  Senior Foreign Law Specialist   ", "page_idx": 61, "bbox": [239.7595672607422, 98.58169555664062, 374.98486328125, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 404, "type": "text", "text": "SUMMARY   Japan’s Pharmaceuticals and Medical Devices Act regulates “beauty products.” Most  beauty products are classified as either quasi-pharmaceutical products or cosmetics  under the Act, and regulated according to that classification. Manufacturers and  marketers of quasi-pharmaceutical products and cosmetics must obtain licenses in  order to operate. A person who intends to market quasi-pharmaceutical products or  certain cosmetics must obtain government approval for each individual product.  Adverse events must be reported. The Act also sets labeling requirements. In principle,  all components included in cosmetics must be listed.      ", "page_idx": 61, "bbox": [71, 151.65811157226562, 542, 258.1424560546875], "page_size": [612.0, 792.0]}
{"layout": 405, "type": "text", "text": "I.  Cosmetics and Quasi-Pharmaceutical Products   ", "text_level": 1, "page_idx": 61, "bbox": [71, 286, 341, 300], "page_size": [612.0, 792.0]}
{"layout": 406, "type": "text", "text": "Japanese cosmetics are regulated under the Act on Securing Quality, Efficacy and Safety of  Products including Pharmaceuticals and Medical Devices (Pharmaceuticals and Medical Devices  Act).  The term “cosmetic products” (beauty products) may include “cosmetics” and “quasi- pharmaceutical products” (medicated beauty products), and possibly some “pharmaceuticals,”  such as severe dry-skin treatment creams. This report focuses on “cosmetics” and “quasi- pharmaceutical products.”  ", "page_idx": 61, "bbox": [71, 314.1017150878906, 542, 395.6784362792969], "page_size": [612.0, 792.0]}
{"layout": 407, "type": "text", "text": "The Act uses the term “cosmetics” to refer to items that are intended to be used on the human  body by rubbing, sprinkling, or other similar means, aiming to clean and beautify it, increase  one’s attractiveness, alter one’s appearance, or keep the skin or hair in good condition, and that  have mild effects on the human body.  This term excludes pharmaceuticals if they are used in the  diagnosis, treatment, or prevention of disease in humans or animals, or to affect the structure and  functioning of a human or animal’s body, even if those pharmaceuticals have the same purpose  as cosmetics.    ", "page_idx": 61, "bbox": [71, 409.8013000488281, 542, 505.058837890625], "page_size": [612.0, 792.0]}
{"layout": 408, "type": "text", "text": "Medicated cosmetic products fall into the category of quasi-pharmaceutical products. Quasi- pharmaceutical products are those that have mild effects on the human body and, according to  the Pharmaceuticals and Medical Devices Act, may be used to prevent nausea, other discomfort,  bad breath, hair loss, heat rash, skin sores, and similar symptoms. They may also be used for  promoting hair growth or for hair removal, among other things. Products that are used for the  diagnosis, treatment, or prevention of disease in humans or animals, or to affect the structure and  functioning of a human’s or animal’s body, are classified as pharmaceutical products. However,  under some circumstances, the Ministry of Health, Labour and Welfare (MHLW) may designate  these products as quasi-pharmaceutical products.   ", "page_idx": 61, "bbox": [71, 519.121337890625, 542, 614.3779296875], "page_size": [612.0, 792.0]}
{"layout": 409, "type": "text", "text": "", "page_idx": 62, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 410, "type": "text", "text": "II.  Licenses   ", "text_level": 1, "page_idx": 62, "bbox": [71, 113, 139, 127], "page_size": [612.0, 792.0]}
{"layout": 411, "type": "text", "text": "In addition to compulsory marketing approvals (See Part III, below.), the following licenses  and/or accreditation are also required when a marketer seeks to obtain an approval for a product  to be marketed.   ", "page_idx": 62, "bbox": [71, 141.60183715820312, 542, 182.19894409179688], "page_size": [612.0, 792.0]}
{"layout": 412, "type": "text", "text": "A.  License for Manufacturing  ", "text_level": 1, "page_idx": 62, "bbox": [71, 195, 225, 210], "page_size": [612.0, 792.0]}
{"layout": 413, "type": "text", "text": "To engage in the business of manufacturing quasi-pharmaceutical products or cosmetics, a  person must obtain from the MHLW a license for manufacturing quasi-pharmaceutical products  or cosmetics for each manufacturing facility.  The license expires in five years but is renewable.   The MHLW may not grant a license when the structure and equipment of the manufacturing  facility do not comply with established standards under the Ministry Ordinance 7  or when the  applicant is not qualified because of a record of violation of the Act in the past, among other  things.  For example, the facility standards for manufacturers of general quasi-pharmaceutical  products requires, among other things, appropriate space, lighting, and ventilation for the  manufacturing facility. The facility must also have equipment or instruments for the prevention  of dust accumulation and the intrusion of insects and mice, wastewater treatment, and sanitizing  workers. The separate requirements under the facility standards apply to the work space used  for weighing raw materials, preparing pharmaceuticals, and filling containers.  While the MHLW  is authorized to conduct an investigation into whether manufacturing facilities are in compliance  with the standards, it may delegate these investigations to the Pharmaceuticals and Medical  Devices Agency (PMDA).   ", "page_idx": 62, "bbox": [71, 223.20083618164062, 542, 427.8388366699219], "page_size": [612.0, 792.0]}
{"layout": 414, "type": "text", "text": "In case of foreign manufacturers intending to export their quasi-pharmaceutical products or  cosmetics to Japan, instead of the license, they must obtain accreditation for each manufacturing  facility outside Japan in accordance with the same facility and qualification standards for  domestic manufacturers.    ", "page_idx": 62, "bbox": [71, 441.9617004394531, 542, 496.1788330078125], "page_size": [612.0, 792.0]}
{"layout": 415, "type": "text", "text": "B.  License for Marketing Business  ", "text_level": 1, "page_idx": 63, "bbox": [70, 72, 247, 86], "page_size": [612.0, 792.0]}
{"layout": 416, "type": "text", "text": "A person who manufactures or imports and sells quasi-pharmaceutical products or cosmetics  must obtain a license from the MHLW.  The license expires in five years but is renewable.  The  MHLW may deny a license if \n\n ", "page_idx": 63, "bbox": [71, 99.42166137695312, 542, 139.95895385742188], "page_size": [612.0, 792.0]}
{"layout": 417, "type": "text", "text": "   the methods for quality control for quasi-pharmaceutical products or cosmetics pertaining to  the application do not comply with the standards established by MHLW ordinance; 14  \n\n    the methods for post-marketing safety control   15    for quasi-pharmaceutical products or  cosmetics pertaining to the application do not comply with the standards under a MHLW  ordinance; 16  or \n\n    the applicant is not qualified because of a record of violation of the Act in the past, among  other reasons.   ", "page_idx": 63, "bbox": [71, 153.66091918945312, 542, 262.8392639160156], "page_size": [612.0, 792.0]}
{"layout": 418, "type": "text", "text": "The Minister of MHLW has delegated the authority to issue manufacturing business licenses to  the prefecture governors.   ", "page_idx": 63, "bbox": [71, 276.9012756347656, 542, 303.81884765625], "page_size": [612.0, 792.0]}
{"layout": 419, "type": "text", "text": "C.  Good Manufacturing Practices  ", "text_level": 1, "page_idx": 63, "bbox": [71, 318, 243, 331], "page_size": [612.0, 792.0]}
{"layout": 420, "type": "text", "text": "The Japan Cosmetic Industry Association (JCIS) had established Cosmetics Good Manufacturing  Practices (GMP) in 1981.   19    After the International Organization for Standardization (ISO)  established its Cosmetics GMP (ISO 22716) in 2007, the JCIS decided to adopt it as its self-imposed  rule.  The MHLW issued a notice that informed prefectures that the JCIS had changed its GMP  rule in 2008,  following discussions between the JCIS and the MHLW.   ", "page_idx": 63, "bbox": [71, 344.8811340332031, 542, 385.4188537597656], "page_size": [612.0, 792.0]}
{"layout": 421, "type": "text", "text": "", "page_idx": 64, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 422, "type": "text", "text": "III.  Marketing Approvals and Safety Standards for Individual Products  ", "text_level": 1, "page_idx": 64, "bbox": [69, 112, 466, 128], "page_size": [612.0, 792.0]}
{"layout": 423, "type": "text", "text": "A person who intends to market quasi-pharmaceutical products, other than some products  subject to MHLW exceptions 23  or cosmetics containing components specified by the MHLW,  must obtain MHLW approval for each type of product.   In principle, all components must be  listed on cosmetics labels (see Part VI(B)), except for those that are exempt from required listing  by the MHLW.  This happens if a  manufacturer does not wish to reveal certain components and  lists them as “others.” For example, when the component is newly invented, the manufacturer  may not wish to reveal it. In such a case, a marketer of the cosmetic must obtain marketing  approval from the MHLW.  If cosmetics do not have such components, the marketer is only  required to report the types of products to the MHLW before placing them on the market.   ", "page_idx": 64, "bbox": [71, 141.60183715820312, 542, 264.2188415527344], "page_size": [612.0, 792.0]}
{"layout": 424, "type": "text", "text": "An applicant for the approval must submit with their written application data concerning the  results of clinical studies and other pertinent data, pursuant to the provisions of an MHLW  ordinance.  The application must be submitted through the PMDA.  The MHLW will deny  marketing approval in the following cases: \n\n ", "page_idx": 64, "bbox": [71, 278.28131103515625, 542, 332.558837890625], "page_size": [612.0, 792.0]}
{"layout": 425, "type": "text", "text": "   Where an applicant fails to obtain the proper marketing business license 29  \n\n    Where the manufacturing facility for the item does not receive the proper license or  accreditation for manufacturing 30   ", "page_idx": 64, "bbox": [71, 346.2608337402344, 542, 394.23919677734375], "page_size": [612.0, 792.0]}
{"layout": 426, "type": "text", "text": "   Where an examination reveals that the quasi-pharmaceutical product does not have the  efficacy or effects indicated in the application, or that its harmful effects outweigh the efficacy  or effects 31  \n\n    Where the quasi-pharmaceutical product or cosmetic falls under the cases described by  MHLW ordinance as not being an appropriate product 32  in view of the health and hygiene  concerns related to its properties or qualities 33     ", "page_idx": 65, "bbox": [71, 72.06100463867188, 542, 161.01882934570312], "page_size": [612.0, 792.0]}
{"layout": 427, "type": "text", "text": "The MHLW has issued specific standards for the marketing approval of hair coloring agents, permanent wave agents,  and bath additives.     ", "page_idx": 65, "bbox": [71, 175.14169311523438, 532.9402465820312, 202.05886840820312], "page_size": [612.0, 792.0]}
{"layout": 428, "type": "text", "text": "In addition, in the case of quasi-pharmaceutical products or cosmetics specified in Cabinet orders,  the methods used to control the manufacturing process and quality of the product at the  manufacturing facility must comply with the standards specified by MHLW Ordinance.    ", "page_idx": 65, "bbox": [71, 216.18173217773438, 542, 256.7188415527344], "page_size": [612.0, 792.0]}
{"layout": 429, "type": "text", "text": "The Minister of MHLW has delegated the authority to issue marketing approvals of specified  quasi-pharmaceutical products to the prefecture governors.   ", "page_idx": 65, "bbox": [71, 270.8417053222656, 542, 297.75885009765625], "page_size": [612.0, 792.0]}
{"layout": 430, "type": "text", "text": "IV. Standards for Properties, Quality Criteria, and Performance, and Prohibition  of Sales  ", "text_level": 1, "page_idx": 65, "bbox": [71, 311, 518, 340], "page_size": [612.0, 792.0]}
{"layout": 431, "type": "text", "text": "The Pharmaceuticals and Medical Devices Act also states that, when necessary in order to prevent  a hazard to health and hygiene, the MHLW may establish standards for the properties, quality  criteria, and performance of quasi-pharmaceutical products or cosmetics,  after consulting with  the Pharmaceutical Affairs and Food Sanitation Council (PAFSC).  Based on this provision, the  MHLW has established the Standards for Cosmetics. The Standards for Cosmetics list  components that are prohibited for use in cosmetics or where only limited quantities may be  used.  Cosmetics that do not meet the Standards cannot be sold.   ", "page_idx": 65, "bbox": [71, 354.42132568359375, 542, 408.6988525390625], "page_size": [612.0, 792.0]}
{"layout": 432, "type": "text", "text": "", "page_idx": 66, "bbox": [71, 72.48171997070312, 542, 113.01882934570312], "page_size": [612.0, 792.0]}
{"layout": 433, "type": "text", "text": "In addition, the Pharmaceuticals and Medical Devices Act prohibits the sale of quasi- pharmaceutical products or cosmetics that \n\n ", "page_idx": 66, "bbox": [71, 127.14169311523438, 542, 154.05880737304688], "page_size": [612.0, 792.0]}
{"layout": 434, "type": "text", "text": "   are subject to approval and whose components or quantities, properties, qualities, or  performance are different from those approved; \n\n    are completely or partially unclean, putrid, or decomposing; \n\n    contain or have foreign substances attached to them; \n\n    are contaminated or suspected of containing pathogens or other disease agents; or \n\n    contain a coal-tar color other than the coal-tar color specified by MHLW ordinance for the  sole purpose of coloring.   ", "page_idx": 66, "bbox": [71, 167.76077270507812, 542, 289.9001770019531], "page_size": [612.0, 792.0]}
{"layout": 435, "type": "text", "text": "V.  Supervision and Adverse Event Reporting    ", "text_level": 1, "page_idx": 66, "bbox": [70, 304, 324, 319], "page_size": [612.0, 792.0]}
{"layout": 436, "type": "text", "text": "The Minister of MHLW or the prefectural governor may inspect marketing approval holders or  manufacturers  of  quasi-pharmaceutical  product  or  cosmetics  to  confirm  whether  Pharmaceuticals and Medical Devices Act regulations are being observed. The Minister or the  governor may require necessary reports or send an officer to the factory, office, or other place of  business to inspect the structure and equipment of the facility; its books and documents, among  other articles; or question employees and other concerned persons.  The Minister or the governor  may assign such inspections to the PMDA.    ", "page_idx": 66, "bbox": [71, 332.1017150878906, 542, 427.3588562011719], "page_size": [612.0, 792.0]}
{"layout": 437, "type": "text", "text": "If necessary to prevent the occurrence or spread of health and hygiene hazards caused by the use  of quasi-pharmaceutical products or cosmetics, the Minister may order marketing approval  holders, manufacturers, or dealers of such products to temporarily suspend selling or providing  them, or take other emergency measures to prevent the occurrence or spread of such hazards.   ", "page_idx": 66, "bbox": [71, 441.4817199707031, 542, 495.6988525390625], "page_size": [612.0, 792.0]}
{"layout": 438, "type": "text", "text": "When the holders of marketing approval for quasi-pharmaceutical products and cosmetics learn  of the occurrence or spread of health and hygiene hazards suspected to be caused by using their  products, they must dispose of, recall, discontinue selling, and provide information on such  products, and take other necessary measures for the prevention of the occurrence or spread of  these hazards.  In such cases, the Pharmaceuticals and Medical Devices Act obligates proprietors  of pharmacies, hospitals, or clinics; other dealers of quasi-pharmaceutical products or cosmetics;  and physicians, dentists, or other medical professionals to make efforts to cooperate in carrying  out the necessary measures.   ", "page_idx": 66, "bbox": [71, 509.8216857910156, 542, 550.4188232421875], "page_size": [612.0, 792.0]}
{"layout": 439, "type": "text", "text": "", "page_idx": 67, "bbox": [71, 72.48171997070312, 542, 140.37887573242188], "page_size": [612.0, 792.0]}
{"layout": 440, "type": "text", "text": "When the holders of marketing approval for quasi-pharmaceutical products or cosmetics learn of  the occurrence of any disease, disability, or death suspected to be caused by the side effects of  their products, or other matters concerning the efficacy and safety of the products, they must  report these issues to the MHLW.  The same reporting obligation is imposed on proprietors of  pharmacies, hospitals, or clinics, and on physicians, dentists, pharmacists, registered sales clerks,  and other medical professionals.  Reporting to the MHLW is also required with regard to recalls  of quasi-pharmaceutical products or cosmetics.    ", "page_idx": 67, "bbox": [71, 154.50173950195312, 542, 249.75881958007812], "page_size": [612.0, 792.0]}
{"layout": 441, "type": "text", "text": "The Minister of MHLW informs the PAFSC of the status of reports of the side effects and recalls  each fiscal year. When the Minister finds it necessary, and after consulting with the PAFSC, the  Minister may take necessary measures to prevent the occurrence or spread of health and hygiene  hazards caused by the use of quasi-pharmaceutical products or cosmetics.    ", "page_idx": 67, "bbox": [71, 263.8212585449219, 542, 318.0988464355469], "page_size": [612.0, 792.0]}
{"layout": 442, "type": "text", "text": "VI.  Labeling   ", "text_level": 1, "page_idx": 67, "bbox": [71, 332, 146, 346], "page_size": [612.0, 792.0]}
{"layout": 443, "type": "text", "text": "The Pharmaceuticals and Medical Devices Act requires that the package inserts, containers, or  capsules for quasi-pharmaceutical products and cosmetics must include information on the  proper dosage, administration, and other necessary care for use and handling.  This information  must be placed at a readily visible location and be precisely written in easily understandable  terms so that a general consumer or user of the product may easily read and understand it.  False  or misleading statements and unapproved statements of efficacy or performance are prohibited  on product labels.   ", "page_idx": 67, "bbox": [71, 360.30169677734375, 542, 455.558837890625], "page_size": [612.0, 792.0]}
{"layout": 444, "type": "text", "text": "The Pharmaceuticals and Medical Devices Act provides for additional labeling requirements  according to product type, as outlined below.  ", "page_idx": 67, "bbox": [71, 469.68170166015625, 542, 496.59881591796875], "page_size": [612.0, 792.0]}
{"layout": 445, "type": "text", "text": "A.    Quasi-Pharmaceutical Products   ", "page_idx": 68, "bbox": [71, 72.24172973632812, 248.86471557617188, 85.47885131835938], "page_size": [612.0, 792.0]}
{"layout": 446, "type": "text", "text": "Labels on quasi-pharmaceutical products must include the following: \n\n ", "page_idx": 68, "bbox": [71, 99.42166137695312, 412.2297058105469, 112.65878295898438], "page_size": [612.0, 792.0]}
{"layout": 447, "type": "text", "text": "   Name and address of the marketing approval holder \n\n    The words “quasi-pharmaceutical products” \n\n    Name of product (in cases where a nonproprietary name is available, then such  nonproprietary name) \n\n    Manufacturing number and code \n\n    The quantity of the contents in terms of weight, volume, number, etc. \n\n    Names of the active components for quasi-pharmaceutical products designated by the  MHLW (in cases where a nonproprietary name is available, then such nonproprietary name)  and the quantity of such components \n\n    For a quasi-pharmaceutical product containing components designated by the MHLW,  the  names of the components \n\n    For quasi-pharmaceutical products designated by the MHLW,  the expiry date \n\n    For quasi-pharmaceutical products subject to specific standards, information that is required  to be printed on the actual container or capsule by those standards \n\n    Other information specified by an MHLW ordinance 58   ", "page_idx": 68, "bbox": [71, 126.30032348632812, 542, 390.2795715332031], "page_size": [612.0, 792.0]}
{"layout": 448, "type": "text", "text": "The package inserts, container, or capsule should also include information about dosage,  administration, and other necessary care for the use and handling of the product.   ", "page_idx": 68, "bbox": [71, 404.4017028808594, 542, 431.31884765625], "page_size": [612.0, 792.0]}
{"layout": 449, "type": "text", "text": "B.   Cosmetics  ", "text_level": 1, "page_idx": 69, "bbox": [71, 71, 144, 85], "page_size": [612.0, 792.0]}
{"layout": 450, "type": "text", "text": "Cosmetics labels must indicate the following: \n\n ", "page_idx": 69, "bbox": [71, 99.42166137695312, 294.5876770019531, 112.65878295898438], "page_size": [612.0, 792.0]}
{"layout": 451, "type": "text", "text": "   Name or address of the marketing approval holder \n\n    Name of the product \n\n    The manufacturing number or manufacturing code \n\n    Names of all components if they are designated by the MHLW \n\n    The expiry date for cosmetics designated by the MHLW \n\n    Any additional information required for cosmetics that have standards specified in the  Cosmetics Standards \n\n    Other matters specified by MHLW Ordinance 60   ", "page_idx": 69, "bbox": [71, 126.30032348632812, 542.7960205078125, 269.1391906738281], "page_size": [612.0, 792.0]}
{"layout": 452, "type": "text", "text": "This information should be displayed on the actual container or wrapper for the cosmetics.   ", "page_idx": 69, "bbox": [71, 283.2012939453125, 518.8977661132812, 296.43841552734375], "page_size": [612.0, 792.0]}
{"layout": 453, "type": "text", "text": "Sweden  ", "text_level": 1, "page_idx": 70, "bbox": [274, 73, 337, 91], "page_size": [612.0, 792.0]}
{"layout": 454, "type": "text", "text": "Elin Hofverberg  Foreign Law Specialist ", "page_idx": 70, "bbox": [255.48028564453125, 98.58169555664062, 356.5161437988281, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 455, "type": "text", "text": "SUMMARY   Sweden, as a European Union (EU) member state, is bound by EU regulation of  cosmetics. In addition to the EU rules, Sweden has also adopted a ban on rinsable  cosmetics that contain added microplastics.    ", "page_idx": 70, "bbox": [71, 154.17813110351562, 542, 195.3829345703125], "page_size": [612.0, 792.0]}
{"layout": 456, "type": "text", "text": "I.   Applicable Law   ", "text_level": 1, "page_idx": 70, "bbox": [71, 225, 179, 240], "page_size": [612.0, 792.0]}
{"layout": 457, "type": "text", "text": "A.   European Union Legislation  ", "text_level": 1, "page_idx": 70, "bbox": [71, 256, 233, 269], "page_size": [612.0, 792.0]}
{"layout": 458, "type": "text", "text": "As a member of the European Union (EU), Sweden is bound by EU law on cosmetics (see EU  report),  specifically Regulation 1233/2009 on cosmetic products as well as Regulation 1907/2006  concerning the registration, evaluation, authorization, and restriction of chemicals (REACH  regulation).  The purpose of the EU regulation is to establish “rules to be complied with by any  cosmetic product made available on the market, in order to ensure the functioning of the internal  market and a high level of protection of human health.” 3  Although directly applicable under  Swedish law, the EU regulation has been transposed into Swedish law in Sweden’s own cosmetic  products regulation (Förordning om kosmetiska produkter).  The L ke me del s ver ket (Swedish  Medical Products Agency), as well as the local municipalities, are responsible for ensuring  compliance.  In accordance with Swedish law, the Swedish Medical Products Agency must aid  the local municipalities in their review of compliance.    ", "page_idx": 70, "bbox": [71, 277.9214782714844, 542, 427.8388366699219], "page_size": [612.0, 792.0]}
{"layout": 459, "type": "text", "text": "B.   National Labeling Requirements and Ban on Microplastics in Cosmetics  ", "text_level": 1, "page_idx": 70, "bbox": [71, 443, 453, 456], "page_size": [612.0, 792.0]}
{"layout": 460, "type": "text", "text": "Sweden imposes requirements in addition to the EU regulation, namely, that the cosmetic  products must be furnished with Swedish labels when sold to end-users in Sweden.    ", "page_idx": 70, "bbox": [71, 465.54193115234375, 542, 492.3988342285156], "page_size": [612.0, 792.0]}
{"layout": 461, "type": "text", "text": "Sweden in 2018 introduced a national ban on microplastics in cosmetic products.   The purpose  of the ban is to limit the amount of microplastics in seas and lakes.  Specifically, the ban forbids  marketing a cosmetic product for use on skin, hair, mucous membranes, or teeth that contains  plastic particles for a cleaning, exfoliating, or polishing effect and which is intended to be rinsed  off or spit out after use.   ", "page_idx": 71, "bbox": [71, 86.16171264648438, 542, 154.05886840820312], "page_size": [612.0, 792.0]}
{"layout": 462, "type": "text", "text": "The Swedish government also plans to work towards more general International Organization  for Standardization standards for microplastics,  as well as lobby the EU to adopt an EU-wide  ban on microplastics in cosmetics.     ", "page_idx": 71, "bbox": [71, 168.18173217773438, 542, 208.71884155273438], "page_size": [612.0, 792.0]}
{"layout": 463, "type": "text", "text": "C.   Regional (Municipal) Production Requirements  ", "text_level": 1, "page_idx": 71, "bbox": [70, 222, 331, 237], "page_size": [612.0, 792.0]}
{"layout": 464, "type": "text", "text": "In addition to the EU rules, under Swedish law, local municipalities in Sweden may adopt more  stringent rules pertaining to the environmental demands of production that take place in the  municipality.  Examples of local rules include requirements on how to store chemicals, sewage  issues, and waste management.     ", "page_idx": 71, "bbox": [71, 245.16189575195312, 542, 299.37884521484375], "page_size": [612.0, 792.0]}
{"layout": 465, "type": "text", "text": "D.   Rules on Cosmetic Waste  ", "text_level": 1, "page_idx": 71, "bbox": [71, 314, 218, 328], "page_size": [612.0, 792.0]}
{"layout": 466, "type": "text", "text": "The deposit of waste in general in Sweden is regulated by the Waste Regulation  (Av falls f r or d ning), and cosmetic waste is classed with wastes from the manufacture,  formulation, distribution and use of greases, lubricants, soaps, detergents, and disinfectants. As  such, it must be labeled with the code 07 06.  In an effort to ensure that its users deposit their  waste in a legal manner, cosmetics vendor Kicks has initiated a project whereby consumers may  return the used product to the store for final disposal by the retailer.    ", "page_idx": 71, "bbox": [71, 337.02154541015625, 542, 418.6588439941406], "page_size": [612.0, 792.0]}
{"layout": 467, "type": "text", "text": "II.   Registration of Cosmetic Facilities  ", "text_level": 1, "page_idx": 72, "bbox": [70, 87, 279, 102], "page_size": [612.0, 792.0]}
{"layout": 468, "type": "text", "text": "Registration of cosmetic facilities is regulated by EU law (see EU report). Under EU law, a  responsible person must be appointed who is tasked with ensuring compliance with EU  regulation.  In addition, the responsible person must submit product information to the EU-wide  Cosmetic Products Notification Portal.  There are currently 605 registered cosmetic facilities  (producers and importers) operating in Sweden.  Together, they produce or import a total of  17,347 products.    ", "page_idx": 72, "bbox": [71, 110.82174682617188, 542, 192.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 469, "type": "text", "text": "III.   Sanctions  ", "text_level": 1, "page_idx": 72, "bbox": [70, 206, 152, 221], "page_size": [612.0, 792.0]}
{"layout": 470, "type": "text", "text": "EU law requires that all member states implement national rules for sanctions as well as labeling  rules for products that are not prepackaged.  Sweden specifies sanctions in the 29th chapter of  its Environmental Code.  The pertinent sanctions are monetary fines or imprisonment,  as well  as a special environmental sanctions fine.   ", "page_idx": 72, "bbox": [71, 230.16171264648438, 542, 284.37884521484375], "page_size": [612.0, 792.0]}
{"layout": 471, "type": "text", "text": "IV.   Cosmetic Labeling  ", "text_level": 1, "page_idx": 72, "bbox": [70, 299, 201, 314], "page_size": [612.0, 792.0]}
{"layout": 472, "type": "text", "text": "Sweden requires that all labels comply with EU regulation and, in addition, that any product that  is sold to end-users in Sweden include labels written in Swedish.   ", "page_idx": 72, "bbox": [71, 323.34173583984375, 542, 350.25885009765625], "page_size": [612.0, 792.0]}
{"layout": 473, "type": "text", "text": "V.    Adverse Event Reporting  ", "text_level": 1, "page_idx": 72, "bbox": [70, 364, 234, 379], "page_size": [612.0, 792.0]}
{"layout": 474, "type": "text", "text": "Sweden is bound by the EU’s regulation on the reporting of adverse events.  Reporting should  be made to the Medical Agency.  Although not legally required, the Agency recommends that  undesired or unintentional effects that are not adverse also be reported to the agency.  Forms for  reporting both adverse effects and unintended effects are published on the Medical Agency’s  website.  No statistics on the number of adverse effects reported in 2019 are available currently  on the agency’s website.   ", "page_idx": 72, "bbox": [71, 387.96173095703125, 542, 442.1784362792969], "page_size": [612.0, 792.0]}
{"layout": 475, "type": "text", "text": "", "page_idx": 73, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 476, "type": "text", "text": "VI.   Swedish Cosmetic Market  ", "text_level": 1, "page_idx": 73, "bbox": [71, 113, 241, 128], "page_size": [612.0, 792.0]}
{"layout": 477, "type": "text", "text": "Cosmetics is not a top-ten export product in Sweden.  Reportedly, Sweden imported cosmetics  worth  $\\S403.4$   million in 2018.  For retail sales, H&M was the highest-grossing seller of cosmetics  and similar products in Sweden.  Export numbers for cosmetic products produced in Sweden  are not readily available.   ", "page_idx": 73, "bbox": [71, 137.22171020507812, 542, 191.43838500976562], "page_size": [612.0, 792.0]}
{"layout": 478, "type": "text", "text": "Turkey  ", "text_level": 1, "page_idx": 74, "bbox": [277, 73, 334, 92], "page_size": [612.0, 792.0]}
{"layout": 479, "type": "text", "text": "Kayahan Cantekin  Foreign Law Specialist ", "page_idx": 74, "bbox": [255.48025512695312, 98.58169555664062, 356.51611328125, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 480, "type": "text", "text": "SUMMARY   The Turkish regulatory framework applicable to cosmetics is largely harmonized with  European Union law. The Cosmetics Regulation of 2005 is the main legislation of the  Turkish cosmetics framework. The Regulation requires the registration of cosmetic  products in the Product Tracking System (Ürun Takip Sistemi,   or   ÜTS) before they are  put on the Turkish market. The information submitted to the ÜTS includes the  formulation, ingredients including nanomaterials, and known undesirable effects of the  cosmetic product. A safety assessment must be made and a safety report must be  prepared before the product is made available. Furthermore, a “responsible technical  employee” must be appointed for each cosmetic product. This person is responsible for  ensuring the product’s compliance with the regulatory framework.  ", "page_idx": 74, "bbox": [72, 156.63809204101562, 542, 289.2222595214844], "page_size": [612.0, 792.0]}
{"layout": 481, "type": "text", "text": "The Turkish Medicines and Medical Devices Agency is authorized to update the  prohibited and limited substances list contained in the annexes of the Cosmetics  Regulation in line with developments in EU law and the state of the art in the relevant  sciences. The Agency and the ÜTS use the European Commission’s database for  cosmetic substances and ingredients, and makes use of the EU’s nomenclature and  numbering system.   ", "page_idx": 74, "bbox": [137, 302.6636657714844, 542, 380.54180908203125], "page_size": [612.0, 792.0]}
{"layout": 482, "type": "text", "text": "Manufacturers of cosmetics products must notify the Agency of all foreseeable  undesirable effects and serious undesirable effects that may occur from the use of the  products. The manufacturer must notify the Agency when a serious undesirable effect  occurs. The Agency is authorized to conduct safety reviews and in-market monitoring  for all cosmetic products, and may order the prohibition, recall, or destruction of  cosmetic products if it discovers that a product is unsafe for general health. The Agency  must notify the European Commission if it takes precautionary measures.  ", "page_idx": 74, "bbox": [137, 393.98321533203125, 542, 484.94122314453125], "page_size": [612.0, 792.0]}
{"layout": 483, "type": "text", "text": "Manufacturers of cosmetics must comply with good manufacturing practices (GMP).  The Agency has published harmonized GMP standards.  ", "page_idx": 74, "bbox": [137, 498.38262939453125, 542, 524.06103515625], "page_size": [612.0, 792.0]}
{"layout": 484, "type": "text", "text": "There are no special provisions for small and medium-sized enterprises.  ", "page_idx": 74, "bbox": [137, 537.5025024414062, 475.1916809082031, 550.1609497070312], "page_size": [612.0, 792.0]}
{"layout": 485, "type": "text", "text": "I.  Overview  ", "text_level": 1, "page_idx": 74, "bbox": [71, 577, 139, 592], "page_size": [612.0, 792.0]}
{"layout": 486, "type": "text", "text": "In Turkish law, rules regarding the safety, quality, and production standards applicable to  cosmetic products made available on the Turkish market and their registration, labeling,  monitoring, and inspection are provided in the legal framework set by Cosmetics Law No. 5324; 1 the Cosmetics Regulation of 2005, which is based on Law No. 5324; 2  and the Guidelines published  by the Turkish Medicines and Medical Devices Agency. The Turkish framework is largely  harmonized with the European Union regulatory framework for cosmetic products.  ", "page_idx": 74, "bbox": [72, 607.3817749023438, 542, 647.9788208007812], "page_size": [612.0, 792.0]}
{"layout": 487, "type": "text", "text": "", "page_idx": 75, "bbox": [71, 72.48171997070312, 542, 113.01840209960938], "page_size": [612.0, 792.0]}
{"layout": 488, "type": "text", "text": "II.  Legal Framework  ", "text_level": 1, "page_idx": 75, "bbox": [71, 127, 187, 141], "page_size": [612.0, 792.0]}
{"layout": 489, "type": "text", "text": "A.  Turkish Framework’s Relationship with the EU Framework  ", "text_level": 1, "page_idx": 75, "bbox": [71, 156, 388, 169], "page_size": [612.0, 792.0]}
{"layout": 490, "type": "text", "text": "The Cosmetics Regulation of 2005 is the main legislation of the Turkish cosmetics framework. The  Cosmetics Regulation was prepared in parallel to the European Union acquis on the regulation  of cosmetics, and in particular, with reference to Directive 76/768/EEC 3  and Commission  Decision 96/335/EC,  with a view to harmonizing Turkish law with European Union law in the  area of cosmetics.  ", "page_idx": 75, "bbox": [71, 183.48165893554688, 542, 251.37881469726562], "page_size": [612.0, 792.0]}
{"layout": 491, "type": "text", "text": "The Turkish framework is designed to be interoperable with the EU system and to facilitate the  movement of cosmetic products within the EU-Turkey customs union. The Cosmetics Regulation  authorizes the Turkish Medicines and Medical Devices Agency to update the prohibited or  limited substances lists provided in the Regulation in line with developments in EU law and the  state of the art in the relevant sciences.  Furthermore, the Turkish cosmetics registry system uses  the European Commission’s database for cosmetic substances and ingredients, known as CosIng,  and the Agency is charged with notifying the European Commission of cases where it has taken  measures against a cosmetic product made available on the Turkish market upon the discovery  that it poses a health hazard to humans.   ", "page_idx": 75, "bbox": [71, 265.5016784667969, 542, 388.058837890625], "page_size": [612.0, 792.0]}
{"layout": 492, "type": "text", "text": "In 2009, the EU framework for cosmetics was revised by the adoption of Regulation  1223/2009/EC, which replaced Directive 76/768/EEC.  The Cosmetics Regulation was amended  in 2015 to reflect in Turkish law the changes to the EU’s regulatory framework.   ", "page_idx": 75, "bbox": [71, 402.18170166015625, 542, 442.7188415527344], "page_size": [612.0, 792.0]}
{"layout": 493, "type": "text", "text": "The Cosmetics Regulation and the framework it establishes is applicable to “cosmetic products,”  defined in the same terms as in article 1(1) of Directive 76/768/EEC,  as  ", "page_idx": 75, "bbox": [71, 456.8417053222656, 542, 483.75885009765625], "page_size": [612.0, 792.0]}
{"layout": 494, "type": "text", "text": "any substance or mixture intended to be placed in contact with the external parts of the  human body (epidermis, hair system, nails, lips and external genital organs) or with the  teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to  cleaning them, perfuming them, changing their appearance, protecting them, keeping  them in good condition or correcting body odours.   ", "page_idx": 76, "bbox": [108, 86.02816772460938, 506, 147.78793334960938], "page_size": [612.0, 792.0]}
{"layout": 495, "type": "text", "text": "The revisions made in 2009 introduced the concept of “responsible person” into the EU  framework, which requires the appointment of a single entity responsible for ensuring  compliance of a cosmetic product with the provisions of Regulation 1223/2009/EC .  The  responsible person concept is not entirely integrated into the Turkish framework, and  consequently the Cosmetics Regulation refers to the “manufacturer” as the responsible party for  many of the obligations that it creates.  Article 4(r) of the Cosmetics Regulation defines the term  “manufacturer”’ of cosmetic products as the natural or legal person who (i) manufactures,  produces, or improves a cosmetic product; (ii) presents itself as the manufacturer by way of  affixing its trade name, brand name, or trademark on the product; (iii) where the manufacturer is  in a foreign country, is the manufacturer’s authorized representative and/or importer; and/or  (iv) is an actor located within the supply chain whose activity effects the safety of the product.  ", "page_idx": 76, "bbox": [71, 160.68173217773438, 542, 310.6587829589844], "page_size": [612.0, 792.0]}
{"layout": 496, "type": "text", "text": "B.  Notification of Cosmetic Products  ", "text_level": 1, "page_idx": 76, "bbox": [71, 323, 258, 337], "page_size": [612.0, 792.0]}
{"layout": 497, "type": "text", "text": "The Cosmetics Regulation requires notification to the Ministry of Health before any cosmetic  product is made available on the market for the first time and designates the Turkish Medicines  and Medical Devices Agency as the responsible body for the administration of the  notification system.    ", "page_idx": 76, "bbox": [71, 351.2401428222656, 542, 405.51885986328125], "page_size": [612.0, 792.0]}
{"layout": 498, "type": "text", "text": "1. Registration in the ÜTS  ", "text_level": 1, "page_idx": 76, "bbox": [71, 419, 191, 432], "page_size": [612.0, 792.0]}
{"layout": 499, "type": "text", "text": "In the EU, the European Commission has set up the Cosmetic Products Notification Portal  (CPNP), which is an EU-wide online notification system. Entities intending to place a cosmetics  product on the EU single market may submit the necessary information to the CPNP and place  the product on the European market without having to make any additional notification at the  level of the individual EU Member States.  Because Turkey is not an EU Member State and does  not participate in the CPNP, it has set up its own national notification portal, the Product Tracking  System ( Ü run Takip Sistemi,   or   Ü TS) .  The  Ü TS has the additional feature of incorporating a  “track-and-trace” system, whereby the cosmetic product is tracked from the point of manufacture  or importation to the final sale to the end user via the registration of each transaction involving  the cosmetic product into the system by scanning the barcode on the product.     ", "page_idx": 76, "bbox": [71, 446.5207824707031, 542, 555.4584350585938], "page_size": [612.0, 792.0]}
{"layout": 500, "type": "text", "text": "", "page_idx": 77, "bbox": [71, 72.48171997070312, 542, 99.39883422851562], "page_size": [612.0, 792.0]}
{"layout": 501, "type": "text", "text": "Manufacturers wishing to place a cosmetic product on the market for the first time are required  to submit to the  Ü TS database the following information: \n\n ", "page_idx": 77, "bbox": [71, 113.46127319335938, 542, 140.37838745117188], "page_size": [612.0, 792.0]}
{"layout": 502, "type": "text", "text": "   The chemical formulation of the product including the chemical components  and concentrations \n\n    Trade name and brand name of the product \n\n    Barcode number of the product \n\n    Nominal volume of the product \n\n    Description of the function of the product \n\n    The function code of the product as listed in Annex IX of the Cosmetics Regulation  \n\n    The production facility in which the product was produced \n\n    Information pertaining to the nanomaterials that the product contains,  if the product  contains nanomaterials other than those used as colorants, UV filters, or preservatives, which  are separately regulated under article 7 of the Cosmetics Regulation \n\n    Additional information to be notified to the National Poison Consultation Center if the  product contains substances that require special responses \n\n ", "page_idx": 77, "bbox": [71, 154.08035278320312, 542, 384.2192077636719], "page_size": [612.0, 792.0]}
{"layout": 503, "type": "text", "text": "2. Appointment of a Responsible Technical Employee  ", "page_idx": 77, "bbox": [71, 397.9226379394531, 309.0643310546875, 411.1597595214844], "page_size": [612.0, 792.0]}
{"layout": 504, "type": "text", "text": "The manufacturer or importer registering a product must appoint a “responsible technical  employee” for the product and submit this person’s contact information to the ÜTS. The  responsible technical employee is responsible for ensuring that the product complies with the  requirements set forth in the cosmetics framework.   ", "page_idx": 77, "bbox": [71, 425.22222900390625, 542, 479.49932861328125], "page_size": [612.0, 792.0]}
{"layout": 505, "type": "text", "text": "C.  Safety Review and In-market Monitoring  ", "text_level": 1, "page_idx": 78, "bbox": [70, 72, 298, 86], "page_size": [612.0, 792.0]}
{"layout": 506, "type": "text", "text": "Before placing a cosmetic product on the market, the manufacturer of the product must subject it  to a safety assessment and have a safety report prepared.  The safety report must be updated if  necessary, and kept in the “product information file,” which is outlined below. The safety  assessment must be conducted by a person with a pharmacology diploma, or a person who has  a diploma in medicine, dentistry, biology, biochemistry, or a similar discipline and has completed  a practical course in toxicology or cosmetic product safety.  The “cosmetic product safety report”  must be prepared according to the instructions provided in Annex I/B of the Cosmetics  Regulation, which is identical to the instructions provided in Annex I of Regulation  1223/2009/EC.   ", "page_idx": 78, "bbox": [71, 99.00222778320312, 542, 221.55886840820312], "page_size": [612.0, 792.0]}
{"layout": 507, "type": "text", "text": "The Cosmetics Regulation authorizes the Agency to conduct in-market controls of cosmetic  products placed on the market. Within three days of the Agency’s request, manufacturers must  make available to the Agency at the address indicated on the label the product information file of  any product they have placed on the market.  For each cosmetic product put on the market, the  manufacturer must put together a product information file, which must be retained for ten years  and include the following information: \n\n ", "page_idx": 78, "bbox": [71, 235.68173217773438, 542, 317.2584228515625], "page_size": [612.0, 792.0]}
{"layout": 508, "type": "text", "text": "   the qualitative and quantitative information describing the product, \n\n    Physico-chemical and microbiological specifications of the basic materials and end product,  and control criteria for the determination of compliance with said specifications, \n\n    a description of the method of manufacturing in compliance with good manufacturing  practices, a statement of such compliance, and education and employment documents  indicating that the manufacturer has sufficient professional qualifications and experience, \n\n    the cosmetic product safety report, \n\n    available data regarding undesirable effects and serious undesirable effects to human health  that may occur as a result of use of the product, and \n\n    data on any animal testing performed relating to the development or safety assessment of the  cosmetic product or its ingredients, including any animal testing performed to meet the  legislative or regulatory requirements of non-EU countries.   ", "page_idx": 78, "bbox": [71, 330.9604187011719, 542, 527.919677734375], "page_size": [612.0, 792.0]}
{"layout": 509, "type": "text", "text": "The Agency is authorized to take any measure necessary to withdraw from the market, recall, or  prevent access to products where a product that complies with the framework is nevertheless  discovered to pose a serious risk to human health.  If the Agency finds that a product is unsafe  for public health upon conducting a safety review or in-market product control, it may order one  or more of the following measures: \n\n ", "page_idx": 78, "bbox": [71, 542.0416870117188, 542, 568.9588012695312], "page_size": [612.0, 792.0]}
{"layout": 510, "type": "text", "text": "", "page_idx": 79, "bbox": [71, 72.48171997070312, 542, 113.01840209960938], "page_size": [612.0, 792.0]}
{"layout": 511, "type": "text", "text": "   prohibiting the product from being placed on the market \n\n    recall of the product,  \n\n    partial or total destruction of the product in cases where the product cannot be rendered safe,  and/or \n\n    notification of the public regarding the safety hazard.    ", "page_idx": 79, "bbox": [71, 126.72036743164062, 542, 215.01937866210938], "page_size": [612.0, 792.0]}
{"layout": 512, "type": "text", "text": "If any of these measures is taken, the Agency must notify the European Commission (via the  Ministry of Economy), providing the Commission with its justifications and evidence regarding  the case, and implement necessary revisions to the framework in accordance with the  consultations made with the Commission.  The manufacturer is responsible for the expenses  associated with the measures.   ", "page_idx": 79, "bbox": [71, 229.14169311523438, 542, 297.0388488769531], "page_size": [612.0, 792.0]}
{"layout": 513, "type": "text", "text": "D.  Communication   of Adverse Effects   ", "text_level": 1, "page_idx": 79, "bbox": [71, 310, 266, 324], "page_size": [612.0, 792.0]}
{"layout": 514, "type": "text", "text": "Under both Turkish and EU law, adverse effects of cosmetic products are referred to as either  “undesirable effects” or “serious undesirable effects.”   ", "page_idx": 79, "bbox": [71, 337.26007080078125, 542, 364.17718505859375], "page_size": [612.0, 792.0]}
{"layout": 515, "type": "text", "text": "According to article 14(4) of the Cosmetics Regulation,  manufacturers of cosmetic products  must immediately communicate the following information to the Agency in the event of a serious  adverse effect:  \n\n ", "page_idx": 79, "bbox": [71, 378.300048828125, 542, 418.83843994140625], "page_size": [612.0, 792.0]}
{"layout": 516, "type": "text", "text": "   all serious undesirable effects which are known to the manufacturer or which may reasonably be  expected to be known to it; \n\n    the name of the cosmetic product concerned, enabling its specific identification; \n\n    the corrective measures taken by the manufacturer, if any.  ", "page_idx": 79, "bbox": [71, 432.4836120605469, 542, 498.0833740234375], "page_size": [612.0, 792.0]}
{"layout": 517, "type": "text", "text": "The manufacturer of the cosmetic product must set up and operate a cosme to vigilance system,  preparing and keeping updated cosme to vigilance procedures that it will employ to monitor and  evaluate all suspicious undesirable effects that are reported to it.   ", "page_idx": 79, "bbox": [71, 512.2217407226562, 542, 552.81884765625], "page_size": [612.0, 792.0]}
{"layout": 518, "type": "text", "text": "E.  Labeling Rules  ", "text_level": 1, "page_idx": 80, "bbox": [71, 72, 165, 86], "page_size": [612.0, 792.0]}
{"layout": 519, "type": "text", "text": "Article 10 of the Cosmetics Regulation provides the information that must be included on the  label, container, or external packaging of the cosmetic product, and the form in which this  information must be placed. These requirements are fully harmonized with European Regulation  1223/2009/EC.   ", "page_idx": 80, "bbox": [71, 99.42166137695312, 542, 153.63882446289062], "page_size": [612.0, 792.0]}
{"layout": 520, "type": "text", "text": "F.  Good Manufacturing Practices  ", "text_level": 1, "page_idx": 80, "bbox": [70, 167, 241, 181], "page_size": [612.0, 792.0]}
{"layout": 521, "type": "text", "text": "Manufacturers of cosmetic products must take the necessary measures to ensure that only  products that comply with the Regulation and its annexes are made available on the market,   and must run their production operation in conformity with the Good Manufacturing Practices  (GMP) Guidelines, which were issued by the Agency.  The Guidelines “[harmonize]  international GMP standards” 31  and appear to be used by the Agency in performing reviews  and monitoring.  The person designated by the manufacturer as the responsible technical  employee must ensure that the cosmetic product for which he or she is registered is produced in  compliance with good manufacturing practices.   ", "page_idx": 80, "bbox": [71, 194.70114135742188, 542, 303.578857421875], "page_size": [612.0, 792.0]}
{"layout": 522, "type": "text", "text": "The Turkish Standards Institution provides the TS EN ISO 22716 “Cosmetics GMP” certification  based on the ISO 22716 standard. However this certification is not listed as a prerequisite for  producing cosmetic products within the regulatory framework.   ", "page_idx": 80, "bbox": [71, 317.70172119140625, 542, 358.298828125], "page_size": [612.0, 792.0]}
{"layout": 523, "type": "text", "text": "G.  Treatment of Small and Medium-Sized Enterprises   ", "text_level": 1, "page_idx": 80, "bbox": [71, 371, 347, 385], "page_size": [612.0, 792.0]}
{"layout": 524, "type": "text", "text": "The Turkish cosmetics framework does not have special provisions regarding obligations of small  and medium-sized enterprises (SMEs).  ", "page_idx": 80, "bbox": [71, 398.88018798828125, 542, 425.79730224609375], "page_size": [612.0, 792.0]}
{"layout": 525, "type": "text", "text": "H.  Export to the United States  ", "text_level": 1, "page_idx": 80, "bbox": [71, 438, 226, 452], "page_size": [612.0, 792.0]}
{"layout": 526, "type": "text", "text": "The Turkish cosmetics framework does not have special provisions regarding cosmetic products  manufactured for the purpose of export. However, the Agency appears to follow the European  Commission in technical matters. Details of EU-US technical cooperation in the field of cosmetics  regulation are provided in the EU survey in this report.  ", "page_idx": 80, "bbox": [71, 466.4390563964844, 542, 520.65576171875], "page_size": [612.0, 792.0]}
{"layout": 527, "type": "text", "text": "United Kingdom  ", "text_level": 1, "page_idx": 81, "bbox": [240, 72, 372, 93], "page_size": [612.0, 792.0]}
{"layout": 528, "type": "text", "text": "Clare Feikert-Ahalt  Senior Foreign Law Specialist  ", "page_idx": 81, "bbox": [239.75982666015625, 98.58169555664062, 374.9521789550781, 125.07827758789062], "page_size": [612.0, 792.0]}
{"layout": 529, "type": "text", "text": "SUMMARY   Although the United Kingdom (UK) left the European Union (EU) on January 31, 2020,  it created a new body of domestic law, known as retained EU law, by transposing all  EU law that applied to the UK immediately before its exit. As a result, cosmetics in the  UK continue to be governed by the EU Regulation on Cosmetic Products. The UK has  acted to implement additional labeling requirements for cosmetics sold without  packaging to ensure that these meet the standards contained in the Regulation. It has  also acted to prohibit the manufacture and supply of certain cosmetic products  containing microbeads.     ", "page_idx": 81, "bbox": [71, 151.65811157226562, 542, 258.1424560546875], "page_size": [612.0, 792.0]}
{"layout": 530, "type": "text", "text": "I.  Introduction  ", "text_level": 1, "page_idx": 81, "bbox": [71, 286, 157, 301], "page_size": [612.0, 792.0]}
{"layout": 531, "type": "text", "text": "Cosmetic products in the United Kingdom (UK) are primarily regulated by the 2009 European  Union (EU) Regulation on Cosmetic Products.  Although the UK left the EU on January 31, 2020,  the EU (Withdrawal) Act 2018 created a new type of law, known as “retained EU law” by  transposing EU law that applied in the UK immediately before the day of exit into a new body of  domestic law to provide legal certainty after the UK's exit.  As a result of this law, the Regulation  continues to apply in the UK in the same way as in member states of the European Union.  ", "page_idx": 81, "bbox": [71, 315.3617248535156, 542, 396.9388427734375], "page_size": [612.0, 792.0]}
{"layout": 532, "type": "text", "text": "The Regulation provides that it is an offense to supply cosmetic products that may cause damage  to human health or cosmetic products that contain restricted or prohibited substances. The term  “cosmetic product” is defined in Article 2 of the Regulation as:  ", "page_idx": 81, "bbox": [71, 411.06170654296875, 542, 451.5984191894531], "page_size": [612.0, 792.0]}
{"layout": 533, "type": "text", "text": "any substance or mixture intended to be placed in contact with the external parts of the  human body (epidermis, hair system, nails, lips and external genital organs) or with the  teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to  cleaning them, perfuming them, changing their appearance, protecting them, keeping  them in good condition or correcting body odours.   ", "page_idx": 81, "bbox": [108, 465.588134765625, 506, 527.347900390625], "page_size": [612.0, 792.0]}
{"layout": 534, "type": "text", "text": "II.  Registration of Cosmetic Facilities  ", "text_level": 1, "page_idx": 81, "bbox": [71, 542, 278, 557], "page_size": [612.0, 792.0]}
{"layout": 535, "type": "text", "text": "Registration of cosmetic facilities is governed by the Regulation as part of the UK’s retained EU  law. For further details, please see the EU report.    ", "page_idx": 81, "bbox": [71, 570.9017333984375, 542, 597.81884765625], "page_size": [612.0, 792.0]}
{"layout": 536, "type": "text", "text": "III.  Safety Review   ", "text_level": 1, "page_idx": 82, "bbox": [70, 72, 175, 87], "page_size": [612.0, 792.0]}
{"layout": 537, "type": "text", "text": "The required safety assessment of cosmetic products in the UK continues to be governed by the  Regulation as part of the UK’s retained EU law. For further details, please see the EU report.   ", "page_idx": 82, "bbox": [71, 102.60171508789062, 542, 129.51882934570312], "page_size": [612.0, 792.0]}
{"layout": 538, "type": "text", "text": "IV.  Adverse Event Reporting  ", "text_level": 1, "page_idx": 82, "bbox": [70, 143, 235, 158], "page_size": [612.0, 792.0]}
{"layout": 539, "type": "text", "text": "The Regulation governs how adverse events involving cosmetics must be reported. The  competent authority across the UK is the Secretary of State. The enforcement authorities in  England, Wales, and Scotland are Trading Standards, and in Northern Ireland, the enforcement  authority is any district council.     ", "page_idx": 82, "bbox": [71, 170.94168090820312, 542, 225.15884399414062], "page_size": [612.0, 792.0]}
{"layout": 540, "type": "text", "text": "V.  Cosmetics Labeling  ", "text_level": 1, "page_idx": 82, "bbox": [71, 239, 201, 254], "page_size": [612.0, 792.0]}
{"layout": 541, "type": "text", "text": "If a cosmetic product is not prepackaged or is packaged at the point of sale upon the purchaser’s  request, the label information required by the Regulation’s article 19(1) must be placed on the  container, or within the immediate proximity of the container.  Cosmetic products that are  prepackaged for immediate sale must also include this information, either on a label, tape, or tag  attached to the package or on a card or an enclosed leaflet. In cases where there are practical  reasons making it impossible to provide the information in this manner, it must be on a notice  immediately next to the container where the cosmetic product is available for purchase.   ", "page_idx": 82, "bbox": [71, 268.2017517089844, 542, 363.4588317871094], "page_size": [612.0, 792.0]}
{"layout": 542, "type": "text", "text": "VI.  Good Manufacturing Practices  ", "text_level": 1, "page_idx": 82, "bbox": [71, 377, 263, 393], "page_size": [612.0, 792.0]}
{"layout": 543, "type": "text", "text": "The UK follows the manufacturing practices set out in the Regulation. In 2017, regulations were  introduced in England banning the use of microplastics (also referred to as microbeads) in the  manufacture of rinse-off personal care products along with the supply of such products  containing microplastics.  Scotland, Wales, and Northern Ireland introduced similar regulations  in 2018 and 2019.  A rinse-off personal care product is defined as  ", "page_idx": 82, "bbox": [71, 407.28173828125, 542, 475.2388610839844], "page_size": [612.0, 792.0]}
{"layout": 544, "type": "text", "text": "any substance, or mixture of substances, manufactured for the purpose of being applied to  any relevant human body part in the course of any personal care treatment, by an  application which entails at its completion the prompt and specific removal of the product  (or any residue of the product) by washing or rinsing with water, rather than leaving it to  wear off or wash off, or be absorbed or shed, in the course of time . . . .   ", "page_idx": 82, "bbox": [107, 489.2281494140625, 506, 550.9879150390625], "page_size": [612.0, 792.0]}
{"layout": 545, "type": "text", "text": "Civil sanctions may be used for offenses that occur in England and Wales. Monetary penalties  may be imposed and the amount is determined by the regulator (local authority) but may not  exceed  $10\\%$   of the annual turnover of the business in England,  or  $10\\%$   of the annual turnover or  £20,000 (approximately   $\\mathrm{US}\\Phi26{,}000)$  , whichever is the lesser amount, in Wales.  In Northern  Ireland and Scotland, the use of microbeads in the manufacture of rinse-off products is a criminal  offense, punishable by a fine of up to £5,000 (approximately   $\\mathrm{US}\\Phi6{,}500)$  ), up to two years’  imprisonment, or both.  The regulator may also issue a compliance notice setting out specific  steps that must be taken to ensure the offense does not continue or reoccur. The regulations apply  to both small- and large-sized companies.    ", "page_idx": 83, "bbox": [71, 86.16171264648438, 542, 208.71884155273438], "page_size": [612.0, 792.0]}
{"layout": 546, "type": "text", "text": "VII.  Sanctions and Enforcement  ", "text_level": 1, "page_idx": 83, "bbox": [71, 224, 250, 238], "page_size": [612.0, 792.0]}
{"layout": 547, "type": "text", "text": "The Regulation on Cosmetic Products is enforced by the Trading Standards under the authority  provided in the Cosmetic Products Enforcement Regulations 2013,  which serves to “create  enforcement powers, offences and penalties within the United Kingdom, in relation to the EU  Regulation.” 15  The UK has provided additional protections in certain areas, including increasing  the maximum fine from £5,000 (approximately   $\\mathrm{US}\\S6{,}500)$  ) to £20,000 (approximately US\\$26,000)  for certain offenses and doubling the maximum term of imprisonment for serious offenses to 12  months to provide consistency with the same penalty levels contained in the UK’s General  Product Safety Regulations,  which cover other consumer goods.     ", "page_idx": 83, "bbox": [71, 253.02169799804688, 542, 362.2467041015625], "page_size": [612.0, 792.0]}
{"layout": 548, "type": "text", "text": "VIII.  Cosmetics Exports into the U.S.  ", "text_level": 1, "page_idx": 84, "bbox": [71, 73, 276, 87], "page_size": [612.0, 792.0]}
{"layout": 549, "type": "text", "text": "Statistics indicate the UK is among the leading countries for exports of cosmetics into the  United States.     ", "page_idx": 84, "bbox": [72, 101.40170288085938, 542.8124389648438, 128.31881713867188], "page_size": [612.0, 792.0]}
